Marquette University

e-Publications@Marquette
Dissertations (2009 -)

Dissertations, Theses, and Professional Projects

Importance of S. Cerevisiae Rcf1 and Rcf2 Proteins
for the Mitochondrial Protonmotive Force
Generation
Vera Strogolova
Marquette University

Recommended Citation
Strogolova, Vera, "Importance of S. Cerevisiae Rcf1 and Rcf2 Proteins for the Mitochondrial Protonmotive Force Generation" (2018).
Dissertations (2009 -). 843.
https://epublications.marquette.edu/dissertations_mu/843

IMPORTANCE OF S. CEREVISIAE RCF1 AND RCF2 PROTEINS FOR
THE MITOCHONDRIAL PROTONMOTIVE FORCE GENERATION

by
Vera Strogolova, B.S., M.S.

A dissertation submitted to the Faculty of the Graduate School,
Marquette University,
in Partial Fulfillment of the Requirements for
the Degree of Doctor of Philosophy

Milwaukee, Wisconsin
December 2018

ABSTRACT
IMPORTANCE OF S. CEREVISIAE RCF1 AND RCF2 PROTEINS FOR
THE MITOCHONDRIAL PROTONMOTIVE FORCE GENERATION

Vera Strogolova, B.S., M.S.
Marquette University, 2018

Mitochondria are the site of oxidative phosphorylation (OXPHOS)
pathway, which can supply majority of energy in a eukaryotic cell. OXPHOS
enzyme activities generate electrochemical gradient known as mitochondrial
protonmotive force (PMF). PMF coordinates OXPHOS enzyme activities and
supports essential cell survival functions such as transport of proteins and
metabolites in and out of mitochondria. PMF is maintained despite variations in
cellular energy demand and oxygen availability.
Mitochondrial proteins belonging to the conserved hypoxia induced gene
domain (HIGD) family improve cell survival during the hypoxic and hypoglycemic
stress. Their molecular function is not fully understood but they seem to act
through regulating OXPHOS enzyme cytochrome c oxidase (complex IV).
Complex IV activity is important for PMF generation.
Using yeast as a model organism, this study addresses function of HIGD
proteins Rcf1 and Rcf2. The data presented here indicate that Rcf1 and Rcf2
support complex IV PMF generation and/or prevent proton leak across the inner
membrane of the mitochondria. Deletion of Rcf1 (Δrcf1) causes lower complex IV
steady state levels and electron transfer activity. Deletion of Rcf2 in Δrcf1 strain
(Δrcf1;Δrcf2) does not further decrease complex IV steady state levels and
electron transfer activity, yet strongly impairs respiratory growth. Analyses of
single mutant strains Δrcf1 and Δrcf2 indicated that deletion of Rcf1 or Rcf2
lowers OXPHOS efficiency and decreases PMF. These defects become more
severe when both Rcf1 and Rcf2 are deleted. The inability to maintain PMF and
PMF-dependent functions is proposed to underlie the strong respiratory growth
deficiency of Δrcf1;Δrcf2 mutant. In addition to this new role of Rcf1 and Rcf2 in
PMF maintenance, several pleiotropic phenotypes of Δrcf1;Δrcf2 mutant – such
as decreased ATP synthase levels, abnormal mitochondrial morphology –
suggest that these proteins may have wider impact on OXPHOS function.
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CHAPTER 1. INTRODUCTION

1.1. Overview

Eukaryotic cells contain energy-generating organelles, mitochondria.
Mitochondria perform many functions in the cell, one of which is to synthesize the
energy molecule adenosine triphosphate (ATP). The extensive cable-like
mitochondrial network maintains electrochemical potential, called protonmotive
force (PMF), across an energy storing mitochondrial membrane. In a process
called oxidative phosphorylation (OXPHOS) mitochondrial PMF transduces
energy from (couples) the electron transport (oxidation) reactions to the synthesis
of ATP. PMF is generated by membrane-embedded proton-transporting
oxidoreductases. The terminal electron transport enzyme cytochrome c oxidase
(CcO, also called complex IV) is central to regulation of electron and proton
transport. Proton pumping function of complex IV provides the mechanism for its
feedback regulation by PMF and maintaining optimal PMF (Hosler et al., 2006).
Mitochondrial proteins belonging to a conserved hypoxia-induced gene 1
domain (HIGD) protein family are proposed to regulate complex IV conformation,
stability, and electron transport activity in response to environmental changes
such as low oxygen. The mechanism of this regulation is currently unknown. This
dissertation characterizes function of yeast HIGD proteins, Rcf1 and Rcf2, and
their relationship to regulating the complex IV enzyme. Findings presented in this
dissertation indicate that these proteins support not only the electron transport
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function, but also proton transport function of complex IV. The absence of Rcf1
and Rcf2 causes mitochondrial defects consistent with PMF maintenance defect.
This defect is observed in the absence of only Rcf2, which does not decrease
complex IV levels or electron transport. A model for Rcf1 and Rcf2 supporting
PMF generation by complex IV is proposed. Additionally, Rcf1 and Rcf2 may
support stability and activity of other OXPHOS enzymes.

1.2. Mitochondrial structure

The double membrane structure of mitochondria is vestige of their
bacterial origin, as the endosymbiosis theory states that mitochondria originated
from proteobacterial symbionts of a eukaryotic progenitor (Martin et al., 2015). An
extensive mitochondrial inner membrane (IM) and a less extensive mitochondrial
outer membrane (OM) surround the inner compartment, mitochondrial matrix.
The portion of the IM that is directly adjacent / parallel to the OM is called inner
boundary membrane (IBM). Pocket-like IM folds, called cristae, extend from the
IBM into the matrix (a diagram of typical mitochondrial cross-section in Figure 1
illustrates these key features). Specialized ring-like structures - cristae junctions separate the area of the IM that form cristae from the IBM (van der Laan et al.,
2016; Harner et al., 2016; Hessenberger et al., 2017). The cristae IM contains
OXPHOS enzymes, which catalyze electron transport, proton transport, and ATP
synthesis reactions. The cristae structure is proposed to promote
compartmentalization of protons and increase PMF (Song et al., 2013).
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Outer membrane

Porins

Inner membrane

Intermembrane space

Cristae

Matrix

ATP synthase

Figure 1. Schematic representation of mitochondria. A typical mitochondrion contains
compartments with net positive and negative charges, represented by red and white color,
respectively, in the diagram. The shape of cristae is highly variable and the communication
between cristae and intermembrane space is sometimes restricted. Proton gradient in the cristae
is higher than in the intermembrane space. Many transmembrane and membrane-associated
protein complexes densely populating the inner and outer membrane are not shown, but their
distribution is represented by the distribution of ATP synthase (circles). Diagram adapted from
Nicholls and Ferguson, Bioenergetics, Academic Press, 4th Edition, 2013.
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The shapes of the cristae are dynamic and rearrange in response to different
respiration levels and PMF levels (Hackenbrock,1966; Cogliati et al., 2016).
Mitochondria are not synthesized de novo; their content in the cell,
maintained by balanced growth, fission and fusion, scales with the size of the cell
(Rafelski et al., 2012). Mitochondria form a reticular network in the cell which is
highly dynamic, continuously undergoing fusion and fission. Fission allows
separation and clearance of defective, depolarized mitochondria via process of
mitophagy, as well as division of the mitochondrial network during mitosis. The
PMF is an indicator of mitochondrial function and represents a regulating factor
of mitochondrial fusion, fission, and degradation. PMF positively regulates cristae
length (Khalifat et al., 2008), providing positive feedback for mitochondrial
biogenesis, morphology, and function.

1.3. Yeast as a model system

Eukaryotic cells can derive energy (ATP) from glycolysis and aerobic
respiration, which occur in cytosol and mitochondria, respectively. The balance of
glycolysis and respiration is determined by the supply of substrates and the need
of the cell. Yeast Saccharomyces cerevisiae are well suited to the study of
mitochondrial function, as its ability to respire is dispensable for survival.
Mitochondrial respiration gives yeast the ability to grow aerobically on nonfermentable carbon sources (e.g. glycerol, ethanol). Defects in respiration are
easily detected by slower or absent growth on non-fermentable substrates. Yeast
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growth on fermentable (e.g., glucose) carbon sources does not require
mitochondrial ATP production, allowing to propagate and study OXPHOS
mutations, such as petite mutants caused by loss of mitochondrial DNA. When
glucose is present, yeast rely only on glycolysis (fermentation) due to repression
of respiration by glucose (Carlson, 1999). However, yeast growing on other
fermentable sugars (e.g., galactose) utilize both glycolysis and respiration
pathways of energy production.
Importantly, mitochondrial genome, proteome, and function, especially
OXPHOS components, are remarkably conserved in yeast and mammalian
mitochondria. This, combined with simple genetic manipulation system in yeast,
resulted in the great utility of yeast as a model organism to understand assembly
and regulation of OXPHOS complexes, and study human mitochondrial
diseases. Since this dissertation is focused on mitochondrial function and
structure in yeast, primarily yeast enzymes will be described, and yeast gene
names and nomenclature will be used unless otherwise noted.

1.4. Mitochondrial function

Mitochondria contain hundreds of proteins and are a site of diverse
metabolic reactions within the cell. Mitochondria participate in initiating wholebody responses to hypoxia and other stresses (Nunnari and Suomalainen, 2012).
In addition to OXPHOS, mitochondria perform many functions critical to the
eukaryotic cell: biosynthesis of heme groups, iron sulfur clusters, amino acids,
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fatty acids, generating and metabolizing signaling molecules such as acetyl-CoA
and reactive oxygen species (ROS), replenishing NAD+ for glycolysis;
furthermore, mitochondria participate in programmed cell death (apoptosis)
(Nunnari and Suomalainen, 2012; Baile and Claypool, 2013).
Mitochondria retain their own mitochondrial genome, and consequently
their own mechanisms of transcription, and their own translation machinery. The
mitochondrial genome is highly reduced from their bacterial ancestor by genetic
transfer to the eukaryotic host nuclear DNA. The mitochondrial genome encodes
only a handful of hydrophobic proteins (13 in human, 8 in yeast mitochondrial
genome) (Bernardi et al., 1972, Anderson et al.,1981). Since so few
mitochondrial proteins are encoded by mitochondrial DNA, nuclear genes encode
the vast majority of mitochondrial proteins (Nicholls and Ferguson, 2013). Protein
import into mitochondria is a process that is essential for life (Baker and Schatz,
1991). Assembly and function of protein translocases, and IMM insertion of
positively charged polypeptide sequences, requires PMF (Martin et al., 1991).
The mitochondrially encoded proteins are essential for assembly and
function of critical OXPHOS enzymes (including complex III, complex IV, and
complex V). These complex OXPHOS enzymes each contain more than ten
protein subunits and are mosaic in origin, meaning that the rest of their subunits
are encoded by nuclear genome, and the assembly of nuclear and mitochondrial
subunits is intricately coordinated.

1.4.a. Mitochondrial electron transport chain (ETC)

7

Mitochondrial OXPHOS is the best-known function of the organelle and
provides eukaryotic cells the most productive way to regenerate ATP. The
OXPHOS enzymes of the IM are multi-subunit molecular machines commonly
referred to as OXPHOS complexes I-V, diagrammed in Figure 2A. The citric acid
cycle in mitochondrial matrix completes metabolism of glycolysis and
fermentation products, such as pyruvate, ethanol, acetate, lactate. Breakdown of
these non-fermentable compounds is coupled to reduction of NAD+ and FAD2+.
NADH and FADH2 are oxidized with reduction of oxygen by the enzymes of
electron transport chain (ETC). The ETC is the chain of OXPHOS complexes IIV. NADH dehydrogenase and succinate dehydrogenase are the alternative
beginnings of the ETC. NADH:ubiquinone oxidoreductase (NADH
dehydrogenase) reduces lipid-soluble electron carrier ubiquinone to form
ubiquinol (reduced form). NADH dehydrogenase in plant and mammalian
mitochondria is the largest OXPHOS enzyme complex (complex I). In
yeast, complex I is replaced by one-subunit NADH dehydrogenase enzyme.
Yeast NADH dehydrogenase isoforms have active sites on the matrix side of the
IM (Ndi1) and on the IMS side of the IM (Nde1 and Nde2); in contrast to complex
I, Ndi1, Nde1, Nde2 do not contribute to the PMF (do not pump protons)
(Rigoulet et al., 2004). Despite their relative simplicity, yeast NADH
dehydrogenases are functionally similar to mammalian mitochondrial complex I
with respect to oxidation of NADH and reduction of ubiquinone; expression of
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B

Figure 2. OXPHOS enzymes and the proton circuit. (A) OXPHOS enzymes NADH
dehydrogenases (Nde and Ndi), complex II, III, IV are represented by red rectangles; complex V
is in green; electron carriers ubiquinone (Q) and cytochrome c, as well as oxygen are represented
by black circles; gray stripes represent phospholipid bilayers; electron flow is depicted with black
arrows, and the flow of protons with blue arrows. (B) The flow of protons in a proton circuit formed
by OXPHOS complex IV and ATP synthase (V) is diagrammed by black arrows. Diagram adapted
from Nicholls and Ferguson, Bioenergetics, Academic Press, 4th Edition, 2013.
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yeast Ndi1 in mammalian cells remedies respiratory deficiency caused by
complex I defects (Yagi et al., 2006). Succinate dehydrogenase (complex II) is
IM-associated enzyme of the citric acid cycle that is conserved on gene and
protein level, in yeast and mammalian mitochondria. Complex II transfers
electrons from its cofactor FADH2 to ubiquinone on the matrix side of the
membrane (Rigoulet et al., 2004).
Electrons from ubiquinol are transferred to cytochrome c reductase,
complex III (ubiquinol-cytochrome bc1 oxidoreductase). Complex III transfers
the electrons to a soluble IMS carrier cytochrome c, simultaneously releasing
ubiquinone and protons at the IMS side of the membrane. By cycling the electron
carrier ubiquinone across the IM, Complex III translocates protons by “loop”
mechanism (Saraste, 1999). The final reaction of ETC is oxidation of
cytochrome c by cytochrome c oxidase, complex IV (CcO). Transport of electrons
by complex IV results in the reduction of molecular oxygen (O2) to form water. In
addition, complex IV translocates protons across the IM by active pumping
mechanism (described in detail in section 1.4.c.).
In yeast mitochondria, complexes III and IV form supercomplexes of
III2IV1-2 stoichiometric composition (Schӓgger and Pfeiffer 2000). A subpopulation
of the III-IV supercomplexes contains also ADP/ATP carrier (AAC) (Dienhart and
Stuart, 2008). AAC is thought to directly assist the assembly and activity of the
III-IV supercomplexes. Supercomplexes containing III and IV are found across
taxa and reflect coordinated assembly of protein and lipid subunits of complex
III and complex IV (Lenaz and Genova, 2009). In mammalian mitochondria, III-IV
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supercomplexes can also contain complex I; the resulting supercomplexes are
referred to as “respirasomes”. Functionally, respirasomes are proposed to
facilitate electron transport to optimize the use of ETC substrates and prevent
formation of reactive intermediates (Cruciat et al., 2000; Lapuente-Brun et al.,
2013; Barrientos and Ugalde, 2013).

1.4.b. PMF powers ATP synthesis

Catalytic activity of electron transporting enzymes enables transport of
protons against concentration gradient from the matrix to the IMS by OXPHOS
complexes III and IV. The IM is relatively impermeable to protons, insulating the
flow of a proton current through the chemiosmotic circuit in a manner analogous
to an electrical circuit (Figure 2B). The proton current powers the synthesis of
ATP by the F1FO ATP synthase (OXPHOS complex V). The protons from the IMS
are transported back into the matrix though the FO portion; the energy of proton
translocation rotates the F1FO ATP synthase, inducing conformational changes
necessary for catalytic phosphorylation of ADP in the F1 sector. Under ideal
conditions, the insulated proton circuit conserves energy cycling between the
OXPHOS enzymes in the form of the PMF; this energy conservation is referred
to as coupling of oxidation and phosphorylation.
The coupling can be empirically evaluated as the number of ATP
molecules formed per atom of oxygen (O), called P/O (phosphorylation/oxidation)
ratio. Each oxygen atom is reduced by two electrons. A transfer of two electrons
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by complex III moves four protons from the matrix to the IMS (4H+/2e-); complex
IV pumps two protons, and removes two more protons from the matrix, which are
combined with the oxygen atom to form water (4H+/2e-). Complex V
stoichiometry is determined by the number of subunits that make up the rotating
FO portion of the enzyme (subunit c, encoded by yeast gene ATP9). Binding of
one proton to every Atp9 subunit results in rotation of the FO portion of the
enzyme, catalyzing three ADP phosphorylation reactions in the F1 portion of the
enzyme. Yeast complex V has ten Atp9 subunits (Devenish et al., 2000), yielding
the 10 H+/3 ATP =3.33 H+/ATP stoichiometry. Finally, the AAC exchange of ATP
for ADP and inorganic phosphate causes the influx of one additional H+/ATP in
addition to those required for ATP synthase rotation (Nicholls and
Ferguson, 2013). Yeast mitochondria can generate up to 1.8 ATP molecules for
every atom of oxygen (O) reduced by transfer of two electrons (Hinkle,
2005); the calculated P/O ratio:
4 H+III + 4 H+IV) / ( 3.33 H+V + 1 H+ADP/ATP exchange) = 1.84
Experimentally determined stoichiometries of the proton translocation by
isolated complexes III, IV and V agree with thermodynamic predictions; however,
considerable and variable proton leak both in vivo and in isolated mitochondria
lowers the OXPHOS coupling.
Transport of protons against the concentration gradient generates
proton (ΔpH) and charge (Δψ) gradients. The contribution of the Δψ and ΔpH
gradients to the PMF which is measured as electrical charge expressed in
millivolts (mV) can be calculated as follows:
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PMF = Δψ - 61 ΔpH
Due to low capacitance of biological membranes, transfer of only a few protons
across a spherical membrane is sufficient to generate considerable Δψ (Bashford
and Thayer, 1977; Nicholls and Ferguson, 2013; Björck and Brzezinski, 2018).
Therefore, charge component to the voltage expression of PMF is greater
than that of the ΔpH component (Perry et al., 2011). Typical PMF values
range from 180 to 220 mV, with Δψ contributing 150-180 mV, and ΔpH of 0.5-1.0
units contributing the remaining 30-60 mV (Nicholls and Ferguson, 2013).
The relative contribution of Δψ and ΔpH to the PMF is variable and depends on
the activity of the ETC, concentration of other cations (Ca2+, K+, Na+, etc.), and
buffering capacity of the mitochondrial matrix.
In addition to ATP synthesis, PMF supports redox homeostasis, import of
proteins across mitochondrial membranes, and activity of mitochondrial solute
carriers. PMF is an indicator of healthy mitochondria and regulates mitochondrial
fission, fusion, and degradation (Nunnari and Suomalainen, 2012).

1.4.c. Proton pumping by complex IV (CcO)

The terminal electron transporting enzyme, complex IV (CcO), confirmed
as a true proton pump in 1970s, performs two coupled reactions: transfer of
electrons from cytochrome c to oxygen and active transport of protons from the
matrix to the IMS (Wikström 1977, Nicholls and Ferguson, 2013). Complex IV
contains two heme groups and two copper atoms and belongs to A-type heme-
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copper oxidase (HCO) family (Sharma and Wikström, 2014; Rauhamaki and
Wikström, 2014). A-type HCOs are the only HCOs containing third subunit Cox3,
the presence of which corelates with proton pumping D channel (Wikström et al.,
2015). Bacterial A-type HCOs are composed of 3 subunits, while mitochondrial
complex IV have more (10-12) subunits (Soto et al., 2012). The three core
subunits of mitochondrial complex IV - Cox1, Cox2, and Cox3 are encoded in the
mitochondrial genome and are remarkably conserved with the bacterial A-type
HCOs. Cox1 and Cox2 are directly involved in the catalysis. Cox3 is not directly
involved in catalysis and it is thought to play a regulatory role (Hosler et al.,
2006). The nuclear genome encodes complex IV subunits Cox4, Cox5a/b, Cox6,
Cox7, Cox8, Cox9, Cox12, Cox13, and Cox26. These subunits are less
conserved and serve structural or regulatory roles (Fontanesi et al., 2006).
Subunits Cox1 and Cox2 are directly involved in transport of electrons
from cytochrome c to oxygen. Cox1 coordinates hemes a and a3 and copper CuB
and Cox2 coordinates copper CuA. Heme a3 and CuB form a binuclear reactive
center (BNC). BNC catalyzes electron transport to oxygen to form water. Cox2,
aided by subunit Cox12, a peripheral subunit in the IMS which makes a “soft and
specific” contact with reduced cytochrome c. The cytochrome c contact site
allows cytochrome c to undergo structural changes without losing the contact
with the enzyme (Shimada et al., 2017). Time-resolved studies demonstrate that
the transfer of electrons proceeds from cytochrome c to CuA to cytochrome aa3
and CuB and finally to oxygen (Nicholls and Ferguson, 2013).
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In every catalytic cycle, complex IV uptakes eight protons, four of which
combine with oxygen to form water, and four more are pumped from the matrix
into the IMS. The current understanding of the mechanism of proton pumping by
complex IV is incomplete. Proton pumping is powered by the electron transfer:
approximately 545 mV is produced per electron spanning the redox potential
difference, ΔEh, between heme a and the BNC: ΔEh = Eh(heme a) – Eh(BNC). This
energy is sufficient for the pumping of one proton per electron transferred
(Blomberg and Siegbahn, 2014; Wikström et al., 2015). Heme redox potentials
are strongly influenced by the PMF (Kim et al., 2012). High PMF lowers redox
differential of the enzyme, making proton pumping less thermodynamically
favorable.
Uptake of protons occurs at proton loading sites (PLS) on the matrix side
of the enzyme. PLS are proton wells, where the local microenvironment (e.g.,
matrix pH and electrostatic interactions) influences the pKa of key amino acid
residues to promote their protonation (Wikström et al., 2015). The two entry
points for the protons involve amino acids Asp(D)92 and Lys(K)315 of the Cox1
subunit. The protons travel via transmembrane ion channels formed by the
transmembrane domains of Cox1 and Cox2; protonation of key residues of these
two subunits creates a proton “wire” across the membrane. Two universally
acknowledged proton pathways are named D and K channels after the
conserved Asp(D)92 and Lys(K)315 residues (Blomberg and Siegbahn, 2014).
Pumping protons across the membrane occurs exclusively by the D channel
(Wikström et al., 2015). The K channel is used for uptake of substrate protons.
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Mutation of conserved K-channel lysine demonstrated K-channel importance for
proton pumping ability of bacterial cytochrome c oxidases. Protonation of K
channel Lys(K)315 decreases the redox potential of the BNC by approximately
30 mV, increasing the redox differential of the enzyme, which is necessary for
pumping protons at high PMF (Sharma and Wikström 2016).
The levels of complex IV enzyme limit the maximal ETC activity. In intact
mitochondria, ETC is operating below its maximal capacity due to negative
regulation of complex IV activity by the PMF. The excess complex IV capacity is
reserved to respond to rapid changes in PMF. The complex IV activity remains
limited by the PMF because of the coupling of electron and proton transport
activities by the enzyme (complex IV coupling). Numerous gating mechanisms
preventing the backflow of the protons through the complex IV proton channels
are proposed (Blomberg and Siegbahn, 2012; Wikström et al., 2015). Multiple
lines of evidence indicate that proton-pumping efficiency of mitochondrial
complex IV can be altered or a subpopulation of the enzyme can develop
elevated proton leak (Kadenbach 2003; Bloch et al., 2004; Bloch et al.; 2009,
Blomberg and Siegbahn, 2012; Siegbahn and Blomberg, 2014). The existence of
proton leak was also reported in enzyme homologous to mitochondrial complex
IV, E.coli cytochrome bo3 (Li et al., 2015). Proton leak in small subpopulations of
HCOs was postulated to alleviate respiratory pressure and ROS production (Li et
al., 2015). The role of the many complex IV subunits and associated proteins, in
regulating redox potential of the hemes, dielectric channels and wells, proton
leak, and proton pumping rates, remains to be discovered.
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1.4.d. Function of the Cox3 subunit

The Cox3 subunit does not directly channel protons or electrons and is
thought to play a regulatory or supporting role in complex IV catalysis (Hosler et
al., 2006). Cox3 importance for proton pumping and mediating the PMF
regulation of complex IV activity was recently revealed, providing an example
of cooperative action of complex IV protein and lipid constituents during catalysis.
Evolutionary comparisons indicate that Cox3 is found only in A-type HCOs
(Wikström et al., 2015) and Cox3 presence correlates with improved proton
pumping ability of HCOs. This suggests that Cox3 supports proton pumping.
Bacterial cytochrome c oxidase enzyme depleted of Cox3 displays diminished
proton pumping, thus confirming the role of Cox3, and specifically the Cox3
amino terminal region, in proton pumping (Varanasi et al., 2012; Alnajjar et al.,
2014). The presence of Cox3 is thought to stabilize the D-channel by increasing
pKa of protonated PLS residues. Cox3 also plays a specific role supporting
proton pumping at high PMF, which requires the K channel. Thus, Cox3 has the
potential to influence both proton uptake pathways. Proton uptake and pumping
are critical for the stability of the BNC and of the enzyme.
Cox3 subunit dissociates when purified bovine complex IV is subjected to
alkaline conditions (pH 9.5), or detergent (1 mM DDM), or elevated temperature
(Kadenbach and Hüttemann, 2015). Removal of Cox3 accelerates destabilization
of BNC, loss of enzyme activity and degradation of the enzyme. This indicates
that Cox3 interactions with the other subunits are critical for enzyme activity and
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stability. Key interface of Cox3 with complex IV is alongside Cox1 subunit. The
Cox1-Cox3 interface is lined with phospholipid molecules that form an oxygen
delivery pathway to the active site of the enzyme (Shinzawa-Itoh et al., 2007).
Dynamics of Cox3 conformations within the enzyme during catalytic activity or
inactivity, are unknown. While the biogenesis and assembly of complex IV
protein subunits have been extensively studied, it is unknown how and whether
subunit switching occurs (e.g. when condition specific isoforms are synthesized
or when peripheral subunits dissociate). Similarly, no mechanisms are known for
assembly of repair of the enzyme’s lipids, even as lipids in the vicinity of the
oxygen delivery pathway are at risk of oxidative damage.

1.4.e. OXPHOS coupling and efficiency

OXPHOS coupling is the relationship between ATP synthesis and oxygen
consumption by the ETC system (P/O ratio). OXPHOS coupling depends on the
degree of insulation of the proton current, or PMF. Non-productive proton leaks
occur across the energized phospholipid bilayer and through transmembrane
protein and protein complexes. The phospholipid bilayer is a source of constant
proton leak and becomes more permeable to protons at higher PMF in a nonlinear manner (Jastroch et al., 2010). Transport-independent proton leak through
the ADP/ATP carrier (AAC) is another source of proton leak (Nicholls and
Ferguson, 2013). It is estimated that such proton leaks dissipate 20-30% PMF in
vivo (Jastroch et al., 2010).
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OXPHOS coupling and the “reserve” capacity of the ETC enzymes both
contribute to respiration efficiency, or the ability of the mitochondria to maintain
optimal P/O ratio in response to varying ATP demand (Gnaiger et al., 1998). The
amount and activity of the ETC enzymes relative to ATP synthase influences the
degree by which the ETC activity is limited by the PMF and the “reserve” capacity
needed to rapidly ramp up the ATP synthesis in response to ATP demand
(Quarato et al., 2011). Proton pumping by complex IV is a regulatory point for the
regulation of the ETC activity by the PMF.
Empirical measurements of ATP production and oxygen consumption in
whole cells and in isolated mitochondria showed that the P/O ratio is optimized to
different ATP synthesis rates in different tissues (i.e., different cell types have
different respiration efficiency). For example, mitochondria in skeletal muscle are
better prepared to support rapid ATP production, while mitochondria liver have
lower P/O ratio and lower apparent affinity for ADP phosphorylation (Gouspillou
et al., 2011). P/O ratio and respiration efficiency are influenced by stress, aging,
diet (Ocampo et al., 2012, Gouspillou et al., 2011, Salin et al., 2018). Differences
in respiration efficiency are a determining factor in survival and fitness of cells,
tissues, and organisms (Stefano and Kream, 2016).

1.4.f. Hypoxia survival adaptation depends on better respiration efficiency

Selective expression of alternative OXPHOS protein subunit isoforms
leads to tissue and condition specific differences in respiration efficiency; the
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mechanism(s) of this phenomenon are currently debated. One such mechanism,
where two different isoforms of Cox5 are expressed (Cox5a, which is expressed
constitutively, and Cox5b, which is induced by low oxygen concentration
(hypoxia)) is proposed to be acting through regulation of complex IV activity
(Kadenbach and Hüttemann; 2015, Sinkler et al., 2017). Hypoxia limits complex
IV activity and leads to oxidative stress and energy depletion. Adaptation to
hypoxia depends on oxygen sensing pathways in mammalian and yeast cells,
that induce expression of hypoxic isoforms of cytochrome c (Cyc7), complex IV
(Cox5b, and equivalent Cox4-2 in mammals) and AAC (Aac3) (Ziello et al., 2007;
Liu and Barrientos 2013; Hon et al., 2003). Adaptation to hypoxia in human
divers was found to be primarily mediated by lowering ETC capacity and
increasing OXPHOS efficiency (Kjeld et al., 2018). The expression of hypoxic
isoforms is thought to promote OXPHOS efficiency (Fukuda et al., 2007; Hwang
et al., 2015) by increasing complex IV affinity for oxygen, thus lowering
incomplete electron transfer events that lead to oxidative stress (Liu and
Barrientos 2013; Waterland et al., 1991). A non-conservative substitution of
Cox3 Trp(W)116 to Arg(R) in the bar-headed geese, is postulated to alter Cox1Cox3 interaction and complex IV activity and endow the geese with a unique
ability to fly at high-altitude, hypoxic conditions, for long periods (Scott et al.,
2011). Overall, complex IV is central to adaptation to hypoxia.
Mitochondrial dysfunctions present in many pathological conditions
(cancer, neuropathies, myopathies, and ischemia/reperfusion injury) can lower
respiration efficiency by altering OXPHOS enzyme levels, activity and kinetics
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(Rak et al., 2016). The changes in the mitochondrial proteome that take place
during short hypoxic preconditioning are protective and can prevent damage from
subsequent hypoxia/ ischemia (Russel et al., 2014; Dumke et al., 2009; Villani et
al., 1998). Recently, it was demonstrated that a mitochondrial disease (Leigh
syndrome) mouse model benefited from hypoxia induced adaptive response
(Jain et al., 2016). Therefore, understanding hypoxia-induced adaptive response
has clinical significance since this response can counteract pathological changes
associated with mitochondrial disease.

1.4.g. OXPHOS associated lipids

Mitochondrial structure and function are influenced by its membrane lipids,
especially non-bilayer phospholipids phosphatidylethanolamine (PE) and
cardiolipin (CL), which support membrane curvature and surround large dynamic
transmembrane enzyme complexes (Ball et al., 2018). CL is a highly charged
lipid only found in mitochondrial IM (Hoch, 1992). CL in artificial lipid bilayer
membranes promotes tubulation and self-maintaining cristae-like shape in
response to local pH gradient in vitro (Khalifat et al., 2008). Thus, CL participates
in feedback regulation of IM morphology by the PMF.
The proximity of the OXPHOS enzymes and lipid environment in the
cristae is proposed to support the lateral proton diffusion from the enzymes of
electron transport chain (ETC) such as complex IV to the ATP-generating
enzyme, F1FO ATP synthase (Sjöholm et al., 2017); CL patches are proposed to
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be especially important for this process (Haines and Dencher, 2002). Membrane
proteins can play a role in modulating organization of lipids in the mitochondrial
membranes, for example by sequestering lipid molecules from circulation
(Chen et al., 2018). Crystallized OXPHOS enzymes have demonstrated that
lipids are integral conserved components of all OXPHOS enzymes. Three CL
molecules bind strongly to the periphery of each AAC molecule, stabilizing it
(Klingenberg, 2009). CL is important for the formation and/or stability of the III-IV
supercomplexes. Structural CL molecules of the complex III support enzyme
structural integrity and proton translocation (Pöyry et al., 2013; Arnarez et al.,
2013; Xia et al., 2013). Complex IV contains 13 lipid molecules, of which three
are associated with Cox3 and two are CL molecules (Shinzawa-Itoh et al., 2007).
Phospholipid molecules at the interface of Cox3 and Cox1 play a crucial role in
oxygen delivery pathway to the core of the complex IV enzyme and prevent loss
of Cox3 (Shinzawa-Itoh et al., 2007). Finally, CL promotes assembly, stability,
and smooth rotation of the F1FO ATP synthase (complex V) required for its
catalytic function. CL binding involves a conserved lysine of the Atp9 subunit
(Duncan et al., 2016). Specific yet transient (on-and-off) interactions with CL
prevent proton leaks through the FO (Duncan et al., 2016; Mehdipour and
Hummer, 2016).
CL is postulated to regulate many aspects of OXPHOS, but many reports
contradict the benefit of CL for OXPHOS efficiency. In liver mitochondria,
increased CL content increases non-productive oxygen consumption, but does
not increase ATP synthesis, therefore lowering OXPHOS efficiency (Bobyleva et
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al., 1997; Julienne et al., 2014; Peyta et al., 2016). Therefore, it appears that CL
levels need to be coordinated with the OXPHOS protein levels for optimal
OXPHOS efficiency.
The pool of mitochondrial phospholipids is regulated by lipid degrading
and remodeling enzymes. CL is synthesized in mitochondria and undergoes acyl
chain remodeling after synthesis. CL remodeling is thought to be a repair
mechanism of CL molecules sustaining oxidative damage of component acyl
chains (Baile et al., 2013; Schlame and Greenberg, 2017). Without remodeling,
CL degradation is increased but how turnover and degradation is regulated is not
known (Xu et al., 2016). CL is essential for viability of the mammalian cells.
Deficient CL remodeling causes human mitochondrial disease (Barth syndrome).
Importantly, loss of CL decreases mitochondrial DNA stability, viability, and
respiration efficiency, but has a mild effect on respiration-based growth in yeast
(Zhong et al., 2004).

1.5. Rcf1 and Rcf2

This dissertation focuses on the yeast respiratory supercomplex
associated factors Rcf1 and Rcf2. These proteins are thought to support
respiration by regulating complex IV (cytochrome c oxidase), yet a possibility that
these proteins influence activity of other OXPHOS enzymes has not been ruled
out. Whether Rcf1 and Rcf2 regulate complex IV proton transport or coupling is
not known.
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Many genes in S. cerevisiae have paralogs arising from an ancient
genome duplication event (Kellis et al., 2004; Dujon et al., 2004). RCF1
(YML030W) and RCF2 (YNR018C) are paralogs; both genes are constitutively
expressed, and encode transmembrane proteins located in the IM. Rcf1 and
Rcf2 were identified as novel proteins interacting with the III-IV supercomplex in
a proteomic screen (Helbig et al., 2009; Hess et al., 2009). These interactions
were confirmed by co-purification of His-tagged Rcf1 and Rcf2 proteins with
almost all subunits of complex III and complex IV (Chen et al., 2012; Strogolova
et al., 2012; Vukotic et al., 2012), with the exception of peripheral subunits Cox12
and Cox13, which were absent in Rcf1HIS-associated complex IV (Strogolova et
al., 2012; Vukotic et al., 2012). Rcf1 and Rcf2 interact with the III-IV
supercomplex independently (Strogolova et al., 2012).
Deletion of RCF1 (Δrcf1) is associated with impaired respiratory growth in
the BY4741 yeast genetic background (Chen et al., 2012) but near-normal
respiratory growth is observed in the W303 genetic background (the genetic
background used in this study) (Strogolova et al., 2012). The S. cerevisiae
BY4741 genetic background exhibits an elevated rate mtDNA loss, due to
several genetic polymorphisms, including one that occurs within the gene
encoding transcription factor HAP1 and negatively affects the expression of
complex IV subunits (Dimitrov et al., 2009; Bruder et al., 2016). Compared to
BY4741, W303 genetic background has more robust complex IV levels and more
stable mitochondrial genome and thus is preferred for mitochondrial studies. The
deletion of the RCF2 gene (Δrcf2) does not appear to negatively impact
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respiratory growth in BY4741 and W303 genetic backgrounds (Strogolova et al.,
2012; Vukotic et al., 2012; Römpler et al., 2016). The double mutant (Δrcf1;Δrcf2)
yeast strain was studied only in W303 genetic background (Strogolova et al.,
2012) and never reported in BY4741 genetic background. The double mutant
(Δrcf1;Δrcf2) in W303 genetic background is characterized by decreased
complex IV activity and a strong respiratory growth defect, which can be
complemented by either RCF1 or RCF2 expression (Strogolova et al., 2012). The
cross-complementation was suggested at the time to indicate that Rcf1 and Rcf2
have a shared function supporting respiration, most likely involving the III-IV
supercomplex.

1.5.a. Rcf1 and Rcf2 are members of a conserved HIGD family of proteins

Immunodetection and quantification of epitope and GFP tagged proteome
estimated Rcf1 protein abundance to be > 1000 molecules per cell
(Ghaemmaghami et al. 2003) while Rcf2 protein was estimated to be twice as
abundant as Rcf1 (Chong et al., 2015); both proteins are constitutively expressed
and abundant. Yeast does not have a hypoxic-regulated HIGD protein isoform.
Rcf1 and Rcf2 sequences are divergent from each other and share strongest
homology near one of their transmembrane domains, where a conserved
(Q/I)X3(R/H)XRX3Q motif is found. The (Q/I)X3(R/H)XRX3Q motif is found in the
hypoxia-induced gene 1 domain (HIG1D or HIGD), found in a conserved HIGD
protein family. HIGD containing proteins are found in yeast, plant, animal
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mitochondria, as well as many α-proteobacteria. Based on the sequence of the
(Q/I)X3(R/H)XRX3Q motif, HIGD protein isoforms are subdivided into type
1 (V/IHLIHMRX3Q) and type 2 (QX3RXRX3Q) (Figure 3A). Type 1 HIGD
proteins are regulated by transcription factor HIF1 and are upregulated during
hypoxia and hypoglycemia (Wang et al., 2006; An et al., 2011). Type 2 HIGD
proteins are constitutively expressed; Rcf1 and Rcf2 are both type 2 HIGD
proteins (Strogolova et al., 2012; Garlich et al., 2017).
Expression of mammalian type 1 HIGD proteins is associated with better
adaptation to hypoxia and hypoglycemia resulting in lower cell death (apoptosis)
(Wang et al., 2006; Zhang et al., 2012; Ameri et al., 2015; Ameri and Maltepe
2015) as well as improved mitochondrial morphology (An et al., 2013). These
characteristics attracted interest to the mechanism of action of HIGD proteins, yet
the mechanism of action remains unknown. Mammalian type 1 HIGD protein
Higd1a has been shown to interact with complex IV and proposed to promote
conformational change and increase the turnover number (electron transport
rate) in vitro (Hayashi et al., 2015). The function of HIGD type 2 proteins had not
been studied.

1.5.b. Rcf1 and Rcf2 function

Rcf1 and Rcf2 interacts transiently with a small sub-population of the
supercomplex III-IV and Rcf1 was reported to minimize reactive oxygen species
(ROS) levels (Chen et al., 2012; Vukotic et al., 2012; Fischer et al., 2015). In the

26

Figure 3. Conservation and position of the Rcf1 and Rcf2 (Q/I)X3(R/H)XRX3Q (QRRQ)
motifs. Sequence alignments and proposed topology of Rcf1 and Rcf2 proteins. (A) Sequence
alignment of the QRRQ motifs from S. cerevisiae Rcf1 (ScRcf1), S. cerevisiae Rcf2 (ScRcf2),
bacterial homologs Rhizobium etli WP_011426989.1 (Re), Bradyrhizobium japonicum
WP_014491643 (Bj), Nitrobacter winogradskii WP_041344966.1 (Nw), Rhodobacter sphaeroides
WP_107672675 (Rs), and animal homologs C. elegans NP_001254152 (CeM05), Seriola
quinqueradiata BAC67703.1 (SqYGHL1), Homo sapiens NP_001093138.1 (HsHIG1-1A)
and NP_620175 (HsHIG1-2A), Heterocephalus glaber XP_021113455.1 (HgHIG1-1A)
and XP_004836396.1 (HgHIG1-2A), Bos taurus NP_001071329 (BtHIG1-2A). (B) Sequence
alignment of S. cerevisiae Rcf1 (ScRcf1) R67 and W68 residues within the QRRQ motif and
Mic60 lipid binding R433 and W434 residues. Sequence alignment includes Rcf1 bacterial
homologs Bradyrhizobium japonicum WP_014491643 (Bj), Rhodobacter sphaeroides
WP_107672675 (Rs), S. cerevisiae KZV09957.1 (ScMic60), H. sapiens NP_006830.2 (HsMic60).
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absence of Rcf1, complex IV abundance is decreased, and consequently fewer
III-IV supercomplexes can be formed. Based on the observed decrease in
supercomplex III-IV levels in absence of Rcf1, Rcf1 and Rcf2 were initially
proposed to be promoting and required for respiratory III-IV supercomplex
formation (Vukotic et al., 2012; Cui et al., 2014). Despite lower complex IV levels,
all of complex IV assembles into the supercomplex in the mitochondria lacking
both Rcf1 and Rcf2 (Strogolova et al., 2012). Furthermore, our lab and others
have demonstrated that Rcf1 is not a stoichiometric component of the III-IV
supercomplexes, as would be expected if it was provided a bridge connecting or
stabilizing the supercomplex structurally (Garlich et al., 2017).
Rcf1 interacts with subunit 3 of complex IV immediately following Cox3
synthesis and prior to its assembly into the enzyme. This observation led to the
suggestion that Rcf1 may be a Cox3 chaperone mediating its folding and
maturation, and possibly lipid modification. Rcf1 can also be found in association
with Cyt1, Qcr6, and AAC, all lipid (CL) binding OXPHOS proteins, which led to
the proposal that Rcf1 may be a lipid (CL) chaperone (Strogolova et al., 2012,
Garlich et al., 2017).
Current structural studies of complex IV and supercomplex III-IV did not
detect Rcf1, Rcf2 or HIGD protein. Rcf1 is in proximity to complex III subunit
cytochrome c1 and AAC; mutation of the QX3RXRX3Q motif influences these
interactions (J.Garlich, PhD disseration, Garlich et al., 2017). The QX3RXRX3Q
motif may be involved in lipid-binding. In addition to the OXPHOS proteins,
Mic10, a component of MICOS complex, which forms cristae junctions, was
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found to co-purify with both Rcf1 and Rcf2 (Alkhaja et al., 2012). Cristae junction
formation is thought to be coordinated with the position of OXPHOS
supercomplexes (Alkhaja et al., 2012, Friedman et al., 2015). Cristae junction
formation is initiated by the lipid remodeling protein Mic60; Mic60 conserved
Arg(R)433 and Trp(W)434 amino acid residues are directly involved in binding
phospholipid membranes (Hessenberger et al., 2017). Arg65 and Trp66 residues
within the Rcf1 QX3RXRX3Q motif are homologous to Mic60 lipid-binding site 1
(LBS1) (Figure 3B), suggesting that Rcf1 may have a lipid binding site.

1.6. Objectives of the research

Despite considerable interest in HIGD proteins, their role in respiration is
not clearly understood. HIGD proteins interact with a subpopulation of III-IV
supercomplex. HIGD proteins, including yeast Rcf1, regulate abundance and
electron transport activity of complex IV, but the mode(s) of regulation are not
determined. Whether proton pumping activity of complex IV or OXPHOS
efficiency are affected by HIGD proteins has never been addressed.
Rcf1 specifically interacts with respiratory complex IV subunit 3 (Cox3)
during its assembly (Strogolova et al., 2012; Su et al., 2014B; Garlich et al.,
2017). In the Δrcf1 mitochondria, steady state levels of Cox3 and of complex IV
are decreased. Despite the decreased OXPHOS complex IV levels, the Δrcf1
strain does not display a strong respiratory growth deficiency, and neither does
Δrcf2 strain. The Δrcf1;Δrcf2 double mutant however has a strong respiratory
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growth deficiency thought to be due to loss of complex IV levels from the loss of
function of Rcf1 and Rcf2. However, previous studies have not indicated a role of
Rcf2 in complex IV assembly or stability. Deletion of RCF2 does not diminish
complex IV or III-IV supercomplex steady-state levels. The molecular function of
the Rcf2 protein is unclear and respiratory growth deficiency when both Rcf1 and
Rcf2 are deleted is not sufficiently explained. As paralogs, Rcf1 and Rcf2 are
thought to function similarly, but this is not confirmed. This dissertation explores
the molecular function of Rcf1 and Rcf2 in yeast mitochondria and seeks a more
complete explanation for the respiratory growth deficiency of the Δrcf1;Δrcf2
strain.
My first aim was bioenergetic characterization of the Δrcf1;Δrcf2
mitochondria with a specific focus on complex IV, PMF maintenance and
OXPHOS efficiency. I determined how the deletion of Rcf1 or Rcf2 affected
mitochondrial respiratory complex levels, activity, oxygen consumption rate, and
mitochondrial PMF.
Rcf1 and Rcf2 may play a wider role and influence non-COX proteins and
functions such as proteolipid interactions or cristae architecture. My second aim
was to characterize the consequences of Rcf1 and Rcf2 deletion on the content
and activity of critical OXPHOS enzymes AAC and ATP synthase, as well as
mitochondrial morphology.
Results presented in this dissertation indicate that both Rcf1 and Rcf2 are
necessary for optimal PMF generation. However, Rcf2 contribution to complex IV
assembly or stability is minor. Overall, Rcf1 and Rcf2 are proposed to regulate
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proton transfer activity of complex IV. This important molecular function of Rcf1
and Rcf2 supports OXPHOS response to ADP, ATP synthesis, mitochondrial
morphology, and respiratory growth. Future studies will focus on proton pumping
activity of the isolated complex IV and identifying proton translocation defects or
proton leaks develop in the absence of Rcf1 and Rcf2.
Additionally, Rcf1 and Rcf2 influence ATP synthase levels and activity,
AAC stability, and proteolytic processing of several mitochondrial proteins. These
non-COX defects can be a consequence of a lower PMF or may reflect additional
functions of Rcf1/2; these explanations are not mutually exclusive and will require
future studies of HIGD proteins in yeast and mammalian mitochondria.
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CHAPTER 2. MATERIALS AND METHODS

This chapter describes the chemicals and biological reagents as well as
molecular biology, cell biology and biochemical methods.

2.1. Materials

2.1.a. Chemical reagents

Chemical reagents used in this study are listed in Table 1.

Table 1. Reagents used in this study.

Source
Alfa Aesar
(Haverhill, MA)
Becton Dickinson
(Sparks, MD)
Calbiochem

Name
Methanol
Ethanol
Bacto™ Agar

ICN biomedicals
(Aurora, Ohio)
Life Technologies
(Carlsbad, CA)

Geneticin disulfide salt (G418)

Mallinckrodt Baker
(Phillipsburg, KY)
Roche

ethylenediaminetetraacetic acid (EDTA), sodium salt

4-acetamido-4’maleimidylstilbene-2,2’-disulfonic acid
(AMS)
Acrylamide
Agarose
Bisacrylamide
Digitonin
n-dodecyl-β-D-maltoside (DDM)
Sodium dodecyl sulfate (SDS)
Hexokinase / glucose-6-phosphate dehydrogenase
Proteinase K
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Serva (Heidelberg,
Germany)
Sigma (St. Louis,
MO)

Ponceau S
P1,P5-di(adenosine-5')pentaphosphate (Ap5A)
Adenine diphosphate (ADP)
Adenine triphosphate (ATP)
Ammonium molybdate
Ascorbic acid
β-mercaptoethanol
Bisacrylamide
Bromophenol blue
Bovine Serum Albumin (BSA)
carbonyl cyanide m-chlorophenylhydrazone (CCCP)
DL-lactic acid
Dithiothreitol (DTT)
ferrous sulfate
Galactose
Glycerol
Glycine
Hydrogen peroxide (H2O2)
KCN
Lithium dodecyl sulfate (LDS)
Luminol
Magnesium Chloride (MgCl2)
Mannitol
N-(2-hydroxyethyl)-piperazine-N’-2-ethanesulfonic acid
(HEPES)
nicotinamide adenine dinucleotide, reduced form (NADH)
NADP, oxidized form
Nigericin
N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD)
Oligomycin
p-coumaric acid
P1,P5-di(adenosine-5')pentaphosphate (Ap5A)
phenylmethylsulphonyl fluoride (PMSF)
Potassium chloride
Potassium hexacyanoferrate (ferrocyanide)
Potassium hydroxide
Potassium phosphate (dibasic)
Potassium phosphate (monobasic)
Rhodamine 123
Sodium dithionite (dithionite)
Sodium hydroxide (NaOH)
Sodium taurodeoxycholate (deoxycholate)
Sorbitol
Sulfuric acid
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Trichloroacetic acid (TCA)
Tricine
Triton X-100
Trizma Base (Tris)
Valinomycin
Sunrise Biologicals Zymolyase
US Biologicals
Dropout mix, synthetic
Peptone
Yeast Extract
VWR
Glucose

2.1.b. Oligonucleotides

Oligonucleotides used in this study in polymerase chain reactions (PCR)
for generation and verification of yeast strains are listed in Table 2.

Table 2. Oligonucleotides used in this study.

Name
ST591 RCF1-FOR
ST592 RCF1-REV
ST727 RCF2-FOR
ST728 RCF2-REV

Sequence
5’-GGTAGCGAATCAAGGAGGGC-3'
5'-GTTTTAAGTGATAGTTATACAAG-3'
5’- CTTTCTTATTTCCCTTTTAACC-3’
5'-CGAATGAATAGTTTTAGTTG-3'

2.1.c. Plasmids

Plasmid pRS416-mtGFP was a gift of R. Jensen (John Hopkins Medical
School, Baltimore, MD). The mtGFP plasmid encodes a fusion of a yeast COX4
mitochondrially targeted presequence (first 21 amino acids) fused to jellyfish
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green fluorescent protein (GFP) and under the control of ADH1 promoter.
Plasmid Yip351-His-Aac2 encodes a His-tagged Aac2p, HISAac2, under the
control of GAL10 promoter (Dienhart and Stuart, 2008).

2.1.d. Yeast strains

Saccharomyces cerevisiae (S. cerevisiae) strains used in this study are
wild-type (WT; W303–1A, Mat a, leu2, trp1, ura3, his3, ade2), Δrcf1 (W303–1A,
Mat a, leu2, trp1, ura3, ade2, RCF1::HIS3), Δrcf2 (W303–1B, Mat alpha, leu2,
trp1, ura3, his3, ade2, RCF2::KAN), Δrcf1;Δrcf2 (W303–1A, Mat a, leu2, trp1,
ura3, ade2, RCF1::HIS3, RCF2::KAN) (Strogolova et al., 2012).

2.1.e. Antibodies

Antibodies used in this study are listed in Table 3.

Table 3. Antibodies used in this study.

Primary antibodies
Targeted epitope

Source

Origin

AAC

Rabbit

Dr. Rosemary A. Stuart

Atp4

Rabbit

Dr. Jasvinder Kaur

Atp9

Rabbit

Dr. Jean Velours (France)
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Ccp1

Rabbit

Dr. Rosemary A. Stuart

Cpr3

Rabbit

Dr. Rosemary A. Stuart

Cox1

Mouse

Cox2

Rabbit

Invitrogen (Carlsbad, CA) # 11D8B7
Dr. Rosemary A. Stuart

Cox3

Mouse

Cox12

Rabbit

Cox13

Rabbit

Cyt b

Rabbit

Invitrogen (Carlsbad, CA) #
459300
Dr. Klaus Pfanner (Freiburg,
Germany)
Dr. Klaus Pfanner (Freiburg,
Germany)
Dr. Rosemary A. Stuart

Cyt b2

Rabbit

Dr. Rosemary A. Stuart

Cyt c

Rabbit

Cyt c1

Rabbit

Dr. Carla Koehler (Los Angeles,
CA)
Dr. Rosemary A. Stuart

F1 sector of ATP synthase

Chicken

Dr. David Mueller (Chicago, IL)

His tag

Rabbit

Bethyl (Montgomery, TX)

Mgm1

Rabbit

Dr. Rosemary A. Stuart

Mcr1

Rabbit

Dr. Carla Koehler (UCLA, CA)

MrpL32

Rabbit

Pgk1

Mouse

PIC

Rabbit

Por1

Rabbit

Dr. Thomas Langer (Cologne,
Germany)
Dr. Anita Manogaran (Milwaukee,
WI)
Dr. Klaus Pfanner (Freiburg,
Germany)
Dr. Rosemary A. Stuart

Qcr7

Rabbit

Rcf1

Rabbit

Dr. Klaus Pfanner (Freiburg,
Germany)
Dr. Rosemary A. Stuart

Rcf2

Rabbit

This study
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Su e of ATP synthase

Rabbit

Dr. Rosemary A. Stuart

Tim17

Rabbit

Dr. Rosemary A. Stuart

Tim44

Rabbit

Dr. Carla Koehler (UCLA, CA)

Sheep
Goat

Amersham Bioscience (England,
UK)
Sigma (St. Louis, MO)

Goat

Sigma (St. Louis, MO)

Secondary antibodies
Anti-rabbit IgG, horseradish
peroxidase linked whole antibody
Anti-mouse IgG, horseradish
peroxidase linked whole antibody
Anti-chicken IgG, horseradish
peroxidase linked whole antibody

2.2. Molecular biology methods

The basic molecular biology techniques such as polymerase chain
reactions (PCR), restriction enzyme digestion of DNA, DNA precipitation, gel
electrophoresis and gel purification of DNA, DNA ligation, preparation of E.coli
competent cells, transformation of E.coli, colony PCR of E.coli cells, plasmid
DNA extraction, DNA concentration determination, preparation of S. cerevisiae
competent cells, transformation of the yeast S. cerevisiae and genomic DNA
isolation were done according to Stuart lab protocols adapted from the book,
Molecular Cloning: A Laboratory Manual by Sambrook, Fritsch and Maniatis.

2.2.a. Creating the RCF1/2 deletion strains

Null Δrcf1 and Δrcf2 mutants were generated by a homologous
recombination technique in the yeast strains W303-1A and W303-1B,
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respectively. Briefly, a selective marker was PCR-amplified adding on either side
of the marker 50-100 nucleotides shoulders, complementary to the DNA
upstream and downstream of the region of interest (ROI). Transformation and
recombination of the PCR product into competent yeast cells resulted in
recombination and replacement of the ROI. The open reading frame YML030W
(RCF1) on chromosome XIII was replaced with the HIS3 gene. The open reading
frame YNR018W (RCF2) on chromosome XIV was replaced with the KANMX ,
geneticin resistance cassette. Chromosomal deletions were confirmed by PCR.
The Δrcf1;Δrcf2 double mutant was created by mating the two single
mutant haploid strains, and tetrad dissection of the resulting diploid strain.
Haploid segregants were selected based on complementation of histidine
auxotrophy and geneticin-resistant growth. The genotype was confirmed by PCR
of the chromosomal DNA.

2.3. Cell biology methods

2.3.a. Growth of yeast cultures
Yeast strains were maintained and cultured using standard protocols at
30°C on YP media supplemented with 2% glucose and 20 mg/L adenine
hemisulfate (YPAD), Strains were stored in 15% glycerol at -80˚C. YP-0.5%
lactate media supplemented with 2% galactose (YPGal), or YP media
supplemented with 3% glycerol (YPG), as indicated. Where indicated the YPAD,
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YPGal, and YPG agar was supplemented with 1.0 µM nigericin, oligomycin,
antimycin A, or cycloheximide, at indicated concentrations.

2.3.b. Growth assays

Yeast strains were streaked fresh from freezer stocks and passaged on
YPAD agar no more than 4 times prior to the assay. Yeast cells growing on
YPAD agar 24 hours were re-suspended in sterile water to OD600nm =0.1, and 10fold serial dilutions in sterile water were made. The cell suspensions (3 µl) were
spotted on nutrient agar. When the spots dried, the petri dishes were incubated
at indicated temperatures.

2.3.c. Petite (rho0/-) occurrence assay

The proportion of petite cells in cultures was measured on YPG plates
supplemented with 0.1% glucose. Petite colonies appear small and stop growing
on this media once the glucose is consumed, and they are unable to use glycerol
(Soubannier et al, 2002). Even though Δrcf1;Δrcf2 cells grow slowly on this
media, they do not stop growing, so that after 6 days the Δrcf1;Δrcf2 colonies
reach the size that the wild-type colonies reach after 3 days. Cultures were
grown overnight in YP-Gal, diluted in sterile water, and plated to yield 25-250
colonies per plate. The number of colonies that appear small (petite) after 5-7
days was counted and expressed as a percent of the total colonies (% rho0/-).
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2.3.d. Microscopy.

Yeast WT and Δrcf1 / Δrcf2 / Δrcf1;Δrcf2 cells were transformed with
pRS416-mtGFP plasmid. The transformants were streaked on a selective
glucose media lacking uracil (SD-URA), grown for 24-48 hours and inoculated
into liquid media containing galactose (SGal-URA). Aliquots of overnight culture
(3 µl) on glass slides were imaged at 100X magnification. Three-dimensional
(3D) images of mitochondria were taken using Leica DMI6000 B microscope (Dr.
Anita Manogaran, Marquette University, Milwaukee, WI) using Z-stack feature.
Nomarski differential interference contrast (DIC) channel and green fluorescent
protein (GFP) channel were used. The excitation wavelength for GFP was 488
nm, and 470-510 nm emission was detected. Initial analysis and scoring of the
images was performed manually using 2D maximal projection setting in the Leica
LASX software. 3D images were subsequently analyzed in ImageJ software
using the software plugin Yeast_MitoMap (Vowinckel et al., 2015).
Yeast_MitoMap automatically identified, traced and counted mitochondrial
networks in each individual cell. Number of individual mitochondrial networks in
each cell was recorded. Mitochondrial network fragmentation index f was
calculated for each cell. The fragmentation index f is defined as a sum of relative
fragment volumes that individually constitute less than 20% of mitochondrial
volume of the network. Main mitochondrial network in each cell was selected by
excluding fragments with volumes less than 20% of the total. Main mitochondrial
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network volume, surface area, and other shape descriptive parameters were
automatically calculated using Yeast MitoMap.

2.3.e. Whole cell protein extracts

Cultures were grown in YPGal at 30˚C and OD600nm =0.6 was collected
and washed with 0.5 ml of 40 mM potassium phosphate buffer pH 6.0. The cell
pellet was resuspended in 75 µl Rodel mix (2.78 M NaOH, 11% βmercaptoethanol, 15 mM PMSF), immediately 500 µl water was added followed
by 575 µl 50% tricarboxylic acid (TCA). The TCA precipitated proteins were
pelleted at 15000 g for 10 minutes and washed once with 0.5 ml of 0.5 M Tris
(pH not adjusted) and once with water. The protein pellet was resuspended in
1.5X Laemmli buffer (3% SDS, 15% glycerol, 0.015% bromophenol blue, 3.25%
β-mercaptoethanol, 90mM Tris, pH 6.8) and loaded on an SDS-PAGE gel.

2.3.f. Whole cell respiration

Whole cell respiration was measured as described previously (Barrientos
2002). Cultures were grown in YPGal at 30˚C to OD600nm =0.6 (1 ml of culture at
OD600nm =0.6 corresponds to 1 x 107 cells). 2 x 107 cells were collected by
centrifugation at 2500 rpm, washed with and resuspended in 1 ml buffer (0.3M
mannitol, 10 mM KCl, 5 mM MgCl2, 10 mM potassium phosphate, pH 7.4) and
placed in an oxygen electrode chamber at 30˚C to measure endogenous
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respiration. KCN (0.7 mM) was added to inhibit respiration. KCN-sensitive
oxygen consumption is expressed as % of the wild-type.

2.3.g. Isolation of mitochondria

Yeast strains were streaked fresh from freezer stocks and grown to
OD600nm 1.5-2 on YPGal at 30˚C. Mitochondria were isolated according to the
previously described method (Herrmann et al.,1994). Following isolation,
mitochondria were resuspended in SEM buffer (250 mM sucrose, 2 mM EDTA,
10 mM MOPS-KOH pH 7.2) at a protein concentration of 10 mg/ml, flash-frozen
in liquid nitrogen in 27 µl aliquots and stored at -80˚C. Aliquots were
subsequently thawed on ice and used only once.

2.3.h. Protein concentration

Mitochondrial protein concentration was determined using the Bradford
dye binding assay (Bradford, 1976). Bovine gamma globulin IgG (Bio-Rad) was
used to generate standard curve.

2.4. Biochemical methods

2.4.a. Spectral analysis of mitochondrial cytochromes
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Complex III or complex IV levels in the wild-type or mutant mitochondria were
quantified based on dithionite reduced – ferrocyanide oxidized absorption
spectra. The absorption spectra depend on the redox state of cytochromes:
reduced c, b, and a type cytochromes absorb light at 552, 560, and 603 nm,
respectively (absorption maxima). Cytochromes c1 and b are part of complex III,
while cytochromes a and a3 are part of complex IV. Mitochondria (1 mg) were
resuspended in 50 mM Tris-KCl, pH 7.4 buffer, containing 2% DDM (500 µl),
incubated at room temperature with occasional mixing by inversion, and
centrifuged 10000 rpm 5 minutes. 450 µl of the clarified supernatant was
transferred to a 1 ml, 1 cm path cuvette. A crystal of potassium ferrocyanide was
added and dissolved completely to oxidize the cytochromes, and absorbance in
the 500 – 700 nm region was read five times. A few grains of sodium dithionite
was added to the same sample to reduce mitochondrial cytochromes, and
dissolved completely by stirring to reduce the cytochromes. Absorbance of the
reduced spectra in the 500 – 700 nm region was recorded five times and the
difference between reduced and oxidized spectra was calculated. A hand-drawn
baseline from 700 nm to 630 nm was used to measure the height of the peak at
603 nm (Tzagoloff et al., 1975).

2.4.b. NADH-cytochrome c reductase activity assay

The NADH-cytochrome c reductase activity was measured by following
the reduction of exogenously added ferro-cytochrome c at 550 nm. Mitochondria
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were solubilized in 0.4% sodium deoxycholate and kept on ice. Mitochondria (20
µg protein) were added to 10 mM potassium phosphate buffer, pH 7.5, containing
0.1 mM KCN, 66 µM horse heart cytochrome c. The reaction was started by the
addition of 0.1 mM NADH. Absorbance increase at 550 nm was recorded for 4560 seconds, the rate cytochrome c reduction rate. (Tzagoloff et al., 1975).
Relative specific activities of the enzyme were calculated.

2.4.c. Cytochrome c oxidase activity assay

Cytochrome c oxidase enzyme activity was measured by following the
oxidation of exogenously added ferro-cytochrome c at 550 nm. Mitochondria
were solubilized with 1 mM n-dodecyl-β-D-maltoside (DDM) and kept on ice.
Horse heart cytochrome c (Sigma) was reduced with 0.5 mM dithiothreitol (DTT)
solution 15 minutes prior to the start of the experiment. Mitochondria (4 µg
protein) were added to 10 mM Tris-HCl buffer, pH 7.0, containing 120 mM KCl,
and 11 µM reduced horse heart cytochrome c. The concentration of KCl in the
buffer was changed where indicated.

2.4.d. Oxygen consumption measurement in isolated mitochondria

Oxygen consumption rates (OCR) were calculated as the rate of decrease
in oxygen concentration measured with a Clark-type oxygen electrode (Rank
Brothers Digital Model 10) at 30˚C. Mitochondria (40 µg protein) resuspended in
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0.5 ml respiration buffer (0.6 M mannitol, 2 mM MgCl2, 1 mg/ml BSA, 20 mM
HEPES-KOH, 1 mM EDTA, 10 mM K2PO4 pH 7.2) were added to the oxygen
electrode chamber and the suspensions were continuously stirred. Oxygen
consumption was recorded for 1 minute after the mitochondria were added to
establish baseline. For state 2 measurements, NADH (1 mM) was added. State 2
OCR was recorded for 8-10 minutes. For state 3 measurements, NADH (1 mM)
was followed by ADP (50-200 µM, as indicated). For state 2oligo measurements,
addition of the mitochondria was immediately followed by oligomycin (20 µM). To
measure maximal OCR, NADH (1 mM) was followed by membrane uncoupler
carbonyl cyanide m-chlorophenylhydrazone (CCCP) (10 µM in DMSO).
For measurement of oxygen consumption by bioenergetically isolated
complex IV, mitochondria (20 µg protein) resuspended in 0.5 ml respiration buffer
(0.6 M mannitol, 2 mM MgCl2, 1 mg/ml BSA, 20 mM HEPES-KOH, 1 mM EDTA,
10 mM K2PO4 pH 7.2) were added to the oxygen electrode chamber and the
suspensions were continuously stirred. Oxygen consumption was recorded for 1
minute after the mitochondria were added to establish baseline. At one minute,
TMPD/ascorbate (1.4 mM N,N,N’,N’-tetramethyl-p-phenylenediamine (TMPD)
and 12.5 mM potassium ascorbate pH 7) were added. OCR was recorded for 1-6
minutes, and initial OCR (1 minute) was calculated. To measure maximal OCR,
TMPD/ascorbate was followed by membrane uncoupler carbonyl cyanide mchlorophenylhydrazone (CCCP) (10 µM in DMSO). A baseline of oxygen
consumption in the absence of mitochondria with TMPD/ascorbate was recorded
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and subtracted. KCN (0.2 mM) was added to inhibit respiration and confirm the
absence of extramitochondrial respiration.

2.4.e. Membrane potential measurements

Rhodamine 123 (R-123) fluorescence at 488/525 nm was recorded using
a fluorimeter (Dr. David Mueller, Chicago, Il). Mitochondria (150 µg protein) were
resuspended in 2 ml of buffer (0.65M mannitol, 0.3 mM EGTA, 3mM Tris
phosphate, 10 mM Tris maleate, pH 6.8) containing 0.5 µM Rhodamine 123 (in
methanol). For State 2 measurements, NADH (2 mM) was added. For State 3
measurements, NADH was immediately followed by ADP (45 µM). At the end of
each trace, the membrane potential was dissipated by CCCP (10 µM).
Fluorescent signal in the presence of NADH+CCCP was set to 100% and
changes in the fluorescence were expressed as % quenching relative to that
signal. Mitochondrial membrane potential generated by ATP hydrolysis was
measured as follows. Mitochondria (150 µg) were resuspended in 2 ml buffer
containing 0.5 µM R-123 (in methanol); following the addition of ethanol (68 mM),
KCN (0.2 mM), 2 mM ATP, 1 mM MgCl2. R-123 fluorescence was recorded for
~1 minute followed by addition of oligomycin (20 µM), and CCCP (10 µM).

2.4.f. ATP synthesis and ATP export
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ATP synthesis and ATP export rate were measured at 30˚C according to
published methods (Hamazaki et al., 2011; De Marcos Lousa et al., 2002) with
modifications described here. Mitochondria (40 µg of protein) were resuspended
in 0.7 ml of ATP detection buffer (0.6 M mannitol, 0.1 mM EGTA, 2 mM MgCl2,
10 mM potassium phosphate, 5 mM alpha-ketoglutarate, 0.01 mM Ap5A, 2.5 mM
glucose, 0.2 mM NADP, 10 mM Tris-HCl, pH 7.4) containing the ATP detection
enzymes (hexokinase (1.7 E.U.) / glucose-6-phosphate dehydrogenase (0.85
E.U.). The exchange reaction was initiated by adding oligomycin (20 µM) and
ADP (20 µM). The rate of ATP release was monitored as the rate of NADPH
formation (increase in NAD(P)H absorbance at 339 nm). The reactions were
carried out in quartz cuvettes (Hellma). Absorbance was measured with
Beckman Coulter DU800 spectrophotometer.
Endpoint ATP synthesis assays were carried out as follows. ADP was
added to the mitochondria (40 µg of protein) resuspended in ATP detection buffer
(0.6 M mannitol, 0.1 mM EGTA, 2 mM MgCl2, 10 mM potassium phosphate, 5
mM alpha-ketoglutarate, 0.01 mM Ap5A, 2.5 mM glucose, 0.2 mM NADP, 10 mM
Tris-HCl, pH 7.4) without the ATP detection enzymes containing ethanol or
succinate in presence of oligomycin (1 µM or lower concentration as indicated in
the experiment) or DMSO. After the indicated times, synthesis was stopped and
mitochondria removed by 10 minute centrifugation at 10000 rpm, and the
supernatant was transferred to a fresh tube. ATP in supernatant was converted
to NADPH by adding the ATP detection enzymes and incubating for 5 minutes at
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30˚C. Alternatively, mitochondrial membranes were solubilized with deoxycholate
(0.2%) and the ATP detection enzymes added to assay total ATP.

2.4.g. ATP hydrolysis

Oligomycin-sensitive F1FO ATPase activity was assayed at 30˚C at pH 8.4
according to Velours et al, 2001 with following modifications. Mitochondria were
diluted to protein concentration 5 mg/ml either with SEM buffer (250 mM sucrose,
2 mM EDTA, 10 mM MOPS-KOH pH 7.2) or with 0.375% Triton X-100, as
indicated. Aliquots containing 50 µg mitochondrial protein were incubated for 2
minutes in reaction buffer (0.9 ml, 0.2 M KCl, 3 mM MgCl2, 10 mM Tris-HCl, pH
8.4) in the presence or absence of oligomycin (20 µM, in ethanol). The reaction
was started with the addition of 5 mM ATP and stopped after 2 minutes by the
addition of tricarboxylic acid (TCA) (0.3 M, final concentration). Following a 10minute, 10000 rpm, 4˚C centrifugation step, inorganic phosphate in the
supernatant was measured using ferrous sulfate / ammonium molybdate method
(Sumner 1944). Mitochondrial extract supernatant or known phosphate
concentration (0.5 ml) was added to measurement solution (2.5 ml) (0.67%
ferrous sulfate, 0.55% ammonium molybdate, 0.75 N sulfuric acid), incubated for
15 minutes at room temperature, and Abs610nm was measured. A standard curve
with 0, 50, 100, 150, 200, 300, 400 500 mmol potassium phosphate was used for
calibration.
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2.4.h. TCA precipitation of proteins

Mitochondria (20 µg of protein) were resuspended in 200 µl of water, and
85 µl of 50% TCA was added. Precipitated proteins were pelleted at 15000 g 10
minutes, washed with 0.5 ml of 0.5 M Tris (pH not adjusted) and with water.
Protein pellet was resuspended in 1.5X Laemmli buffer (3% SDS, 15% glycerol,
0.015% bromophenol blue, 3.25 % β-mercaptoethanol, 90mM Tris, pH 6.8) and
loaded on an SDS-PAGE gel.

2.4.i. SDS-PAGE

17.5% acrylamide, 0.2% bis-acrylamide sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) gels were prepared according
to Laemmli, 1970. Molecular weight markers (14-116 kDa, ThermoFisher) was
used to estimate position and size of the proteins.10-15 µl of sample in 1X
Laemmli buffer (2% SDS, 10% glycerol, 0.01% bromophenol blue, 2.5 % βmercaptoethanol, 60mM Tris, pH 6.8) was loaded on each lane of the gel. SDSPAGE was performed at 25 mA in 1X electrophoresis buffer (2M glycine, 0.1%
SDS, 50 mM Tris) for 2 hours.

2.4.j. BN-PAGE
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Mitochondria (30 µg) were solubilized in 10 µl Invitrogen pink buffer (50
mM Bis-Tris, 6N HCl, 50 mM NaCl, 10% w/v glycerol, 0.001% Ponceau S, pH
7.2) with the addition of either 1% digitonin or 0.6% DDM. Samples were
incubated 20 minutes on ice and centrifuged for 10 minutes at 15000 rpm, 4˚C.
The clarified supernatant was transferred to a new tube and G250 Coomassie
added to final concentration of 1.75%. Following sample preparation,
mitochondrial respiratory complexes and other proteins were separated on a 312% Blue Native PAGE (BN-PAGE). NativeMark™ protein standards were used
to estimate the molecular weights of the complexes. Pre-cast 3-12% Bis-Tris
mini-gels (8cm x 8cm, 1.0 mM thickness) were ran for 5 hours at 4˚C using
Novex® NativePAGE™ Bis-Tris gel system (Invitrogen/ThermoFisher Scientific).
The gels were transferred to nitrocellulose membrane (Whatman) using semi-dry
blotting system and Western blotting buffer (20% Methanol, 150 mM glycine,
0.02% SDS, 20 mM Tris, pH not adjusted), with the modification of 1 hour
transfer time. Blots were prepared for detection by incubating in Western strip
buffer (25 mM glycine, 100 mM NaCl, 0.05% Tween-20, pH 2.0) and blocked with
5% milk in TBS solution for 30 minutes.

2.4.k. Two-dimensional electrophoresis

Second-dimension-PAGE separation was performed after the BN-PAGE
step. Mitochondria (200 µg protein) were solubilized in lysis buffer (34 mM
potassium acetate, 34 mM HEPES-KOH, pH 7.4, 11.4% glycerol, and 1 mM

50

PMSF) containing 1% digitonin. Samples were incubated on ice 30 minutes and
subjected to a clarifying spin for 30 min at 30,000 g, 4°C. The supernatant from
each sample was analyzed on a BN-PAGE as described (Cruciat et al., 2000;
Saddar et al., 2008). Individual lanes of the BN-PAGE were excised with a razor
blade gel. Each gel strip was incubated in lithium dodecyl sulfate (LDS) (4X LDS
(106 mM Tris-HCl, 14 mM Tris Base, 2% LDS, 10% glycerol, 0.51 mM EDTA,
0.22 mM G250 Coomassie, 0.175 phenol red, pH 8.5). Strips were incubated for
30 minutes in each, LDS-DTT (50 mM dithiothreitol (DTT), 1 X LDS), LDS-DMA
(N,N-dimethylacrylamide) (50 mM DMA, 1X LDS), and LDS-Ethanol-DTT (5 mM
DTT, 20% ethanol, 1X LDS). Each strip was inserted on top of a denaturing
NuPAGE™ Bis-Tris gel, and electrophoresis was performed at 100 V for 1.5-2
hours. NativeMark™ and protein standards were used in the first dimension to
estimate the molecular weights of the complexes. 14-166 kDa molecular weight
markers (ThermoFisher) were used in the second dimension to determine the
sizes of protein subunits.

2.4.l. Western blot analysis

Proteins were transferred from polyacrylamide gels to nitrocellulose
membrane (Whatman) using semi-dry blotting method for 1.5 hours (unless
otherwise specified) at 250 mA in transfer buffer (20% Methanol, 150 mM
glycine, 0.02% SDS, 20 mM Tris) (Kyhse-Andersen, 1984). Membranes were
stained with Ponceau S solution to visualize molecular weight markers, then
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rinsed completely with water. Membrane was then used for autoradiography, or
blocked in 5% milk in 1X TBS (150 mM NaCl, 10 mM Tris-HCl pH 7.5) for 1 hour
before immunodetection. Membranes were incubated in primary antibody
solution. Signal generation was then achieved using secondary antibodies
conjugated with horseradish peroxidase (HRP) via chemiluminescence in a buﬀer
containing 100 mM Tris pH 8.5, 0.23 mM p-coumaric acid, 1.25 mM luminol,
0.00015% [v/v] H2O2 as previously described (Roswell and White, 1978). Films
were developed using an automated developing machine (AGFA CP1000).

2.4.m. Ni NTA affinity purification

Mitochondria from the wild-type and Δrcf1;Δrcf2 cells expressing HISAac2
were subjected to Ni-nitrilotriacetic acid (Ni-NTA) affinity purification. His-tagged
protein and their interacting partners were purified from isolated mitochondria
(200 μg total protein) solubilized in 300 μl of lysis buffer (31 mM HEPES, 80 mM
potassium acetate, 10% glycerol, 1mM PMSF and 0.6% Digitonin) for 30 min on
ice. After a clarifying spin (10000 rpm, 10 min at 4˚C), the supernatant was
collected, supplemented with imidazole (30 mM final concentration) and
incubated with Ni-NTA beads (pre-equilibrated in lysis buffer) for 1 hour at 4˚C.
The beads were then washed three times with lysis buffer containing imidazole
and the bound proteins were eluted with SDS-sample buffer containing 5% βmercaptoethanol and 450mM Imidazole. Samples were analyzed by SDS-PAGE
and Western blotting.
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2.4.n. Mitochondrial translation

Translation in organello with [35S] methionine labeling was performed for
as described in Hell et al., 2001. Briefly, translation was carried out for 20
mintues at 30˚C in presence of [35S] methionine. Translation was stopped by
addition of puromycin and excess unlabeled methionine, followed by 5-minute
incubation. The mitochondria were collected by centrifugation and subjected to
SDS-PAGE.

2.4.o. Quantitation of Western blot band intensities.

Exposed films were scanned in 600 dpi transmission mode on Epson
V750 PRO scanner and band density was quantified using ImageJ Gel Analysis
method (Gassmann et al, 2009). Relative density was adjusted to loading control.

2.4.p. Statistical analysis.

Data were collected and analyzed using GraphPad Prism software version
7 (La Jolla, CA). Mean and standard error of mean (SEM) values (McDonald,
2014) are derived from at least 3 experiments unless otherwise noted. Where
applicable, statistical significance between two experimental variables was
evaluated using Student’s t-test (p<0.05 was considered significant).
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CHAPTER 3. Deletion of Rcf1 and Rcf2 cumulatively impairs OXPHOS coupling,
evidenced by elevated oxygen consumption and lowered membrane potential

Introduction

The RCF1 and RCF2 genes are needed for optimal yeast growth on nonfermentable carbon sources. Utilization of non-fermentable carbon sources
(glycerol, ethanol, lactate) for energy requires activity of the electron transport
chain (ETC) of the yeast mitochondria, including the activities of the cytochrome
bc1 reductase (complex III) and the cytochrome c oxidase (CcO, complex IV)
enzymes.
In yeast mitochondria, all complex IV molecules are assembled into
supercomplexes of III2IV2 or III2IV1 composition. Prior studies identified Rcf1
involvement in chaperoning Cox3 prior to its assembly into the supercomplex IIIIV and supporting assembly and enzyme activity of complex IV (Strogolova et al.,
2012; Garlich et al., 2017). The role of Rcf2 in complex IV assembly or enzyme
activity, or III-IV supercomplex content is not apparent (Strogolova et al., 2012;
Römpler et al., 2016; Fischer et al., 2015). Deletion of Rcf1 or Rcf2 (Δrcf1 and
Δrcf2 strains) does not strongly influence respiratory growth, but the combined
deletion of Rcf1 and Rcf2 together leads to a respiratory growth defect.
In this chapter, the consequences of Rcf1 and Rcf2 deletion on
mitochondrial respiration was evaluated by growth and respiration assays and
measuring the steady-state levels and catalytic activities of complex III and
complex IV. Previous studies focused only on electron transfer (oxygen
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consumption) capacity of complex IV enzyme. In particular, this study
investigated whether Rcf1 or Rcf2 regulate proton transport function of complex
IV. Direct measurement of proton transport by complex IV is not trivial since it
requires purified enzyme inserted in phospholipid vesicles. Detergent purified
enzyme tends to lose stability, activity, and proteolipid context. Alternatively,
complex IV proton transport activity can be accurately inferred from ETC
response to ADP or CCCP, obtained from the oxygen consumption rates (OCR)
measurements in isolated mitochondria (Barrientos 2002; Brand and Nicholls,
2011; Gouspillou et al., 2011). Protonmotive force (PMF) also can be measured
in respiring mitochondria using membrane-potential dye Rhodamine 123 (R123).
In order to dissect the bioenergetic consequences of Rcf1 and/or Rcf2 removal,
measurements of OCR and PMF in intact mitochondria in response to controlled
substrates are presented in this chapter.

Results

3.1. RCF1 or RCF2 can independently support respiratory growth.

In order to understand the bioenergetic consequences of Rcf1 and/or Rcf2
removal, respiratory growth phenotypes of Δrcf1 and Δrcf2 mutants (Δrcf1::HIS3
and Δrcf2::KANMX) in the yeast strain W303-1A were studied. Deletion of RCF1
slightly hindered respiration-based growth (Figure 4A, second column in each
panel). We conclude therefore that deletion of RCF1 does not severely
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compromise the ability of the cell to grow by aerobic respiration in the genetic
background (W303) used in this study.
The deletion of the RCF2 gene by homologous recombination (Materials
and Methods) did not impair growth on non-fermentable carbon sources such as
glycerol (YPG) or lactate (YPL) (Figure 4A, third column in each panel). This is
consistent with the Δrcf2 phenotypes reported in the BY4741 genetic background
(Vukotic et al., 2012, Römpler et al., 2016). In contrast to growth on solid agar,
respiration-based growth of Δrcf2 mutant in liquid media was slower than the wild
type and Δrcf1 strains (Figure 4B). The slower respiration-based growth in liquid
media was not linked to slower glucose de-repression, since this phenotype was
the same whether cultures were pre-grown in YPD or YPG or YPL. Stress, such
as growth in liquid culture or elevated temperature conditions, can enhance
subtle respiratory deficiencies, such as that of the Δcoa6 mutant (Ghosh et al.,
2014). This indicates that the Δrcf2 strain, which otherwise has been described
as showing normal respiration-based growth, has a modest but measurable
respiratory deficiency.
It is possible that slower Δrcf2 respiration-based growth in liquid media is
resulting from the lower concentration of dissolved oxygen compared to that
available on the surface of agar (Somerville and Proctor, 2013). If this was the
case, limiting oxygen levels would decrease Δrcf2 growth solid agar media. To
test this, respiratory growth on solid media was assayed in a hypoxic chamber
(2% oxygen). In contrast to normoxia (21% oxygen), Δrcf2 grew slower than wild
type in a hypoxic chamber (Figure 4C, right panel). This result confirms the sub-
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Figure 4. Respiratory growth of single mutants. (A) Serial dilutions of wild type, Δrcf1, Δrcf2
yeast cells were spotted on YP media containing 2% glucose, 3% glycerol, or 2% lactate and
Figure 4
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incubated at 30˚C for 3 days. In these and subsequent growth assays, the relative cell
concentration is indicated by the black wedges. (B) Overnight wild type (green), Δrcf1 (blue) and
Δrcf2 (orange) liquid cultures were inoculated in fresh liquid YP media containing 2% glucose, 3%
glycerol, or 2% lactate at 30˚C with a starting OD600 of 0.1. OD600 was measured at indicated
times. (C) Serial dilutions of wild type (WT), Δrcf1 (Δ1), Δrcf2 (Δ2) were spotted on YP media
containing 2% glucose or 3% glycerol and incubated at 21˚C for 5 days under normoxia (21%
oxygen) or hypoxia (2.5% oxygen). (D) Serial dilutions done as in (A) and incubated at elevated
temperature (37˚C) for 5 days. In this and subsequent figures, the wild type, Δrcf1, and Δrcf2
mutants are denoted as WT, Δ1, Δ2, respectively.

threshold respiration defect in Δrcf2 strain that was enhanced by limiting oxygen.
Respiration-based growth of Δrcf1 on glycerol was slowed down by
decreased (21˚C) (Figure 4C, second panel) or increased temperature (37˚C)
(Figure 4D, second panel), compared with optimal temperature (Figure 4A,
second panel). This is consistent with the presence of respiratory growth defect
in Δrcf1 strain that can be exacerbated by suboptimal temperature conditions.
In summary, Rcf1 or Rcf2 alone (as in the Δrcf2 and Δrcf1 strains,
respectively) are sufficient for S. cerevisiae respiratory growth under optimal
conditions. Stress conditions such as hypoxia or suboptimal temperature reveal
that the removal of Rcf1 or Rcf2 caused a subthreshold respiratory growth
inefficiency.

3.2. Deletion of RCF1 and RCF2 together impairs respiratory growth.

The Δrcf1;Δrcf2 double mutant was created by mating the single mutant
haploid strains (Δrcf1::HIS3; MAT A and Δrcf2::KANMX; MAT α) to generate a
diploid (RCF1/Δrcf1::HIS3; RCF2/Δrcf2::KANMX). The diploid was subjected to
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sporulation (meiosis) and tetrad dissection to generate double mutant haploid
strains (Δrcf1::HIS3; Δrcf2::KANMX). Respiratory growth of four independently
isolated Δrcf1;Δrcf2 double mutant haploids was analyzed, and all showed
identical growth defect on non-fermentable carbon sources. The Δrcf1;Δrcf2
respiratory growth was slow on glycerol, lactate (Figure 5), methanol, acetate,
succinate, ethanol, as carbon sources (not shown); thus, the respiratory defect
was not linked to inability to utilize a specific carbon source. Some OXPHOS
mutants display increased loss of mitochondrial DNA (rho), resulting in formation
of spontaneous rho0/rho- petite colonies. RCF1 and RCF2 genes were identified
in a genomic screen for alleles associated with abnormal inheritance of
mitochondrial DNA (AIM) (Hess et al., 2009); deletion of these genes individually
decreased the rate of spontaneous rho0/rho- petite colonies. To test whether
accumulating rho0/rho- petite cells was responsible for respiratory deficiency of
the Δrcf1;Δrcf2 strain, the rate of spontaneous rho0/rho- petite colonies was
assessed by colony count on YPG plates supplemented with 0.1% glucose (see
Materials and Methods). The rate of rho0/rho- petite formation was not increased
in Δrcf1;Δrcf2 (0.6 ± 0.8%) compared to wild type (3.3 ± 1.6%).
In summary, the Δrcf1; Δrcf2 mutant strain (but not the Δrcf1 or Δrcf2
single mutants) displays a robust, reproducible growth defect on non-fermentable
carbon sources. No increase in rho0/rho- petite formation was detected in the
mutant. Our lab previously showed that the Δrcf1;Δrcf2 respiratory growth could
be restored by ectopic expression of Rcf1 or Rcf2 protein with C-terminal His12
tag (Strogolova et al., 2012). This is consistent with the RCF1 and RCF2 gene
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products having partially redundant or overlapping function(s) that support
respiration-based growth.

Glucose
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Figure 5. Respiratory growth of Δrcf1;Δrcf2 mutant. Serial dilutions wild type , Δrcf1, Δrcf2,
and the Δrcf1;Δrcf2 (Δ1;Δ2) cultures were spotted on rich (YP) agar containing glucose (2%),
galactose (3%), or non-fermentable substrates glycerol (3%), lactate (2%), and incubated for 3
days at 30˚C. A wild type petite control strain (ρ0) is shown for comparison.

3.3. Deletion of RCF2 increased endogenous cell respiration.

To further explore whether the observed growth defect of the Δrcf1;Δrcf2
cells was due to decreased mitochondrial content of these cells and/or
decreased mitochondrial oxygen consumption, levels of mitochondrial proteins in

60

whole cell extracts and respiration in whole cells were measured. Whole cell
oxygen consumption was measured in cultures in liquid galactose containing
media. Galactose can be used as a fermentable or non-fermentable carbon and
energy source (Lagunas 1986; Herrero et al., 1985; Fendt and Sauer, 2010).
Mitochondrial dysfunction leads to enhanced galactose fermentation (Jelicić et
al., 2005), and the Δrcf1;Δrcf2 grew slower than wild type on galactose, but not
as slow as on glycerol (Figure 5). Despite their respiration-based growth defect,
oxygen consumption in the Δrcf1;Δrcf2 cells was ~90% of the wild type cells
(Figure 6A, Table 4). A similar oxygen consumption rate was measured for the
Δrcf1 cells. Surprisingly, the oxygen consumption rate in Δrcf2 cells was even
increased and was ~140% of that in wild type control. This result is in agreement
with previously reported increased oxygen consumption by Rcf2-deficient
mitochondria with various respiration substrates (pyruvate/malate, succinate,
TMPD/ascorbate, and ADP) (Römpler et al., 2016). The nearly normal or
enhanced oxygen consumption rates indicate that the respiration-based growth
defect observed in the absence of Rcf1 and Rcf2 is not merely due to the inability
of the cells to consume oxygen.
To determine whether cell mitochondrial content was altered (or even
increased) in the absence of Rcf1 and/or Rcf2, levels of mitochondrial proteins in
the cell were analyzed. Whole cell protein extracts were prepared from cultures
grown in galactose and were analyzed by SDS-PAGE and Western blotting
(Figure 6B). Mitochondrial content was determined by measuring the levels of the
mitochondrial outer membrane protein (Por1) and was found to be similar
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Figure 6. Whole cell respiration and mitochondrial content from the Δrcf1, Δrcf2, and
Δrcf1;Δrcf2 mutants. Indicated strains were grown on YPGal to exponential phase and
harvested at an OD600nm=0.6. (A) Endogenous respiration was measured in YPGal grown cells.
KCN-sensitive oxygen consumption rate (OCR) was expressed as % of the wild type. Average ±
SEM is shown and statistical significance (Student’s t-test) p<0.05 denoted by asterisk. (B) Whole
cell protein extracts were analyzed by SDS-PAGE and Western blotting using antibodies to 3phosphoglycerokinase (Pgk1), mitochondrial outer membrane porin (Por1), mitochondrial inner
membrane Tim17, and complex IV subunit 3 (Cox3). Relative band intensity adjusted to Pgk1 is
indicated below each band. The positions of the molecular mass standards are indicated on the
right (in kilodaltons).

Table 4. Whole cell respiration of the Δrcf1, Δrcf2, and Δrcf1;Δrcf2 mutants.
Summary of oxygen consumption data represented in Figure 6A.

Strain
WT
Δ1
Δ2
Δ1;Δ2

Cell endogenous respiration
% of WT
100
92 ± 3
141 ± 7
89 ± 13

Figure 3
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between all cell types. The ratio of Por1 to the cytoplasmic protein 3phosphoglycerate kinase (Pgk1) was not affected by the absence of Rcf1 or Rcf2
(Por1/Pgk1 signal in wild type= 1.0, Δrcf1 = 0.8, Δrcf2 =1.2, Δrcf1;Δrcf2 = 1.1)
(Figure 6B). Similar result was obtained for the levels of the inner membrane
translocase subunit protein Tim17. Tim17 and Por1 are proteins that are
constutively expressed and frequently used to evaluate mitochondrial levels. We
conclude therefore that the absence of Rcf1 and Rcf2 did not alter the cell’s
mitochondrial levels. In contrast, the levels of complex IV marker, subunit 3
(Cox3) were decreased in Δrcf1, Δrcf2 and Δrcf1;Δrcf2 cells compared to the wild
type cells, indicating a decrease in complex IV (Figure 6B). This indicates
decrease in complex IV steady state levels relative to other mitochondrial
membrane proteins (see section 3.4.).
In summary, the analysis of whole cell respiration and mitochondrial
content established that the observed impaired growth of the Δrcf1;Δrcf2 strain
on non-fermentable carbon sources is not due to limiting mitochondrial levels or
the ability of these mitochondria to consume O2. Moreover, the enhanced O2
consumption rate of the Δrcf2 strain may suggest an inefficiency of the ETC
system to generate and/or maintain a PMF, and thus require an elevated O 2
consumption rate to maintain the PMF at levels required to sustain OXPHOSbased ATP synthesis.

3.4. Deletion of Rcf1 and Rcf2 lower complex IV steady-state levels, but
deletion of Rcf1 is epistatic to deletion of Rcf2.
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Both complexes III and IV contribute to the establishment of the PMF. To
gain more insight into the possible problem with establishing or maintaining the
PMF in the absence of Rcf2 (and possibly Rcf1), the content and activities of
these enzymes in isolated mitochondria were initially analyzed.
The cytochromes of the OXPHOS complexes within the mitochondria are
heme-containing proteins, whose spectral properties can be used to quantify
their content. The complex III (cytochrome bc1) and complex IV (cytochrome aa3)
levels were initially quantified in the wild type or mutant mitochondria by
recordings of the dithionite reduced – ferrocyanide oxidized spectra (Figure 7A,
Table 5). In Δrcf2, complex IV cytochrome aa3 levels were moderately decreased
to 69% of the wild type levels. In Δrcf1, the cytochrome aa3 levels were
decreased more substantially (52% of wild type). The cytochrome aa3 levels in
the Δrcf1;Δrcf2 mitochondria (49% of wild type) were similar to those measured
in the Δrcf1 mitochondria (Table 5).

Table 5. Quantification of mitochondrial cytochromes
The absorption bands corresponding to cytochromes (aa3, b, and cc1) were quantified using A603
nm (to account for sloping baseline, a baseline was hand-drawn through A700 and A630 and
extended to 603 nm), A560 nm (baseline at A575 was subtracted) and A550 nm (baseline at
A575 was subtracted). Average and S.E.M. values are reported, expressed as % of wild type
control.

Strain
WT
Δ1
Δ2
Δ1;Δ2

aa3
100 ± 4
52 ± 15
69 ± 10
49 ± 7

b
100 ± 6
116 ± 4
122 ± 2
155 ± 12

cc1
100 ± 5
92 ± 7
92 ± 6
129 ± 11
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Figure 7. Levels of mitochondrial cytochromes and OXPHOS complexes III and IV. (A)
Dithionite reduced – ferrocyanide oxidized spectra of mitochondrial cytochromes. 1 mg of
mitochondria was solubilized in 50 mM Tris-KCl, 2% DDM, pH 7.4 for the analysis. Spectra of
complex IV core cytochromes a, a3 (603 nm peak) in wild type (green), Δrcf1 (blue), Δrcf2
(orange), and the Δrcf1;Δrcf2 (red) mitochondria are enlarged in the inset to show detail. (B)
Steady-state levels of supercomplexes components from wild type, Δrcf1, Δrcf2, and the
Δrcf1;Δrcf2 mitochondria (25 μg protein) analyzed by SDS-PAGE, Western blotting and
immunodecoration with the antibodies to: α-Cob/Cytc1 for cytochromes b (upper band) and c1
(lower band), α-Cyc1 for cytochrome c, α-Cox1, and α-Tim44 as indicated). Tim44 was used as a
loading control. (C) Mitochondria (30 µg protein) isolated from wild type, Δrcf1, Δrcf2, and the
Δrcf1;Δrcf2 strains were solubilized in 1% digitonin and subjected to BN-PAGE analysis, Western
blotting, and immunodecoration with antibodies α-Cytc1 for complex III component cytochrome c1.
(D) BN-PAGE analysis performed as in (C) except 0.6% DDM was used instead of digitonin, and
antibodies α-Qcr7 for complex III component Qcr7 c, α-Cox3 for complex IV component Cox3,
were used as indicated.
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The levels of complex III cytochromes b and c1, and soluble electron
carrier cytochrome c were not negatively affected in the absence of Rcf1 or Rcf2.
An increase in spectral signal corresponding to reduced b type cytochromes
without a corresponding increase in the signal corresponding to the c type
cytochromes, was observed in Δrcf1, Δrcf2, and Δrcf1;Δrcf2 mitochondria without
a corresponding increase in the signal corresponding to the c type cytochromes,
thus resulting in an increase in the apparent ratio of b:cc1 (Table 5).
Immunodetection of complex III components cytochrome b and
cytochrome c1 with Cob (cytochrome b) and Cyc1 (cytochrome c1) specific
antibodies indicated that complex III components were not affected by the
RCF1/2 deletion (Fig 7B). Cytochrome c levels were also found not to be
compromised. Increased levels of other cytochrome b-containing proteins, such
as cytochrome c peroxidase, cytochrome b2, catalase, or yeast flavohemoglobin
(Yhb1) may be contributing to the increased cytochrome b signal. Reduced levels
of the Cox1 protein (containing cytochromes a,a3) were observed in the Δrcf1
and Δrcf1;Δrcf2 mitochondria, a result which is consistent with the measured
cytochrome aa3 spectral content (Figure 7B).
Spectral quantification of complex III and complex IV cytochromes
operates under an assumption that extinction coefficient properties of the
cytochromes are not altered by the deletion of Rcf1 or Rcf2. While the spectral
absorption maxima of the cytochromes was not altered, not sufficient evidence is
available to validate this assumption. Therefore, steady state levels of the III and
IV complexes were assayed using an independent method, BN-PAGE followed
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by Western blotting. BN-PAGE can be used to detect the level and assembly
state of the III-IV supercomplex populations (when mitochondria are solubilized
with the mild detergent, digitonin), or for the individual complexes III and IV
(when mitochondria are solubilized with a stronger detergent, dodecylmaltoside
(DDM)). Using an antibody against cytochrome c1 (of complex III), in wild type
mitochondria majority of the supercomplex III-IV was observed to be present in
the III2-IV2 form, whereas in the absence of Rcf1, an increase in the levels of III2IV2 and III2 forms relative to III2-IV2 supercomplex form was observed. A similar
result was obtained with the Δrcf1;Δrcf2 mitochondria, whereas the absence of
Rcf2 had not great effect on the III2-IV2 supercomplex organization, which largely
mirrored that of the wild type control. Thus, it appears that slightly lower
cytochrome aa3 content in the Δrcf2 mutant does not noticeably alter the level of
the III2-IV(1-2) supercomplex assembly.
Analysis of the levels of the individual III and IV complexes following DDM
solubilization confirmed the levels of complex III in the Δrcf1, Δrcf2, and
Δrcf1;Δrcf2 mitochondria levels were similar to those of the wild type control, a
result which is consistent with the spectral analysis (Figure 7B). Antibody to
complex IV Cox3 subunit detected the previously described two forms of complex
IV in DDM solubilized mitochondria (Figure 7B). The two forms, designated IV
and IV*, differ in the association of subunit Cox13 and Cox12 (Vukotic et al.,
2012, Garlich et al., 2017). As reported previously, when RCF1 is deleted, there
was a decrease in both the IV and IV* populations (Figure 7B). A similar
decrease in IV and IV* was observed in Δrcf1;Δrcf2 mitochondria, indicating that
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the levels of the IV and IV* were not further adversely impacted when Rcf2 in
addition to Rcf1 was absent. The qualitative nature of BN-PAGE analysis
precludes complete certainty, yet the levels of IV and IV* in the Δrcf2
mitochondria appeared similar to wild type levels.
To summarize, complex IV (cytochrome aa3) is decreased to a similar
extent in the Δrcf1 and Δrcf1;Δrcf2 mitochondria, indicating that the deletion of
RCF2 in the Δrcf1 background does not further decrease complex IV steady
state levels. Thus, despite having similar reduced levels of complex IV the
Δrcf1;Δrcf2 mutant displays a strong respiratory growth defect, whereas the
single Δrcf1 mutant does not. As the growth defect of the Δrcf1;Δrcf2 mutant
cannot be solely attributed to a reduced content of complex IV, this result
prompted us to investigate complex III and IV enzymatic activities to explain the
respiratory growth deficiency of the Δrcf1;Δrcf2 mutant.

3.5. Rcf1 and Rcf2 support complex IV electron transport activity, but
deletion of Rcf1 is epistatic to deletion of Rcf2.

Complex III and IV relative specific enzyme activities in the absence of
Rcf1 and/or Rcf2 were determined by spectrally monitoring the rate of exogenous
cytochrome c reduction or oxidation, respectively. The cytochrome c reduction
assay indicated that the activity of detergent solubilized complex III in wild type,
Δrcf1, and Δrcf2 was similar, while in Δrcf1;Δrcf2 mitochondria it was even
increased (Figure 8A, Table 6 first column). The cytochrome c oxidation assay
indicated that the activity of detergent-solubilized complex IV was substantially
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Table 6. Complex III and complex IV activity in mitochondria from the Δrcf1, Δrcf2, and
Δrcf1;Δrcf2 mutants.
Reduction (complex III activity, WT (n=9), Δ1 (n=9), Δ2 (n=9), Δ1;Δ2 (n=9)) or oxidation (complex
IV activity, WT (n=23), Δ1 (n=9), Δ2 (n=4), Δ1;Δ2 (n=21)) of exogenous cytochrome c was
measured spectrophotometrically (Materials and Methods), and expressed as % of the wild type.
Complex IV activity was also measured as oxygen consumption rate (OCR, nmol O2 / minute /
mg protein). OCR was recorded at 30˚C upon the addition of complex IV specific substrate TMPD
with ascorbate (Asc/TMPD, 12.5 mM ascorbate/1.4 mM TMPD) to mitochondria (20 µg) in
presence (WT (n=11), Δ1 (n=3), Δ2 (n=6), Δ1;Δ2 (n=5)) and absence (WT (n=11), Δ1 (n=6), Δ2
(n=6), Δ1;Δ2 (n=5)) of uncoupler CCCP (10µM). Auto-oxidation of Asc/TMPD substrate
measured without mitochondria was subtracted from the OCR. Average and S.E.M. values are
reported; **, p value < 0.01; *, p value < 0.05.

NADH - cytochrome c reductase
(complex III)
% of WT

Cytochrome c oxidase
(complex IV)
% of WT

WT

100 ± 14

100 ± 6

Δrcf1

83 ± 6

** 31 ± 3

Δrcf2

105 ± 12

** 62 ± 2

Δrcf1;Δrcf2

**126 ± 14

** 28 ± 2

Asc/TMPD OCR
(complex IV)
nmol O2/min/mg

Asc/TMPD
+ CCCP OCR
(complex IV)
nmol O2/min/mg

+/- CCCP ratio
(effect of PMF)

WT

620 ± 30

1419 ± 62

2.3

Δrcf1

**338 ± 30

** 527 ± 12

1.6

Δrcf2

*486 ± 28

** 999 ± 26

2.1

Δrcf1;Δrcf2

** 278 ± 12

** 404 ± 19

1.5
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mitochondria. (A) Complex III activity. Mitochondria (20 µg protein) were solubilized as
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decreased in Δrcf1 mitochondria (31% of the wild type levels) while it was
decreased to a lesser extent in Δrcf2 mitochondria (62% of the wild type) (Figure
8B, Table 6 second column). The cytochrome c oxidation rate in Δrcf1;Δrcf2
mitochondria (27% of the wild type) was not significantly different from that of the
Δrcf1 mitochondria, allowing us to conclude that removal of Rcf2 does not further
impair electron transport activity of complex IV in the Δrcf1 background.
The cytochrome c reduction and oxidation assays are normally performed
at the physiological conditions of high ionic strength (I=120 mM) (Cortese et al.,
1995), which support the electrostatic interaction of cytochrome c with the IM.
Electrostatic interactions support cytochrome c binding to complex IV distant lowaffinity binding site (Moreno-Beltrán et al., 2015) from which site it is channeled
to the site of its oxidation formed by complex IV subunits Cox2, Cox12, and
Cox13 (Shimada et al., 2017). A previous study (Rydström Lundin et al., 2016)
found that Δrcf1 mitochondria display different oxidation kinetics with
exogenously added horse heart cytochrome c than with the yeast cytochrome c,
and proposed a role for Rcf1 in recruiting or coordinating cytochrome c to the
supercomplex. Additionally, affinity between mammalian HIGD1A protein and
cytochrome c was reported (Guerra-Castellano et al., 2018). If Rcf1 and Rcf2 are
necessary for recruiting cytochrome c, the complex IV activity in Δrcf1;Δrcf2 and
mitochondria may be sensitive to disruption of the electrostatic interactions. To
test this possibility, sensitivity of cytochrome c oxidation to lower buffer ionic
strength was assayed. Lowering buffer ionic strength decreases electrostatic
interactions that support cytochrome c availability and oxidation by complex IV.
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The cytochrome c oxidation activities in wild type and Δrcf1;Δrcf2 mitochondria
were equally sensitive to inhibition by lower salt concentration (Figure 8C). This
result indicates that the absence of Rcf1 and Rcf2 did not negatively affect
cytochrome c binding or recruitment to complex IV.
The cytochrome c reduction and oxidation assays are performed with
detergent-solubilized mitochondria in the presence of excess cytochrome c. This
is necessary to quantify changes in cytochrome c redox spectra. A second
independent approach was used to compare the rate of complex IV specific
oxygen consumption in intact mitochondria, and compare complex IV electron
transport activity in Δrcf1 and Δrcf1;Δrcf2 mutants. Oxygen consumption rate
(OCR) was calculated as the change in oxygen concentration over time,
measured using an oxygen electrode. TMPD/ascorbate, complex IV specific
substrate was used to supply electrons to endogenous cytochrome c. The use of
TMPD bypasses the upstream ETC complexes, bioenergetically isolating
complex IV activity. This allows us to measure the oxygen consumption capacity
of the complex IV enzyme.
Complex IV specific OCR’s were decreased in Δrcf1, Δrcf2, and in Δrcf1;
Δrcf2 mitochondria (Δrcf1 = 55%, Δrcf2 = 78%, Δrcf1;Δrcf2 = 45% of the wild
type control) (Figure 8D and Table 6 third column). The decrease in the complex
IV activity was less in intact mitochondria than the aforementioned cytochrome
aa3 levels and in the cytochrome c oxidation assays. This could be due to
complex IV activity being less constrained by the PMF.
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PMF was completely dissipated by the addition of an uncoupling
ionophore CCCP, stimulating maximal oxygen consumption since complex IV
was no longer controlled by the PMF. Maximal complex IV OCR in the presence
of CCCP was determined to be strongly decreased in Δrcf1 (37% of the wild
type) while it was reduced to a lesser extent in Δrcf2 mitochondria (70% of the
wild type); and was not significantly less in Δrcf1;Δrcf2 mitochondria (28% of the
wild type) than in Δrcf1 (Figure 8D, Table 6 fourth column). This maximal
complex IV OCR was consistent with complex IV activity levels determined by
other assays, and indicated that Rcf1 and Rcf2 functionally overlap with respect
to complex IV electron transport activity.
Complex IV oxygen consumption was stimulated by the addition of CCCP
in all mitochondrial samples (Table 6). This indicates the extent of the constraint
imposed by the PMF. CCCP stimulation was smaller in the absence of Rcf1 or
Rcf2 compared to wild type control (Table 6 last column). This indicates that PMF
maintenance requires greater utilization of complex IV oxygen consumption
capacity in mitochondria lacking Rcf1 and/or Rcf2. These results are consistent
with uncoupling, or partial loss of PMF in the mutant mitochondria and are
consistent with elevated whole cell respiration in the absence of Rcf2.
To summarize, the absence of Rcf2 in the Δrcf1 background does not
further decrease complex IV content or electron transport from cytochrome c to
oxygen. The cytochrome c reduction and oxidation rates were not significantly
different in Δrcf1;Δrcf2 mitochondria from those of the Δrcf1 mitochondria.
Therefore, decreased electron transport activity due to decreased complex IV
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levels cannot explain respiratory growth defect of the Δrcf1;Δrcf2 strain which is
not as pronounced as in the Δrcf1 strain. Decreased CCCP-dependent
stimulation of oxygen consumption by the mutant mitochondria suggests that the
Δrcf1;Δrcf2 uses more of its complex IV capacity to maintain PMF. Similar to
elevated cellular oxygen consumption in the absence of Rcf2 (Figure 6), these
results are consistent with the uncoupling, or loss of PMF in the Δrcf2 strain. If
the capacity to maintain the PMF is worse in the Δrcf1;Δrcf2 than in the single
mutants, it would likely result in respiratory growth defect, because the PMF
supports the F1FO ATP synthase-driven ATP synthesis and other mitochondrial
functions.

3.6. Elevated state 2 and lowered state 3 respiration indicated that deletion
of Rcf1 and Rcf2 impairs OXPHOS coupling.

To further investigate the nature of OXPHOS uncoupling in Δrcf1;Δrcf2
mitochondria, we performed oxygen consumption and membrane potential
measurements. Respiration measurements in intact mitochondria with controlled
substrates are a powerful bioenergetic tool that reveal many aspects of
mitochondrial function: oxygen consumption is proportional to the total proton
current flowing in mitochondria. The activity of the individual ETC complexes,
ATP synthase activity, and the magnitude of proton leak, could be inferred from
the OCR’s because of a tight coupling between electron and proton transfer and
the requirement of the PMF established by the ETC to support the ATP synthesis
activity of the F1FO ATP synthase enzyme.
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Isolated mitochondria from the wild type, Δrcf1, Δrcf2, and Δrcf1;Δrcf2
strains were subjected to bioenergetic profiling. In the presence of a respiratory
substrate, such as NADH, mitochondria respire at a steady low rate (state 2).
State 2 oxygen consumption counteracts intrinsic proton leak across
phospholipid membranes in the absence of ongoing ATP synthesis. Elevated
state 2 oxygen consumption was observed in Δrcf2 and in Δrcf1;Δrcf2
mitochondria (Figure 9A, Table 7 first column), despite the reduced levels of
cytochrome aa3 and complex IV. This result suggests the Δrcf2 mitochondria
exhibit difficulty in maintaining an optimal PMF. Elevated state 2 oxygen
consumption in Δrcf2 mitochondria from BY4741 strain was previously reported
but not further investigated (Römpler et al., 2016). Interestingly, state 2 OCR was
not just elevated in Δrcf1;Δrcf2 mitochondria, but it increased during the time of
the assay, in contrast to the state 2 OCR of the wild type control (Figure 9B). This
increase in OCR was observed in Δrcf1;Δrcf2 mitochondria did not appear to be
linked to PMF consumption by the F1FO ATP synthase since it was still observed
in the presence of the F1FO ATP synthase inhibitor oligomycin (Figure 9C).
When ADP is added to mitochondria (condition known as state 3), oxygen
consumption accelerates since ATP synthesis consumes PMF. Following ADP
addition, OCR peaks and then returns to pre-ADP level. State 3 OCR peak in the
Δrcf1 and Δrcf1;Δrcf2 mitochondria was lower than wild type; state 3 OCR peak
in the Δrcf2 mitochondria was similar to wild type (Figure 10A, Table 7 second
column). The OCR peak associated with ATP synthesis was not observed in
Δrcf1;Δrcf2 mitochondria; the increase in OCR was stunted and only slightly
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Figure 9. Deletion of Rcf1 and Rcf2 results in increased state 2 respiration. (A) State 2
respiration (oxygen consumption rate, nmol O2 / minute / mg protein) was measured for 6-8
minutes after the addition of with NADH. Averages and SEM of at least 4 experiments are shown.
(B) Changes in OCR with NADH (state 2 respiration) over 10 minute time period. (C) Effect of
oligomycin on state 2 respiration in Δrcf1;Δrcf2 mitochondria and wild type control. Mitochondria
(40 µg) were added 0 minutes, immediately followed by oligomycin (state 2oligo) or vehicle
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experiment is shown.
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Table 7. Oxygen consumption by mitochondria from the Δrcf1, Δrcf2, and Δrcf1;Δrcf2
mutants.
Mitochondria (40 µg) were isolated from indicated strains grown in YPGal at 30˚C and
resuspended in buffer. OCR was recorded at 30˚C upon the addition to mitochondria of NADH
(1mM) (state 2, WT (n=6), Δ1 (n=5), Δ2 (n=9), Δ1;Δ2 (n=4)), or NADH (1mM) + ADP (200 µM)
(state 3, WT (n=5), Δ1 (n=4), Δ2 (n=4), Δ1;Δ2 (n=7)), or NADH (1mM) + CCCP (10µM) (maximal,
WT (n=6), Δ1 (n=3), Δ2 (n=4), Δ1;Δ2 (n=3)). No substrates auto-oxidation was detected without
mitochondria. Average and S.E.M. values are reported, **, p value < 0.01; *, p value < 0.05.

OCR
NADH

(nmol O2/min/mg)

NADH + ADP

NADH + CCCP

+/ADP
ratio

+/CCCP
ratio

WT

184 ± 10

423 ± 18

874 ± 63

2.19

4.53

Δrcf1

207 ± 13

** 344 ± 22

** 398 ± 56

1.66

2.03

Δrcf2

** 258 ± 17

452 ± 72

** 530 ± 40

1.75

2.05

Δrcf1;Δrcf2

** 269 ± 13

** 358 ± 16

** 362 ± 6

1.33

1.35

exceeded the observed increasing state 2 OCR (Figure 10B, Figure 9B).
Following state 3, ADP/ATP equilibrium is restored, and PMF is reestablished,
the OCR will decrease to a steady low rate again (state 4). The Δrcf1;Δrcf2
mitochondria were unable to return to the pre-ADP OCR; Δrcf1;Δrcf2 state 4
OCR remained higher than state 2 OCR, in contrast to wild type control. The
increased state 2 OCR in the Δrcf1;Δrcf2 mitochondria is utilizing almost all ETC
capacity and leaves very little reserve (Figure 10A). To account for the state 2
differences between different mitochondrial types and illustrate the OXPHOS
capacity in both the Δrcf1 and Δrcf1;Δrcf2 mitochondria, the level of ADPstimulated O2 consumption was calculated (i.e. state 3 minus state 2 OCRs at the
peak time) at 50, 100, and 200 µM ADP. The ADP-stimulated O2 consumption
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was less in Δrcf1;Δrcf2 mitochondria than in the Δrcf1 at all ADP concentrations
tested (Figure 10C). This was also reflected by the respiratory control ratio
(RCR), the ratio of state 3 / state 2 oxygen consumption rate. RCR decreased in
the absence of Rcf1 and further decreased in the absence of both Rcf1 and Rcf2
(+/- ADP, wild type = 2.19, Δrcf1 = 1.66, Δrcf2 = 1.75, Δrcf1;Δrcf2 = 1.33, Table
7, fourth column). As a result, the bioenergetic capacity to support ATP synthesis
is most compromised in the Δrcf1;Δrcf2.
The addition of an uncoupling ionophore such as CCCP stimulates the OCR
because the ETC enzymes are no longer constrained by the PMF (maximal
OCR. Maximal OCR measured in the Δrcf1, Δrcf2, and Δrcf1;Δrcf2 mitochondria
with NADH as a substrate was decreased (Table 7). The absolute OCR in
presence of CCCP obtained with different ETC substrates is not the same. This
is illustrated by the smaller maximal OCR with NADH as a substrate (Figure 10A,
Table 7) than with the TMPD/Ascorbate (Figure 8E, Table 6). TMPD supports a
higher maximal OCR because the electrons directly reduce complex IV via
endogenous cytochrome c and bypass the upstream ETC enzymes, NADH
dehydrogenase and complex III. With NADH as the substrate, the CCCP
stimulation was smaller in the absence of Rcf1 or Rcf2 compared to wild type
control (Table 7). Smaller CCCP-dependent stimulation of oxygen consumption
by the mutant mitochondria supports the conclusion that PMF maintenance is
impaired in mitochondria lacking Rcf1 and/or Rcf2.
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Figure 10. Lower ATP synthesis associated respiration indicates that Rcf1 and Rcf2
deletion decreased OXPHOS coupling. (A) Comparison of the OCR with NADH (state 2),
NADH + 0.2 mM ADP (state 3), and NADH + CCCP (Maximal). Averages of at least 4
experiments are shown. (B) Changes in OCR with NADH (state 3 respiration). Arrows indicate
NADH (1 mM) and ADP (50 µM) additions. (C) State 3 - state 2 respiration indicates the OCR
stimulation associated with ATP synthesis. Arrows indicate NADH (1 mM) and ADP (50-200 µM)
additions. Averages of at least 4 experiments is shown.
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Previous experiments already established decreased complex IV levels
and the electron transport capacity of complex IV and the electron transport
chain in the absence of Rcf1 and to a lesser extent in the absence of Rcf2. The
deletion of both Rcf1 and Rcf2 did not lead to greater decrease in the complex IV
levels and electron transport activity than the deletion of Rcf1 alone. However,
the respiration profiling indicates that deletion of both Rcf1 and Rcf2 was additive
with the respect to the OXPHOS coupling, and resulted in a more severe
impairment than the deletion of Rcf1 alone.

3.7. Rcf1 and Rcf2 promote optimal mitochondrial PMF.

The mitochondrial PMF driving the protons from the IMS into the matrix is
a combination of both the mitochondrial membrane potential (Δψ, a charge or
electrical gradient) and the mitochondrial pH gradient (ΔpH). Typical PMF values
range from 180 to 220 mV, with Δψ contributing 150-180 mV, and ΔpH of 0.5-1.0
units contributing the remaining 30-60 mV (Nicholls and Ferguson, 2013).
To directly investigate the ability of the Δrcf1;Δrcf2 mitochondria to
establish and maintain PMF during state 2, state 3 depolarization, and state 4
repolarization, Δψ measurements in isolated mitochondria were performed using
the lipophilic, cationic dye Rhodamine-123 (R123). R123 dye accumulates within
mitochondria forming aggregates, which quenches some of its fluorescent
emission. Under these conditions, once the dye is loaded into the mitochondria, a
subsequent depolarization releases some of the dye, unquenching the loaded
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dye, and transiently increasing the fluorescent signal. On the other hand, a
repolarization will cause more dye to enter the mitochondria and cause a relative
decrease in a fluorescent signal. R123 is sensitive to mitochondrial charge (Δψ)
and does not measure pH specifically (Perry et al., 2011). However, respiring
mitochondria maintain constant PMF, thus the changes in Δψ parallel the
changes in ΔpH, while different in magnitude.
Isolated mitochondria were resuspended in a buffer containing R123 and placed
in a fluorimeter (S. Saddar, PhD dissertation). In wild type mitochondria, stable
quenching of R123 fluorescence signal was achieved during state 2 respiration
when NADH was used as a substrate. Upon the addition of ADP to drive state 3
respiration, a peak in R123 fluorescence signal was observed, corresponding to
a transient loss of mitochondrial quenching of the dye fluorescence due to
transient state 3 depolarization (Figure 11A). The depolarization indicates the
entry of protons through the ATP synthase, which lowers both pH and charge
components of the PMF. This fast depolarization was followed by somewhat
slower repolarization due to ETC-dependent proton translocation. At the end of
repolarization, mitochondria re-establish state 4 membrane potential comparable
to state 2 prior to ADP addition, and R123 fluorescence quenching. Complex III
and IV regenerate ΔpH to maintain state 4 PMF. At the end of each experiment,
the PMF was dissipated by addition of an uncoupler, CCCP. CCCP addition
completely depolarizes mitochondria, results in some dye molecules exiting the
mitochondria, and the fluorescence signal of the loaded dye increases, observed
as unquenching. The magnitude of R123 fluorescence after CCCP addition was
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Figure 11. Changes in state 2 and state 3 membrane potential in mitochondria from the
Δrcf1, Δrcf2, and Δrcf1;Δrcf2 mutants. (A) Representative R-123 fluorescence traces.
Mitochondria (150 µg) were resuspended in 2 ml buffer containing 0.5 µM R-123 (in methanol);
additions were NADH (2 mM), ADP (45 µM), CCCP (10 µM). (B) Membrane potential (% R123
fluorescence quenching) was calculated as a % difference in signal in the presence between
NADH and NADH+CCCP (state 2, black bars) or NADH+ADP and NADH+CCCP (state 3, gray
bars). The average and SEM are shown (WT (n=3), Δ1 (n=2), Δ2 (n=3), Δ1;Δ2 (n=3)). (C)
Average time after the addition of ADP to achieve state 4 membrane potential. The average and
SEM are shown (WT (n=3), Δ1 (n=2), Δ2 (n=3), Δ1;Δ2 (n=3)).
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set to 100% and R123 fluorescence levels during state 2 and state 3 quenching
were expressed as % change from that value. The time required to repolarize
after the addition of ADP was monitored and interpreted to be an indication of the
capacity of proton pumping by complex IV (as well as proton translocation by
complex III) to offset dissipation of membrane potential required for ATP
synthesis.
All mutants established lesser state 2 membrane potential with NADH
than the wild type. When energized with NADH substrate (state 2), wild type
mitochondria quenched ~45% of R123 fluorescence, while Δrcf2 mitochondria
had ~35% quenching, indicating that these mitochondria have reduced capacity
to generate PMF. Quenching was similar (~25%) in Δrcf1 and Δrcf1;Δrcf2 (Figure
11B). State 3 respiration was induced by the addition of 45 µM ADP. Wild type
mitochondria R123 signal changed from ~45% quenched to ~30% quenched
during peak depolarization. Lesser depolarization (smaller state 3 peak) was
observed in Δrcf1 (from ~25% to ~17%) and Δrcf1;Δrcf2 mitochondria (from
~26% to 16%) showed than the wild type (Figures 11A and 11B). State 3
depolarization was minimal in Δrcf2 (from ~35% to ~30%). This indicates
decreased rate of ATP synthesis / entry of protons through the F1FO ATP
synthase in the absence of Rcf1 and/or Rcf2, possibly because the capacity to
regenerate ΔpH needed for ATP synthesis is inadequate.
Repolarization time was increased in Δrcf2 (168 seconds) and Δrcf1;Δrcf2
mitochondria (295 seconds); Δrcf1;Δrcf2 mitochondria took twice the time to reestablish state 4 PMF compared to wild type mitochondria (119 seconds) (Figure
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11C). More severe repolarization delay was associated with the absence of Rcf2
(Δrcf2 repolarization times were significantly longer than wild type, and
Δrcf1;Δrcf2 were significantly longer than Δrcf1). These findings suggest that in
the absence of Rcf2 the ΔpH component of the PMF is limiting, indicating an
impaired proton translocation during state 3, despite elevated OCR. Further
lengthening of repolarization time in Δrcf1;Δrcf2 mitochondria indicate that their
capacity to generate and maintain ΔpH is more severely compromised compared
to the Δrcf1 and Δrcf2 single mutants.

3.8. Deletion of RCF2 sensitized respiratory growth to nigericin.

Evidence presented so far indicates that the mitochondria become
uncoupled, i.e. unable to generate and/or maintain an optimal PMF, in the
absence of Rcf1 and Rcf2. To test whether uncoupling through dissipation of
ΔpH affects respiration-based growth in the absence of Rcf1 or Rcf2, growth
assays were done in the presence of low concentration of PMF uncoupler
nigericin. Nigericin is an electroneutral K+/H+ antiporter which dissipates ΔpH, the
mitochondrial proton gradient, and diverts the ETC from supporting ATP
synthesis. Nigericin does not dissipate membrane potential Δψ dependent on the
exchange of other charged ions, including potassium, across the mitochondrial
inner membrane. Nigericin action in the cell is specific to mitochondrial
membrane, and therefore it is suitable for whole cell growth assays (Kovac et al.;
1982, Kucejova et al., 2005). When the wild type control cells were grown on
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1µM nigericin, their respiration-based ability to grow on galactose and glycerol
was compromised but not completely inhibited, indicating that this level of
nigericin was subtoxic for OXPHOS-based growth. The growth of Δrcf2 on
galactose displayed a heightened sensitivity to nigericin (Figure 12). Thus,
despite its normal growth on glycerol media (compared to wild type control) the
increased nigericin sensitivity of the Δrcf2 mutant indicates its reduced capacity
to establish/maintain a sufficient PMF, an observation consistent with the
elevated O2 consumption rate of this mutant. Sensitivity to nigericin in galactose
media was observed in the Δrcf1;Δrcf2 mutant, but not in the Δrcf1 (Figure 12).
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Figure 12. Sensitivity of Δrcf1, Δrcf2, and the Δrcf1;Δrcf2 respiratory growth to an
uncoupler nigericin. Serial dilutions of wild type (WT), Δrcf1 (Δ1), Δrcf2 (Δ2), and the
Δrcf1;Δrcf2 (Δ1;Δ2) cultures were spotted on YP agar containing 2% glucose, 2% galactose, or
3% glycerol, with or without 1 µM nigericin, as indicated. The relative cell concentration is
indicated by the black wedges.
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Nigericin inhibited the growth of Δrcf2, Δrcf1, and Δrcf1;Δrcf2 on glycerol media
(Figure 12).

Summary

This study of the consequences of Rcf1 and Rcf2 deletion for the
mitochondrial bioenergetic energy conversion demonstrated the importance of
coupling proton pumping to oxygen consumption, and preventing proton leak
during the electron transport, known as OXPHOS coupling . ETC complex III and
complex IV enzymes both generate PMF, which is necessary for the ATP
synthesis by the F1FO ATP synthase and other essential processes driven by the
ΔpH-dependent proton current. Decreased OXPHOS coupling and PMF may
indicate altered complex IV proton pumping stoichiometry or proton back-leak
through the enzyme, resulting in chronic sustained decreased PMF generation.
Additinally, the phenomenon of acute instability of PMF or proton leak indicates
proton leak that may be mediated by complex IV or other sources of proton leak.
The objective of this research was to better understand the common and
distinct functions of Rcf1 and Rcf2 and explain the impaired respiration-based
growth of the Δrcf1;Δrcf2 mutant, as deletion of RCF1 and RCF2 individually
does not strongly impair respiratory growth. Deletion of RCF1, more so than
deletion of RCF2, lead to decreased complex IV steady state levels and electron
transport activity (Figure 7, Figure 8), consistent with cytochrome oxidation
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activity reported by others (Rydström Lundin et al., 2016). In Δrcf2 mitochondria,
complex IV content and electron transport from cytochrome c to oxygen were
somewhat decreased, to 70% of the wild type control. Thus, Rcf2 plays a minor
role, if at all, in complex IV assembly or stability. With respect to complex IV
levels and electron transport activity, deletion of RCF1 was epistatic to deletion of
RCF2 as these were not statistically different between Δrcf1 and Δrcf1;Δrcf2
mutants.
Of note, cytochrome c oxidation assay in this study utilized titrated
cytochrome c reductant (dithiothreitol) to avoid extra reductant remaining in the
assay, and a detergent (dodecylmaltoside instead of deoxycholate) considered to
be optimal for complex IV activity assays (Thompson and Ferguson-Miller 1983,
Rosevear et al., 1980). As a result, cytochrome c oxidase activity reported here
differs quantitatively from our previously published results obtained using a
different cytochrome c reduction method (with sodium dithionite) prone to
artifacts due to excess of the reductant (our previous values were 70% of the wild
type activity in Δrcf1, 95% of the wild type activity in in Δrcf2, and 20% of the wild
type activity in in Δrcf1;Δrcf2) (Strogolova et al., 2012). Importantly, cytochrome c
oxidase activities obtained in all subsequent experiments were not statistically
different between Δrcf1 and Δrcf1;Δrcf2 mutants.
Deletion of RCF2 led to reduced respiration-based growth in spite of
elevated oxygen consumption rate. This is consistent with decreased respiratory
coupling in the absence of Rcf2. Corroborating these phenotypes, increased
sensitivity of Δrcf2 respiration-based growth to uncoupler nigericin and lower
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PMF was observed in Δrcf2 mitochondria despite the elevated oxygen
consumption. Therefore, respiratory coupling during PMF generation appears to
be a function distinctly supported by Rcf2, likely by regulation of complex IV
proton pumping activity.
The effect of Rcf1 and Rcf2 deletion on the OXPHOS coupling was
cumulative. Increasing state 2 OCR (NADH) indicated an enhanced and
progressive proton leak in the Δrcf1;Δrcf2 mitochondria. Interestingly, Δrcf1 and
Δrcf1;Δrcf2 mitochondria achieved similar state 2 membrane potential, indicating
that the progressive increase in ETC activity was temporarily able to counteract
proton leak in Δrcf1;Δrcf2 in the absence of ATP synthesis. Yet monitoring PMF
return to state 4 after ADP addition revealed that re-polarization is also affected
by the deletion of Rcf2: Δrcf1 mitochondria repolarized with kinetics similar to
wild type, whereas Δrcf1;Δrcf2 and Δrcf2 mitochondria repolarized more slowly.
These membrane potential measurements were consistent with state 3 OCR
measurements and demonstrated greater OXPHOS coupling defect in
Δrcf1;Δrcf2 mitochondria than in the Δrcf1 mitochondria. Decreased ETC activity
in response to ADP is predicted to limit the ATP synthesis rate. ATP synthesis,
as well as additional PMF-dependent mitochondrial functions: ADP/ATP
exchange, mitochondrial translation and morphology, are adressed in Chapter 4.
The results presented in this chapter suggest that Rcf1 and Rcf2 operate
through complex IV yet exhibit functional differentiation: Rcf1 plays a more
prominent role than Rcf2 in assembly or stability of complex IV and electron
transport capacity from cytochrome c to oxygen. However, Rcf2 alone can
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maintain PMF and ATP synthesis at this level of ETC activity as demonstrated by
Δrcf1 respiratory growth capacity. Membrane potential measurements indicate
that Δrcf1 mitochondria maintained somewhat low state 2 PMF, yet retained
capacity to stimulate proton-pumping activity under state 3 conditions and reestablish state 4 membrane potential with kinetics similar to the wild type control.
Deletion of Rcf2 appears to increase oxygen consumption without corresponding
increase in membrane potential, or PMF. Results presented here suggest that
Δrcf1;Δrcf2 suffers from combined lower complex IV levels and lower proton
pumping of the remaining complex IV. This complex IV pumping defect resulting
in OXPHOS uncoupling is consistent with the previously proposed role fore HIGD
proteins in modulating complex IV proton pathways (Hayashi et al., 2015) and
redox potential (Schäfer et al., 2018) and will be discussed more in chapter 5.
.
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CHAPTER 4. Rcf1 and Rcf2 deletion affects PMF-dependent mitochondrial
pathways and several lipid-binding OXPHOS proteins

Introduction

As shown in Chapter 3, Rcf1 and Rcf2 support complex IV ability to
establish protonmotive force (PMF). The PMF is necessary for many functions
including mitochondrial protein import and translocation across the inner
membrane (IM) and outer membrane (OM) of mitochondria. A loss of PMF can
impair maturation and proteolytic degradation of newly synthesized and
misfolded proteins by a variety of mitochondrial proteases and peptidases
(Schleyer et al., 1982, Clarkson and Poyton, 1989, Baker and Schatz, 1991,
Martin et al., 1991, Herrmann et al., 1995, Geissler et al., 2000, Fox 2012). In this
chapter, mitochondrial protein synthesis and processing of mitochondrial and
nuclear encoded proteins in the absence of Rcf1 and Rcf2 were examined and
some changes consistent with lower PMF (ΔpH) are reported.
PMF is also essential for ATP synthesis by the F1FO ATP synthase
(complex V) and the activity of metabolite carriers which provide the substrates
for ATP synthesis, most notably ADP/ATP carrier (AAC) and phosphate carrier
(PIC). In this chapter, the steady-state levels of F1FO ATP synthase, PIC and
AAC were evaluated. Activity of AAC (mitochondrial ADP/ATP exchange) and
F1FO ATP synthase (ATP synthesis and hydrolysis rates) were assayed in the
absence of Rcf1 and/or Rcf2. Evidence is presented in this chapter that AAC
molecular environment is altered in the absence of Rcf1. However, AAC-
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mediated adenine nucleotide exchange function appears to remain normal in the
absence of Rcf1 and Rcf2. PMF-dependent ATP synthesis rate by F1FO ATP
synthase is decreased in the absence of Rcf1 and Rcf2. Additionally, steadystate levels of some of the F1FO ATP synthase protein subunits, and PMFindependent ATP hydrolysis and oligomycin sensitivity of this enzyme were also
decreased. Rcf1 is proposed to be a lipid chaperone of Cox3 (Strogolova et al.,
2012, Garlich et al., 2017), and may influence lipid composition of a wider range
of OXPHOS proteins. Lipids are essential for stability and function of F1FO ATP
synthase, AAC, and PIC. It is possible that Rcf1 and Rcf2 as lipid chaperones
support stability and function of these enzymes in a PMF-independent manner.
In addition to OXPHOS enzyme activity, PMF regulates mitochondrial
network morphology. Loss of membrane potential in individual organelles triggers
mitochondrial network fragmentation. Mitochondrial network in YPGal growing
WT, Δrcf1, Δrcf2, Δrcf1;Δrcf2 cells was examined. The Δrcf1;Δrcf2 mitochondrial
networks are not more fragmented than the wild type mitochondrial networks.
Yet, Δrcf1;Δrcf2 mitochondrial networks have a unique appearance,
characterized by decreased surface area and uneven fluorescent signal
distribution of a mitochondrially-targeted GFP molecule.

Results

4.1. Mitochondrial translation and protein processing in the absence of
Rcf1 and Rcf2.
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Mitochondrial membrane potential is not required for synthesis of proteins
encoded in the mitochondrial genome (Fox 2012), but it supports the maturation
of mitochondrially synthesized protein Cox2 after translation (Clarkson and
Poyton, 1989, Herrmann et al., 1995). Mitochondrial membrane potential also
controls import and maturation of many nuclear-encoded mitochondrial
preproteins into the mitochondria (Schleyer et al., 1982, Baker and Schatz, 1991,
Martin et al., 1991, Geissler et al., 2000).
Mitochondrial translation is a key part of mitochondrial protein synthesis
essential for the assembly of OXPHOS enzymes. Mitochondrial translation
supplies subunits of respiratory supercomplexes III (cytochrome b), IV (Cox1,
Cox2, and Cox3), and V (Atp6, Atp8 and Atp9) as well as Var1, a component of
small subunit of the mitochondrial ribosome.
To test whether altered PMF in the absence of Rcf1 and/or Rcf2
influenced the synthesis of mitochondrially encoded subunits, mitochondrial
translation in energized mitochondria was assessed in the presence of [35S]methionine. [35S]-labeled translation products were analyzed using SDS-PAGE,
Western blotting, and autoradiography. The Δrcf1, Δrcf2, and Δrcf1;Δrcf2
mitochondria were capable of translation, although the amount of translated
products was lowered in Δrcf2 (Figure 13). However, the mitochondrial
translation pattern was altered compared to that of the wild-type control.
Specifically, the translation of Var1, Cox2, and Cox3 increased in Δrcf1
mitochondria; translation of Cox1, Cox3, Cytb and Atp8 was decreased in the
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Figure 13. Deletion of Rcf1 and Rcf2 alters mitochondrial translation profile and leads to
accumulation of Cox2 precursor. In organello translation was performed as described in
Materials and Methods and products assessed by SDS-PAGE and autoradiography. The
positions of the molecular mass standards and mitochondria-encoded proteins, Var1, Cox1,
Cox2, cytochrome b (Cytb), Cox3, Atp6, Atp8, and Atp9, are indicated. Asterisk (*) indicates Cox2
precursor.

Δrcf2 mitochondria; and the presence of some Cox2 precursor (Cox2p) was
observed in Δrcf1 and Δrcf1;Δrcf2 mitochondria (Figure 13, marked with an
asterisk).
The Cox2 N-terminal signal sequence is translocated from the matrix
where Cox2p translation takes place into the IMS, where the signal sequence is
proteolytically removed by the Imp1 protease on the IMS side of the IM (Clarkson
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and Poyton, 1989, Herrmann et al., 1995). The translocation is supported by both
the Δψ and ΔpH (Herrmann et al., 1995). Membrane potential is also required for
translocation of C-terminus of Cox2 to the IMS and proper insertion of mature
Cox2 into the IM in Nout-Cout orientation (Herrmann et al., 1995).
Accumulation of Cox2p is indicative of lower Δψ and/or ΔpH or impaired Imp1
function in Δrcf1 and Δrcf1;Δrcf2 mitochondria. To test Imp1 function, processing
of other substrates cytochrome b2 (Cyb2) and NADH-cytochrome b5 reductase
(Mcr1) were analyzed (Figure 14). Both Cyb2 and Mcr1 are nuclear-encoded
proteins that are imported into the mitochondria in a Δψ-dependent manner
(Geissler et al., 2000, Schneider et al., 1991). Mcr1 is a 34-kDa protein that can
be delivered to two locations: OM (where full-length Mcr1 is present, Mcr134) and
IM (where Mcr1 is processed to a smaller, soluble form (Mcr132) by Imp1
protease). Mcr1 import into the IM is Δψ-dependent (Hahne et al., 1994, Haucke
et al., 1997). Similarly, Cyb2 precursor is imported into the IM in Δψ-dependent
manner and Imp1 processing of IM-inserted Cyb2 releases mature Cyb2 as
soluble IMS protein. The steady-state levels of processed Mcr1 (Mcr132) were not
decreased and even slightly elevated in Δrcf1 and Δrcf1;Δrcf2 mitochondria,
resulting in increased ratio of Mcr132:Mcr134 This ratio difference may indicate
increased Δψ. No inhibition of Imp1 processing of Cyb2 was observed, which
indicates that Imp1 proteolytic activity is not impaired in the absence of Rcf1 and
Rcf2 (Figure 14B). Therefore, we conclude that Cox2p maturation protease
Imp1 activity is not impaired in the absence of Rcf1 and Rcf2, and the Cox2p
maturation was impaired due to decreased ΔpH component of the PMF.
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Figure 14. Changes in protein processing observed in the absence of Rcf1 and Rcf2.
Steady state levels of non-OXPHOS proteins in wild type (WT) and Δrcf1;Δrcf2 (Δ1;Δ2) evaluated
using SDS-PAGE and Western blotting. (A) Steady-state levels of IMS protein Erv1, IMS protein
cytochrome b2 (Cyb2) and Mcr1, which is distributed from the IM to the IMS by proteolytic
processing. Tim44 was used as a loading control. (B) Proteolytic processing of Pcp1 substrate
Mgm1 and Pcp1/i-AAA substrate Ccp1. (C) Processing of i-AAA substrate MrpL32 and Pcp1/iAAA substrate Ccp1. Mitochondria from Δyta10 strain (lacking i-AAA protease) were used as a
reference. (p, precursor protein; m, mature protein).

Import of another nuclear encoded protein into the IMS, Erv1, is not PMFdependent; rather, its import into the IMS is mediated by mediated by chaperone
Mia40. Erv1 levels were increased in in Δrcf2 and in Δrcf1;Δrcf2 mitochondria,
indicating that PMF-independent protein import is not decreased, and is even
increased (Figure 14B).
In the course of another experiment, we observed accumulation of some
precursor form of cytochrome c peroxidase (Ccp1) in the absence of Rcf1 and
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Rcf2, suggesting a protein control defect. Ccp1p processing requires m-AAA
protease (Yta10/Yta12), which pulls Ccp1 precursor, Ccp1p, out of the IM into
the IMS. The pulling by m-AAA protease requires ATP hydrolysis and is impaired
in mutants deficient in Yta10 (Δyta10) (Tatsuta et al., 2007, Michaelis et al.,
2005). The m-AAA protease also processes another substrate, MrpL32, which
does not depend on ATP hydrolysis (Nolden et al., 2005, Schmidt et al., 2011).
Processing of MrpL32 precursor was normal in the absence of Rcf1 and Rcf2
(Figure 14C). This indicates that pulling activity of the m-AAA protease, but not
its proteolytic activity, is affected in the Δrcf1;Δrcf2 mitochondria, likely related to
lower ATP synthesis or an altered membrane environment in this mutant. ATPdependent surveillance proteases - i-AAA and m-AAA proteases - are involved in
the protein control of the IMS and matrix, where they monitor and remove nonassembled and misfolded membrane proteins such as Ccp1p, Cox2p and Erv1
(Schreiner et al., 2012). However, pCox2 was not detectable in mitochondria
isolated from Δrcf1;Δrcf2 cells, indicating that in vivo it is turned over and does
not accumulate.
In summary, the protein processing defects observed in Δrcf1, and to a
greater extent in Δrcf1;Δrcf2 mitochondria indicate that Rcf1 and Rcf2 indirectly
support ΔpH-dependent and ATP-dependent protein translocation.

4.2. F1FO ATP synthase.
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The PMF is the driving force for the ATP synthesis by mitochondrial F1FO
ATP synthase. This enzyme is composed of F1, FO, and stator sectors which are
assembled separately and join to form F1FO ATP synthase (complex V).
Transmembrane FO sector of the F1FO ATP synthase is a proton channel largely
composed of an oligomeric ring of Atp9 subunits. The FO sector interacts with
Atp6 and Atp8 subunits and a number of other nuclear encoded transmembrane
proteins; a linker (stator) joins FO and F1 sector coupling their rotation. Proton
translocation from the IMS to the matrix through Atp6-Atp9 oligomer of the FO
sector rotates the enzyme, driving ATP synthesis from ADP and phosphate in the
catalytic sites of the matrix F1 sector. If PMF is dissipated, F1FO ATP synthase
can reverse its direction, operating as a secondary proton pump. In this case,
protons are translocated from the matrix to the IMS powered by ATP hydrolysis
catalyzed by F1 producing ADP and phosphate. Both ATP synthesis and ATP
hydrolysis can be inhibited by oligomycin, which binds to a conserved Glu59 of
Atp9 subunit and blocks the FO proton channel (Symersky et al., 2012).
Similar to other membrane proteins, the position of F1FO ATP synthase
(complex V) in the IM is sealed by interactions with membrane lipids (Mehdipour
and Hummer, 2016). Complex V is found at cristae rims, where it normally forms
dimeric supercomplexes, V2, which are compatible with highly curved
phospholipid environment. Specific, yet intermittent (on and off), interactions of
cardiolipin (CL) with a conserved Lys43 of the Atp9 subunit promote assembly,
stability, and smooth rotation of the ATP synthase required for its catalytic
function (Duncan et al., 2016).
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4.2.a. F1FO ATP synthase levels in the absence of Rcf1/2.

The levels of the F1Fo ATP synthase complex were initially examined using BNPAGE, SDS-PAGE, and Western blotting. BN-PAGE / Western blotting indicated
that the levels of the roughly 700-kDa F1FO ATP synthase complex were similar
in wild-type, Δrcf1, Δrcf2, and Δrcf1;Δrcf2 mitochondria (Figure 15A). Similarly,
SDS-PAGE and Western blotting indicated that the levels of the Atp4 (stator
subunit) were nor changed. However, steady-state levels of Atp9 were
decreased in the absence of Rcf1 and Rcf2 (Figure 15B). Atp9 protein selfoligomerizes even in presence of SDS, so it was detected following TCA
precipitation. Possibly, Atp9 self-oligomers are structurally different and more
difficult to break in Δrcf1;Δrcf2 mitochondria. Additionally, the levels of F1 subunit
Atp1 and peripheral subunit e (Sue) essential for complex V stability and
dimerization, were decreased in Δrcf1;Δrcf2 mitochondria (Figure 15B). The
decreased detection of F1Fo ATP synthase subunits may indicate moderate
decrease in stability of the enzyme or assembly defects (e.g., decreased
stoichiometry of Atp9 oligomers) in the absence of Rcf1 and Rcf2 which was not
detected on a BN-PAGE.
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Figure 15. F1FO ATP synthase subunit Atp9 levels are altered in absence of Rcf1 and Rcf2,
while the levels of the assembled F1FO ATP synthase are unchanged. (A) Mitochondria (30
µg protein) isolated from wild-type (WT), Δrcf1, Δrcf2, and the Δrcf1;Δrcf2 strains were solubilized
in 0.6% DDM and subjected to BN-PAGE analysis, Western blotting, and immunodecoration with
antibodies to F1 sector of ATP synthase (F1 α/β). (B) Steady-state levels of F1FO ATP synthase
subunits. Mitochondria (25 μg protein) from wild-type (WT), Δrcf1, Δrcf2, and the Δrcf1;Δrcf2
strains were subjected to SDS-PAGE, Western blotting and immunodecoration with the
antibodies to Atp1 (F1 sector subunit), Atp4 (stator subunit), subunit e (Sue) (peripheral
transmembrane subunit), Atp9 (Fo sector subunit). To detect Atp9, mitochondrial proteins were
TCA-precipitated before SDS-PAGE, because Atp9 oligomer can be SDS-resistant. Tim44 was
used as a loading control. (C) A diagram indicates relative position of the subunits analyzed.
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4.2.b. F1FO ATP synthase activity in the absence of Rcf1/2.

Oligomycin-sensitive ATP synthesis by the F1FO ATP synthase was
measured using hexokinase/glucose-6-phosphatase coupled end point assay
(Materials and Methods). ATP synthesized and exported (by ADP/ATP exchange
via AAC) by wild type, Δrcf1, Δrcf2, and Δrcf1;Δrcf2 mitochondria when fueled
with ADP and ethanol as a ETC substrate, was measured. Oligomycin-sensitive
ATP synthesis was found to be decreased in mitochondria lacking Rcf1 and Rcf2
(Δrcf1=69%, Δrcf2=84%, and Δrcf1;Δrcf2=45% of wild-type) (Table 8 third
column). The decrease was greatest in Δrcf1;Δrcf2 mitochondria. To confirm that
the ATP export from the mitochondria reflected total ATP synthesis, a similar
experiment was conducted, except that the mitochondria were solubilized with
detergent to quantify total ATP before and after ATP synthesis. In this
experiment, oligomycin-sensitive ATP synthesis by Δrcf1;Δrcf2 mitochondria was
measured to be 46% of the wild-type (Table 9 third column), providing support for
the extent of the ATP synthesis impairment detected by the oligomycin-sensitive
ATP export assay. Such decrease in ATP synthesis in Δrcf1;Δrcf2 mitochondria
is consistent with the inability to maintain optimal PMF during state 3 respiration
in the absence of Rcf1 and Rcf2.
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Table 8. ATP synthesis and export decreased in the absence of Rcf1 and/or Rcf2.
Mitochondria (40 µg) were resuspended in ATP detection buffer containing ethanol (ETC
substrate) with oligomycin (1 µM) (+ Oligo) or DMSO ( - Oligo). Reaction was started by addition
of ADP (100 nmol), incubated for 5 minutes at 30˚C. Mitochondria were pelleted through
centrifugation, and supernatant collected. ATP in supernatant was measured with ATP detection
enzymes, as described in Materials and Methods. The amount of ATP synthesized was
calculated by subtracting the amount of ATP in a control reaction (no ethanol, 1.0 µM oligomycin,
100 nmol ADP; i.e., pre-existing mitochondrial ATP). Wild type, Δrcf1, Δrcf2 and Δrcf1;Δrcf2
oligomycin-sensitive ATP synthesis (calculated by subtracting second column from first column,
and expressed as % of wild-type (WT)) is reported in third column; statistically significant values
(p<0.05) are indicated by an asterisk. ATP synthase sensitivity to oligomycin, calculated by
comparing ATP synthesis in presence and absence of oligomycin, is reported in last column.
Average and S.E.M. values (WT (n=6), Δ1 (n=4), Δ2 (n=4), Δ1;Δ2 (n=6)); **, p value < 0.01.

ATP synthesis

- oligomycin
nmol ATP

+ oligomycin
nmol ATP

oligomycin
sensitive
% of WT

Sensitivity to
oligomycin
% inhibition

WT

46.9 ± 0.5

1.9 ± 1.3

100%

96%

Δrcf1

34.2 ± 2.2

3.3 ± 0.4

**69%

90%

Δrcf2

42.6 ± 1.5

4.8 ± 2.2

**84%

89%

Δrcf1;Δrcf2

24.8 ± 1.2

4.7 ± 0.8

**45%

81%

Table 9. Total ATP synthesis is decreased in absence of Rcf1 and Rcf2.
Mitochondria (40 µg) were resuspended in ATP detection buffer containing succinate (ETC
substrate) and oligomycin (20 µM) or DMSO. Reaction was started by addition of ADP (200 nmol)
and incubated for 3 minutes at 30˚C. Mitochondrial membranes were solubilized with
deoxycholate (0.2%) for 5 minutes, and the total ATP in the sample was measured with ATP
detection enzymes.

Total ATP
- oligomycin
nmol ATP

+ oligomycin
nmol ATP

oligomycin-sensitive
% of WT

WT

49.07

24.7

100%

Δrcf1;Δrcf2

31.07

19.79

46%
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4.2.c. Sensitivity of F1FO ATP synthase to oligomycin.

ATP synthesis in oligomycin-treated Δrcf1, Δrcf2, and Δrcf1;Δrcf2
mitochondria was observed to be greater than in wild type mitochondria (Table 8,
second column). Oligomycin sensitivity is calculated as ATP synthesis in
oligomycin-treated sample relative to ATP synthesis in absence of oligomycin. In
addition to the decreased ATP synthesis rate, sensitivity of ATP synthesis to
oligomycin was somewhat decreased in Δrcf1, Δrcf2, and Δrcf1;Δrcf2
mitochondria (Table 8, last column). Sensitivity of ATP synthesis to oligomycin
was not measured when mitochondria were solubilized with detergent since the
ATP present in oligomycin treated mitochondria likely reflected total
mitochondrial ATP, and not ATP synthesis (Table 9, second column).
To further explore oligomycin sensitive ATP synthesis, the concentration of
oligomycin in the assay was titrated (0.5 µM and 0.1 µM). Wild type mitochondria
were equally sensitive to 1.0 µM and 0.5 µM oligomycin concentration, which
inhibited 89% and 88% of ATP synthesis, respectively. In contrast, Δrcf1 and
Δrcf1;Δrcf2 mitochondria were less sensitive to 0.5 µM oligomycin concentration,
which inhibited 78% and 68% of ATP synthesis, respectively (Table 10).
Oligomycin sensitivity was not decreased in Δrcf2 mitochondria. The 0.1 µM
oligomycin concentration inhibited 50% or less ATP synthesis in wild type, Δrcf1
and Δrcf1;Δrcf2 mitochondria.
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Table 10. Oligomycin sensitivity of ATP synthase in the absence of Rcf1/Rcf2.
Mitochondria (40 µg) were resuspended in ATP detection buffer (0.5 ml) containing ethanol and
oligomycin (1.0 µM, 0.5 µM, 0.1 µM) or DMSO (no oligomycin) (-). Reaction was started by
addition of ADP (100 nmol), incubated for 5 minutes at 30˚C, mitochondria were pelleted, and
supernatant collected. ATP in supernatant was measured. The amount of ATP synthesized was
calculated by subtracting ATP in a control reaction (no ethanol, 1.0 µM oligomycin, 100 nmol
ADP, i.e. pre-existing mitochondrial ATP). ATP synthesis is reported in the upper table (n=2 for
every condition). ATP synthesis inhibition (% sensitivity) relative to ATP synthesis in absence of
oligomycin, is reported in the lower table.

ATP synthesis [nmol]

[oligomycin], µM

0

0.1

0.5

1.0

WT

47.8 ± 0.2

27.1 ± 1.2

6.0 ± 0.0

5.2 ± 0.4

Δrcf1

31.9 ± 4.1

19.1 ± 0.5

7.1 ± 0.4

2.8 ± 0.5

Δrcf2

44.7 ± 2.2

18.2 ± 1.8

2.2 ± 0.2

3.3 ± 1.0

Δrcf1;Δrcf2

23.1 ± 2.7

12.8 ± 0.1

7.3 ± 1.0

2.4 ± 0.5

% inhibition by oligomycin

[oligomycin], µM

0.1

0.5

1.0

WT

43%

88%

89%

Δrcf1

40%

78%

91%

Δrcf2

59%

95%

93%

Δrcf1;Δrcf2

45%

68%

90%
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To determine whether lower sensitivity of OXPHOS ATP synthesis to
oligomycin was observed not only in isolated mitochondria, but also in cells
lacking Rcf1 and Rcf2, the effect of oligomycin on respiratory growth was
evaluated. When oligomycin concentration in the growth media was titrated to the
threshold of inhibiting respiratory growth of wild-type cells (0.1-0.3 mg/L), the
respiratory growth of the Δrcf1 and Δrcf1;Δrcf2 mutant was not inihibted by this
concentration of oligomycin (Figure 16A, third panel). Greater concentration of
oligomycin (1.0 mg/L) was needed to inhibit respiratory growth of these mutants
(Figure 16A, last panel). We conclude that these experiments show a decreased
sensitivity to oligomycin in the absence of Rcf1.
Some mutations trigger mitochondrial signaling pathway (called retrograde
response) resulting in expression of multidrug resistance transporter genes such
as PDR5, which confer resistance to oligomycin and other drugs, e.g.
cycloheximide (Katzmann et al., 1995). To test whether Δrcf1;Δrcf2 cells were
multidrug resistant, growth on cycloheximide containing media was evaluated
(Figure 16B). The Δrcf1;Δrcf2 cells did not display decreased sensitivity to
cycloheximide on glucose or glycerol media. These results lead us to conclude
that changes in oligomycin binding to F1FO ATP synthase, not the expression of
multidrug resistance pumps, confers the oligomycin resistant growth to the Δrcf1
and Δrcf1;Δrcf2 strains. Alternatively, an increased level of mitochondrial
substrate level phosphorylation may explain increased ATP synthesis in
presence of oligomycin.
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A

B

Figure 16. Decreased inhibition of respiratory growth by oligomycin in the absence of
Rcf1. (A) Serial dilutions wild type, Δrcf1, Δrcf2, and Δrcf1;Δrcf2 cultures were spotted on rich
(YP) agar containing glucose (2%) or glycerol 3% containing low (0.3 mg/L) or high concentration
(1.0 ml/L) of oligomycin and incubated for 3 days (Glucose) or 6 days (glycerol) at 30˚C. (B)
Serial dilutions were performed as in (A) on agar containing no or 100 ng/ml cycloheximide and
incubated for 5 days at 30˚C.

Oligomycin partitions to lipid-water interface and binds Atp9; rotation of the
F1FO-ATP synthase FO sector brings oligomycin deeper into the transmembrane
region where it stalls the rotation at the site of Atp9 interaction with subunit a, and
therefore blocks the passage of protons (Zhou and Faraldo-Gómez, 2018).
Decreased inhibition of ATP synthase by oligomycin is consistent with altered
conformation of Atp9 or its affinity for oligomycin in the absence of Rcf1.
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4.2.d. F1FO ATPase activity in the absence of Rcf1/2.

When PMF is dissipated, the rotation of F1FO ATP synthase can be reversed,
resulting in ATP hydrolysis (ATPase) activity (Bustos et al., 2005). ATPase
activity was initially measured in mitochondria solubilized with Triton X-100
(0.0375%). The reaction was carried out for 2 minutes and stopped by the
addition of trichloroacetic acid (TCA) to denature proteins; phosphate in the
supernatant was measured. Oligomycin-sensitive ATP hydrolysis by detergentsolubilized Δrcf2 mitochondria was similar to the wild-type; and in Δrcf1 and
Δrcf1;Δrcf2 mitochondria ATP hydrolysis was decreased, to 73% and 77% of the
wild-type ATP hydrolysis rate, respectively (Table 11). Decreased ATP hydrolysis
was consistent with decreased Atp9 content in the Δrcf1;Δrcf2 mitochondria, but
contrasts with elevated Atp9 levels detected in Δrcf1 mitochondria (Figure 15B),
indicating altered assembly or stability of F1Fo ATP synthase.
Detergent solubilization of mitochondria can sometimes disturb the
interaction of membrane-embedded Fo sector of ATP synthase with the F1 sector.
Free F1 sector can still hydrolyze ATP but is not sensitive to oligomycin because
is no longer associated with Fo sector. Therefore, sensitivity of ATP hydrolysis to
oligomycin in this assay does not accurately reflect oligomycin sensitivity of intact
enzyme, and it was low in wild type mitochondria (66%, Table 11 last column).
ATP hydrolysis in presence of oligomycin in Δrcf1 and Δrcf2 mitochondria was
greater than in wild-type mitochondria (Table 11 second column); this was
consistent with the increased Atp9 levels detected (Figure 15B) and indicates
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Table 11. ATP hydrolysis in mitochondrial lysate. Mitochondria (50 µg) was solubilized in
buffer (0.9 ml, 0.2 M KCl, 3 mM MgCl2, 0.0375% TritonX-100, 10 mM Tris-HCl, pH 8.4) at 30˚C in
presence or absence of oligomycin (20 μM). Reaction was started by addition of 5 mM ATP and
stopped with TCA after 2 minutes, followed by centrifugation for 10 minutes at 10000 rpm.
Phosphate concentration in supernatant was measured using ammonium molybdate-ferrous
sulfate colorimetric assay. Average and S.E.M. values are reported (WT (n=27), Δ1 (n=7), Δ2
(n=9), Δ1;Δ2 (n=19)).

Table 12. ATP hydrolysis in intact mitochondria. Mitochondria (50 µg) was resuspended in
buffer (0.9 ml, 0.2 M KCl, 3 mM MgCl2, 10 mM Tris-HCl, pH 8.4) at 30˚C in presence or absence
of oligomycin (20 μM). Reaction was started by addition of 5 mM ATP and stopped with TCA after
2 minutes, followed by centrifugation for 10 minutes at 10000 rpm. Phosphate concentration in
supernatant was measured using ammonium molybdate-ferrous sulfate colorimetric assay.
Average and S.E.M. values are reported (WT (n=7), Δ1 (n=5), Δ2 (n=5), Δ1;Δ2 (n=7)).

107

decreased stability of F1FO ATP synthase in these mitochondria.
ATP hydrolysis was next measured in intact mitochondria (without
detergent) (Dienhart et al., 2002). ATP hydrolysis in intact mitochondria was
slower than in detergent solubilized mitochondria (similarly for wild type and
mutant samples), reflecting the limitation posed by the rate of ATP import into the
mitochondrial matrix, which is catalyzed by the ADP/ATP carrier (AAC). Also,
ATP hydrolysis was more sensitive to oligomycin in intact mitochondria than in
detergent mitochondria, reflecting that the association of F1 and FO sectors of
ATP synthase was not disturbed. ATP hydrolysis activity in intact Δrcf1 and was
similar to that of the wild type mitochondria. This contrasted with the ATP
hydrolysis in detergent solubilized Δrcf1 mitochondria. We were unable to
determine why ATP hydrolysis in detergent solubilized, but not in intact Δrcf1
mitochondria, was impaired. ATP hydrolysis activity in Δrcf2 and Δrcf1;Δrcf2
mitochondria was decreased. Oligomycin-sensitive ATP hydrolysis in Δrcf2 and
Δrcf1;Δrcf2 was measured to be 64% and 52% of the wild-type ATP hydrolysis
rate, respectively (Table 12). Sensitivity of ATP hydrolysis to olifomycin was not
significantly different in the absence of Rcf1 or Rcf2 (Table 12, last column).
ATP hydrolysis activity in intact mitochondria normally pumps the protons
out of the matrix and can sustain membrane potential, although at a lower level
than the PMF generated by the electron transport chain (ETC) (Wang et al.,
2007). The capacity of the ATP synthase to reverse its direction and establish the
PMF upon inhibition of ETC was measured in intact mitochondria using
membrane potential indicator, Rhodamine-123 (R-123) and in collaboration with
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Dr. David Mueller (Rosalind Franklin University, Chicago, IL), using previously
established methods (S. Saddar, PhD dissertation). The ATPase (F1FO ATP
synthase reversal) activity generated the membrane potential (Table 13) in Δrcf1,
Δrcf2, and Δrcf1;Δrcf2 mitochondria and similar to the wild type mitochondria,
indicating that F1FO ATP synthase retained proton pumping capacity through the
Fo sector. However, the membrane potential was only monitored for 1 minute and
it is possible that membrane potential was not maintained for a long period of
time.

Table 13. Capacity of ATPase to establish mitochondrial membrane potential upon
inhibition of ETC. Mitochondrial membrane potential generated by ATP hydrolysis was
measured using Rhodamine-123 (R-123) as described in Materials and Methods. Membrane
potential established by ATPase (% fluorescence quenching) was calculated as a % difference in
signal with 2 mM ATP, 1 mM MgCl2 and signal following depolarization (oligomycin and CCCP
addition).The average and SEM are shown (WT (n=4), Δ1 (n=4), Δ2 (n=2), Δ1;Δ2 (n=4)).

ATP hydrolysis associated fluorescence quenching,
WT

19 ± 1%

Δrcf1

26 ± 1%

Δrcf2

17 ± 6%

Δrcf1;Δrcf2

20 ± 1%

The inconsistencies observed between the normal levels of F1Fo ATP
synthase complex on a BN-PAGE, increased Atp9 subunit levels on an SDS-
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PAGE, and different ATP synthesis and ATP hydrolysis rates in the in Δrcf1 and
Δrcf2 mitochondria, are without a comprehensive explanation.
The ATP hydrolysis in the Δrcf1;Δrcf2 mitochondria was consistently
decreased. We conclude that not only decreased PMF generation by the ETC,
but also decreased ATP synthase levels and/or stability contributed to the
decreased ATP synthesis in the absence of Rcf1 and Rcf2.

4.3. ADP/ATP carrier (AAC)

4.3.a. Stability and environment of AAC in the absence of Rcf1/2.

Exchange of metabolites across the IM is mediated by metabolite carrier
proteins of the mitochondrial carrier family (MCF). Critical MCF proteins AAC and
PIC preferentially import ADP and phosphate, respectively, into the mitochondrial
matrix. AAC catalyzes exchange of ADP3- for ATP4- (Nicholls and Ferguson,
2013). The directionality of the AAC transport that is driven by the Δψ maintains
the ATP/ADP ratio in the mitochondrial matrix hundreds of times lower than the
ATP/ADP ratio in the cytoplasm (Gout et al., 2014). PIC catalyzes H2PO4-/H+
symport that is driven by ΔpH (Nicholls and Ferguson, 2013). Due to the action of
PIC, the phosphate concentration in mitochondrial matrix is 3 times greater than
in the cytoplasm. The decrease in PMF in the Δrcf1;Δrcf2 mitochondria may
therefore be limiting for ADP/ATP exchange or phosphate import.
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To test whether deletion of Rcf1 and Rcf2 influenced AAC and PIC,
steady-state levels of these proteins were assessed by Western blotting. The
AAC and PIC levels were not adversely affected in the absence of Rcf2
compared to the wild-type control, while PIC levels were even higher in the
absence of Rcf1 (Figure 17A).
AAC is found in association with the III-IV and TIM23 supercomplexes, yet
AAC interaction with Rcf1 is independent of complex III and IV (Strogolova et al.,
2012). Factors that influence AAC interaction with the supercomplexes are
largely unexplored. To test whether removal of Rcf1 and/or Rcf2 would alter AAC
association with the III-IV and TIM23 supercomplexes, His‐tagged Aac2p was
expressed in wild-type and Δrcf1;Δrcf2 cells and mitochondria were isolated and
solubilized in 0.6% digitonin, which preserves AAC association with the
supercomplexes (Dienhart and Stuart, 2008). HISAac2 was subjected to affinity
purification (Ni-NTA pull-down) assay. Affinity co-purification of complex IV
component Cox3 and TIM23 complex component Tim17 with a HISAac2 isoform
was detected in wild-type mitochondria. HISAac2 co-purified Tim17 and Cox3 in
Δrcf1;Δrcf2 mitochondria; less Cox3 was affinity purified with Aac2, reflecting
decreased levels of complex IV in Δrcf1;Δrcf2 mitochondria (Figure 17B). We
conclude that AAC association with the supercomplexes does not require Rcf1
and Rcf2.
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Figure 17. AAC steady state levels and environment in the absence of Rcf1 and Rcf2. (A)
Steady-state levels of MFC carriers AAC and PIC. Mitochondria (25 μg protein) from wild-type,
Δrcf1, Δrcf2, and the Δrcf1;Δrcf2 strains were subjected to SDS-PAGE, Western blotting and
A
B
immunodecoration with antibodies to AAC, PIC, Por1. Outer mitochondrial membrane porin Por1
WTa loading
D1;D2 control.
Daac2 (B) AAC association with III-IV and TIM23 supercomplexes.
was used as
Mitochondria (30 µg) from WT or Δrcf1;Δrcf2 strains expressing HISAac2 were solubilized in
digitonin (0.6%) and subjected -toVNi-NTA affinity purification. Mitochondrial sample (5%
st
2
Dimension BN-PAGE
supernatant) and NiNTA bound material
were subjected to1SDS-PAGE,
Western blotting and
immunodecoration with antibodies to AAC, Cox3, or Tim17.
WT

2
WT
AAC is a source of considerable
proton leak and its misfolding can lower

- 60 kDa
- 20 kDa

a-Atp4

- AAC
membrane potential (Brand
et al., 2005, Liu et al., 2015). While the AAC proteins
D1;D2

are thought to operate as monomers, they are present as dimers in the
membrane, which are partially stable following detergent extraction. In order to
evaluate AAC dimerization and possible misfolding/aggregation in the absence of
Rcf1 and Rcf2, AAC monomers and oligomers were resolved in a non-denaturing
native gel (BN-PAGE). Previously our lab observed that immunodetection of AAC
monomers and oligomers in their native form on non-denaturing gel was impaired
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in Δrcf1;Δrcf2 mitochondria in spite of close to wild type AAC levels on an SDSPAGE (J. Garlich, PhD dissertation and Figure 18A, compare with Figure 17A).
Decreased immunodetection of non-denatured AAC molecules may be attributed
to differential accessibility of the antigenic epitopes in AAC native form, and
suggests that either AAC conformation or associated lipids are altered in the
absence of Rcf1 and Rcf2. AAC detection was restored when first dimension
non-denaturing gel electrophoresis was followed by second dimension
denaturing SDS-PAGE. In addition, a shift in mobility was observed, the AAC
dimer and monomer had faster mobility in the absence of Rcf1 and Rcf2, and the
AAC dimer was decreased in proportion to AAC monomer (Figure 17B). Faster
migration of AAC on a native gel may indicate decreased association or absence
of one or more CL molecules from the carrier protein (Jiang et al., 2000).
Overall, these results indicate that AAC association with the supercomplex
III2IV1-2 was retained in the absence of Rcf1 and Rcf2. However, AAC
dimerization was reduced and gel mobility of AAC monomer was faster, possibly
indicating a loss of one or more CL molecules. We conclude that the absence
Rcf1 and Rcf2 impairs AAC association with lipid molecules.
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Figure 18. AAC molecular environment in the absence of Rcf1 and Rcf2. (A) Altered
detection of AAC on a BN-PAGE in Δrcf1;Δrcf2 mutant. Mitochondria (30 μg protein) from wildtype, Δrcf1;Δrcf2 and Δaac2 strains were solubilized in 0.2% digitonin (Jiang et al., 2000) and
subjected to BN-PAGE and Western blotting with α-AAC antibody. The positions of molecular
mass markers and the dimeric and monomeric ATP synthase (V 2, approximately 1000 kDa, V,
approximately 500 kDa) are indicated. (B) Two-dimension analysis of the AAC monomer and
dimer mobility. Mitochondria (30 µg) from WT or Δrcf1;Δrcf2 (Δ1;Δ2) strains were solubilized in
digitonin (1%) and subjected to BN-PAGE (1st dimension), then the two gel lanes were excised
and subjected to SDS-PAGE (2nd dimension), followed by Western blotting, and decoration with
antibodies to AAC or to Atp4 subunit of ATP synthase, as indicated.
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4.3.b. Deletion of RCF1/2 did not impair AAC-mediated adenine nucleotide
exchange.

Changes in AAC-associated lipids or its surrounding proteins observed in
the absence of Rcf1 and Rcf2 may impact adenine nucleotide exchange or alter
this protein’s inherent propensity for proton leak. To test whether Rcf1 or Rcf2
alter the adenine nucleotide exchange activity of the AAC, ATP export rate
concomitant with ADP import was measured in WT, Δrcf1, Δrcf2, and Δrcf1;Δrcf2
mitochondria. To this end, the rate of preexisting ATP release stimulated by the
addition of ADP in the absence of ATP synthesis (in presence of 20 µM
oligomycin) in isolated mitochondria was measured. The rate of ATP release was
determined using a coupled hexokinase/glucose-6-phosphatase assay
converting ATP to NADPH and measuring the increase in NADPH fluorescence
in the supernatant over time. This assay is sensitive and suitable to measure the
ATP export rate by AAC isoforms in organello (Hamazaki et al., 2011, De Marcos
Lousa et al., 2002). In absence of ADP, ATP release was minimal (Table 14, first
and second column). When ADP and succinate were added, the ATP release
rate was greater, reflecting release of pre-existing and newly synthesized
mitochondrial ATP. In presence of oligomycin, the rate of ATP release was
decreased, consistent with the inhibition of the ATP synthesis. The rate of ATP
release in presence of oligomycin, ADP, and substrate, was used to estimate the
AAC-dependent ATP export. The AAC-dependent ATP export in Δrcf1 and
Δrcf1;Δrcf2 mitochondria was similar to the wild-type, while Δrcf2 was a little
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decreased (Table 14, last column). We conclude that AAC adenine nucleotide
exchange activity is not impaired in Δrcf1;Δrcf2 mitochondria.

Table 14. AAC-dependent ATP export activity.
Mitochondria (40 µg) were resuspended in ATP detection buffer (Materials and Methods)
containing ETC substrate succinate (10 mM, where indicated), oligomycin (20 µM, where
indicated), and ATP detection enzymes. Reaction was started by addition of 14 nmol ADP (where
indicated) and monitored for 3 minutes at room temperature. AAC activity (ATP export rate in
presence of ADP, succinate, and oligomycin) is reported in lower table. Average and S.E.M.
values are reported (WT (n=15), Δ1 (n=9), Δ2 (n=6), Δ1;Δ2 (n=15)).

In summary, while AAC exhibited altered mobility due to decrease
association of lipid molecules in the absence of Rcf1 and Rcf2, the ADP/ATP
exchange function of the carrier was not impaired. It remains possible that these
changes increased AAC non-specific proton leak.
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4.4. Mitochondrial network morphology in the absence of Rcf1/2.

The number of individual mitochondria in the cell is variable, because
mitochondria frequently undergo fission(division) and fusion. Mitochondrial fusion
connects individual mitochondrial inner and outer membranes and leads to a
mixing of their contents. Multiple fused mitochondria contain multiple
mitochondrial DNA molecules extend into moving and dynamic mitochondrial
network. Morphology of mitochondrial network within the cell is incredibly
dynamic and changes in response to the changes in respiratory activity and PMF
(Egner et al., 2002, Lackner, 2014, Rafelski et al., 2012, Rafelski, 2013).
Specifically, depletion of mitochondrial membrane potential( e.g. by the addition
of an uncoupler CCCP) causes fragmentation in the mitochondrial network
(Legros et al., 2002, Vowinckel et al., 2015, Jones et al., 2017). However, the
relevance of mitochondrial morphology for organelle function is not completely
understood; although some proteins are known to modulate both respiratory
function and mitochondrial architecture (Harner et al., 2014). Many respiratory
deficient mutants have apparently normal mitochondrial network morphology
(Rafelski et al., 2012). Emerging evidence indicates that respiration and,
specifically, PMF controls mitochondrial volume. Mitochondrial swelling is
observed in vivo after mitochondrial depolarization (Safiulina et al., 2006, Kaasik
et al., 2007, Miyazono et al., 2018).
We hypothesized that the mitochondrial network may be altered in the
absence of Rcf1 and Rcf2, reflecting decreased PMF and possibly contributing to
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the respiratory growth defect. In order to visualize the mitochondrial network, 3D
images were collected of YPGal grown WT, Δrcf1, Δrcf2, and Δrcf1;Δrcf2 cells
expressing mitochondrially targeted GFP (mtGFP) protein (n=86 WT cells, n=132
Δrcf1 cells, n=121 Δrcf2 cells, n=94 Δrcf1;Δrcf2 cells). The mitochondrial
networks were evaluated by manual observation and manual scoring and the
Δrcf1;Δrcf2 mitochondrial networks appeared fragmented compared to wild-type
control (Figure 19A). 3D images were analyzed in ImageJ software using the
software plugin Yeast_MitoMap (Vowinckel et al., 2015), which automatically
processes 3D images, and identifies the individual mitochondrial networks in
each cell and calculates volume, surface area, and other shape descriptive
parameters. The fragmentation index f, defined as a sum of relative fragment
volumes that individually constitute less than 20% of the mitochondrial network
volume, was then calculated for each cell (Table 15 second column).
Mitochondrial fragmentation index f tended to be higher in cells lacking Rcf1 but
the increase was not statistically significant (p=0.141), and in Δrcf2 and
Δrcf1;Δrcf2 cells, f was not higher than the wild-type. The uneven mtGFP signal
in the Δrcf1;Δrcf2 mitochondrial network appears to have caused the discrepancy
between manual and automatic scoring results. The automatic processing of
mitochondria had utilized a lower threshold than that of a human eye when
distinguishing mtGFP signal from the background. On the other hand, the
interspersed regions with weaker mtGFP signal within a continuous network
visually (to a human eye) appeared as distinct mitochondria. The distinct, ragged
morphology of Δrcf1;Δrcf2 appeared fragmented (Figure 19A, last panel).
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Other parameters were used to characterize the shape of the main
mitochondrial network (main network comprising 20% or more of the total
mitochondrial volume of each cell) – volume (V), surface area (SA), SA:V ratio
(Vowinckel et al., 2015) (Table 15). Deleting Rcf1, but not Rcf2, decreased
mitochondrial network volume. This was likely because smaller mitochondrial
fragments were more numerous in Δrcf1 cells, decreasing the main network
volume. Deleting Rcf2 increased mitochondrial network volume and increased
surface area. Deleting both Rcf1 and Rcf2 increased mitochondrial network
volume and decreased surface area. Although the changes in SA and V were not
statistically significant due to large variation in mitochondrial size corresponding
to variations in the cell size, SA:V ratio was calculated for each cell individually
and provided normalization for the variation caused by the cell size; the SA:V
ratio of mitochondrial networks in Δrcf1;Δrcf2 cells was significantly decreased
(Figure 19B). SA:V ratio is a simple shape descriptor. An inflated balloon is
characterized by lower SA:V ratio than the same balloon, deflated. A decreased
SA:V ratio indicates that Δrcf1;Δrcf2 mitochondria appear thicker, more inflated
than wild-type mitochondria. Such changes may reflect increased swelling of the
Δrcf1;Δrcf2 mitochondria.
A decreased SA:V ratio can be the result of changes in the mitochondrial
architecture, which was addressed using electron microscopy approach.
Preliminary electron microscopy (EM) imaging of wild-type and mutant cells was
performed in collaboration with Dr. Benedikt Westermann and Dr. Till Klecker
(Universitaet Bayreuth, Germany) according to standard protocols (Unger et al.,
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Figure 19. Mitochondrial network morphology in the mutants. (A) Representative images of
the YP-Gal grown yeast cells (brightfield images, top panel) mitochondrial network visualized with
mtGFP (GFP, bottom panel). (B) Wild type, Δrcf1, Δrcf2, and the Δrcf1;Δrcf2 mtGFP images were
analyzed using Yeast_MitoMap plugin. Surface area (SA), volume (V), and SA:V ratio calculated
for every cellular mitochondrial network. Average +/- SEM is shown; ** indicate statistically
significant difference (Student’s t-test p<0.01). (C) Wild type (WT), Δrcf1 (Δ1), Δrcf2 (Δ2), and the
Δrcf1;Δrcf2 (Δ1;Δ2) mitochondrial morphology was visualized using electron microscopy (EM) in
collaboration with Dr. Benedikt Westermann and Dr. Till Klecker (Universitaet Bayreuth,
Germany). Two representative mitochondrial cross-sections from each strain are shown.
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Table 15. Mitochondrial shape parameters.
Wild type (WT), Δrcf1 (Δ1), Δrcf2 (Δ2), and the Δrcf1;Δrcf2 (Δ1;Δ2) mtGFP images were analyzed
using Yeast_MitoMap plugin. Fragmentation index, f, mitochondrial shape parameters (volume,
surface area, SA:V ratio, compactness, distribution isotropy, sphericity, radius variance)
calculated for every cellular mitochondrial network. Average +/- SEM are shown; statistically
significant values are denotes by * (p<0.05) and ** (p<0.01).

WT
Δ1
Δ2
Δ1;Δ2

number of
cells, n
86
132
121
94
Compactness

WT
Δ1
Δ2
Δ1;Δ2

0.108
0.100
0.129
0.089

fragmentation
index, f
3.7 ± 0.9
5.8 ± 1.0
2.2 ± 0.4
3.1 ± 0.7
Distribution
isotropy
0.62
0.60
0.63
0.61

3

2

Volume [µm ]

Surface area [um ]

SA:V

8.96 ± 0.42
8.14 ± 0.29
9.70 ± 0.30
9.7 0 ± 0.30

73.4 ± 3.4
62.9 ± 2.3
77.1 ± 2.6
66.4 ± 2.9

8.27 ± 0.14
7.79 ± 0.08 *
7.94 ± 0.08 *
6.86 ± 0.08 **

Sphericity

Radius Variance

0.44
0.49
0.43
0.47

0.16
0.12
0.18
0.19

Isoperimetric
quotient
0.31
0.36
0.30
0.33

Table 16. EM analysis of mitochondrial cristae. Wild type (WT), Δrcf1 (Δ1), Δrcf2 (Δ2), and
the Δrcf1;Δrcf2 (Δ1;Δ2) cells grown to exponential phase in YPGal, chemically fixed, embedded
and cryo-sectioned for electron microscopy (EM) in collaboration with Dr. Benedikt Westermann
and Dr. Till Klecker (Universitaet Bayreuth, Germany) to analyze mitochondrial architecture.
Mitochondrial cross-sections were manually analyzed to identify cristae morphology (Harner et
al., 2016). Normal cristae shapes (lamellae and tubules) were recorded and counted. Abnormal
cristae shapes (septa, which completely cross the matrix space, onion-like morphology, or
stacked sheets of cristae membrane) were recorded and counted. Mitochondrial cross-section
diameter was measured for all mitochondria observed on the EM images.
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2017). Yeast cells were grown to exponential phase in YPGal, chemically fixed,
embedded and cryo-sectioned (Griffith et al., 2008). Mitochondrial cross-sections
were manually scored. In the absence of Rcf1 and Rcf2 a weak cristae
phenotype was observed (Table 16) characterized by abnormal cristae in some
Δrcf1;Δrcf2 mitochondria (representative images in Figure 19C demonstrates one
mitochondrion exhibiting abnormal stacked or onion-shaped cristae), while the
majority of organelles look similar to the wild type mitochondria. The diameter of
the mitochondrial cross-sections was measured and average diameter of
Δrcf1;Δrcf2 mitochondria found to be modestly but significantly increased
compared to wild-type (Table 16), supporting the observation that the branches
of mitochondrial network in Δrcf1;Δrcf2 cells are wider than the WT mitochondria.
Increased diameter of mitochondrial cross-sections may be due to mitochondrial
swelling due to ion homeostasis defect. Increased swelling and widening of the
mitochondrial compartment may result in more diffuse mtGFP signal.
To summarize, neither increased mitochondrial fragmentation nor severe
mitochondrial cristae defects was observed in the absence of Rcf1 and/or Rcf2.
However, modest changes in mitochondrial size (branch diameter and SA:V
ratio) were detected, resembling the swelling of depolarized mitochondria. There
are few detailed characterizations of mitochondrial morphology of respiratory
deficient mutants. Further study is needed to characterize mitochondrial
morphology and dynamics in the absence of Rcf1 and Rcf2 and to determine
whether the morphology is the consequence of the respiratory chain / PMF
defects and/or contributes to them.
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Summary

The mitochondrial PMF drives ATP synthesis by F1FO ATP synthase. As
expected from the decreased PMF observed in mitochondria lacking Rcf1 and
Rcf2, the level of ATP synthesis in these mitochondria is decreased as well.
Consistent with a more severe defect in PMF maintenance, the impairment of
ATP synthesis is more severe in the double Δrcf1;Δrcf2 mutant compared to the
single mutants.
F1FO ATP synthase complex levels appeared similar, but levels of certain
subunits were altered in the absence of Rcf1 and Rcf2. The level of cardiolipinbinding, FO ring forming Atp9 subunit was increased in Δrcf1 and Δrcf2, yet
decreased in Δrcf1;Δrcf2 mitochondria relative to Tim44 protein in comparison to
the wild type control. Additionally, decreased F1FO ATP synthase reverse activity
(ATP hydrolysis) and sensitivity of ATP synthase to oligomycin, the inhibitor
which binds to Atp9 at the membrane interface, were observed in the absence of
Rcf1 and Rcf2. This is consistent with altered stoichiometry or conformation of
the Atp9 subunit in the absence of Rcf1 and Rcf2. Altered oligomycin sensitivity
of ATP synthase was confirmed by respiratory growth of the Δrcf1 and
Δrcf1;Δrcf2 cells which was resistant to sub-inhibitory doses of oligomycin,
compared to the wild-type control.
PMF also supports the activity of AAC and PIC. Deletion of Rcf1 and Rcf2
did not impair AAC-mediated ATP export. PIC mediated import, while not
measured, could have contributed to ATP synthesis impairment.
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Additionally, changes in AAC BN-PAGE mobility consistent with impaired
lipid binding to AAC were observed in Δrcf1;Δrcf2 mitochondria. Specific, CL
dependent interaction of Rcf1 with AAC was detected by Rcf1-AAC crosslinking
(J. Garlich, PhD dissertation). AAC mobility in Δrcf1;Δrcf2 mitochondria is
consistent with Rcf1 and Rcf2 role supporting AAC-associated CL molecules.
Decreased PMF generation by the ETC does not provide explanation for all of
these pleiotropic phenotypes, some of which may be related to altered
mitochondrial lipid distribution among OXPHOS proteins.
Consistent with the decreased PMF in the absence of Rcf1 and Rcf2,
processing of newly translated Cox2 precursor (pCox2) was defective in
Δrcf1;Δrcf2 mitochondria. Membrane translocation of pCox2 is PMF-dependent,
as is translocation of many nuclear encoded proteins; an altered processing of
Mcr1 was also observed in the absence of Rcf1 and Rcf2. Unexpectedly, Mcr1
processing was increased, indicating increased Δψ. The explanation for this
observation is unclear. The absence of Rcf1 and Rcf2 was not associated with
defects in activity of any specific protease.
Analysis of morphology of mitochondrial network and mitochondrial
ultrastructure (i.e. cristae) of Δrcf1;Δrcf2 mitochondria does not indicate network
fragmentation or strong cristae abnormalities. However, measurement of
mitochondrial surface area and volume indicates that the mitochondrial networks
are more swollen, results which are consistent with impaired mitochondrial PMF
maintenance and lower ATP synthesis in the absence of Rcf1 and Rcf2.
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CHAPTER 5. DISCUSSION

Introduction.

Mitochondrial electron transport chain (ETC) enzymes establish and
maintain proton-motive force (PMF) by transporting protons against the
concentration gradient. The efficient conversion of oxidation energy into the PMF
depends on ETC complex IV, cytochrome c oxidase, harnessing the energy of
electron transport to pump protons (complex IV coupling). The PMF powers the
synthesis of ATP by the F1FO ATP synthase. PMF also supports protein
translocases and metabolite carriers, and is dissipated by proton leaks. The yield
of ATP synthesis relative to oxygen consumption reflects the coupling of
oxidation and phosphorylation (OXPHOS coupling). Mitochondrial ATP synthesis
relative to oxygen consumption in respiring cells and tissues is also referred to as
respiration efficiency. OXPHOS coupling is variable; it is influenced by many
factors including ETC activity, proton leak, ATP demand, and expression of
tissue-specific and condition-specific OXPHOS enzyme isoforms (Kadenbach
and Merle, 1989, Gouspillou et al., 2011, Liu and Barrientos, 2013, Sinkler et al.,
2017, Salin et al., 2018). Improved respiration efficiency can promote hypoxic
survival of cells and tissues and provide a competitive advantage to organisms.
Thus, the OXPHOS coupling in isolated mitochondria and on a cellular level is
relevant and contributes to the fitness of multicellular organisms.
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5.1. The role of Rcf1 and Rcf2 in respiratory efficiency.

5.1.a. The role of Rcf1 and Rcf2 in respiratory growth.

Respiration inefficiency in the yeast Saccharomyces cerevisiae is detected
by slower or absent growth on non-fermentable carbon sources (e.g. glycerol,
ethanol). Yeast mutants with defective OXPHOS capacities can be analyzed
without losing viability on fermentable non-repressing carbon sources, such as
galactose.
Yeast Rcf1 and Rcf2 are both needed to support optimal respiratory
growth, which has previously been interpreted as evidence of the overlapping
function(s) of these proteins (Strogolova et al., 2012). A more complete
characterization of the functions of these proteins represents the goal of this
study. Respiration-based growth of single Δrcf1, Δrcf2, and double Δrcf1;Δrcf2
mutants was compared, with the goal of characterizing which aspects of
OXPHOS function, if any, were affected in the absence of Rcf1 and/or Rcf2.
Genetic deletion of Rcf1 in the W303 background strongly decreased
complex IV protein levels, yet Δrcf1 strain displayed almost normal growth on
non-fermentable carbon sources under optimal aerobic growth conditions (30˚C,
21% O2) on agar and in liquid media. Despite having less complex IV, the rate of
cellular oxygen consumption was not strongly decreased in the Δrcf1 mutant, and
the Δrcf1 mitochondria exhibited basal (state 2) oxygen consumption rates
(OCR) similar to those of the wild-type mitochondria. Kinetic analysis of state 2
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respiration however indicated that the OCR slightly increased over time,
suggesting that the IM may have a proton leak when ETC function was induced
in the absence of Rcf1. The respiration-based growth of the Δrcf1 strain was not
more sensitive than wild type strain to nigericin, a H+ ionophore that dissipates
PMF ΔpH component and uncouples OXPHOS. The growth of Δrcf1 strain was
sensitive to suboptimal oxygen and temperature conditions (21˚C, 21% O 2; 37˚C,
21% O2; and 21˚C, 2% O2). This observation is consistent with previous reports
(Vukotic et al., 2012, Strogolova et al., 2012) and indicates an OXPHOS defect
that does not strongly limit respiration-based growth.
We report here that genetic deletion of Rcf2 moderately decreased
complex IV protein levels and had no noticeable impact on respiratory growth
under optimal conditions. Respiration-based growth of Δrcf2 mutant was,
however, slowed down when performed in liquid media or under limiting oxygen
concentration, or in presence of low concentration of nigericin. To compensate
for partial dissipation of ΔpH component of PMF by nigericin, the ETC has to
pump more protons, so that ΔpH is quickly converted to Δψ by activity of
electroneutral H+/ion transporters, and PMF increases (Lambert and Brand,
2004). Defective proton pumping is expected to cause nigericin sensitivity.
Furthermore, despite having almost normal levels of complex IV, Δrcf2 cells
exhibited significantly elevated rate of cellular oxygen consumption which, in
contrast to the Δrcf1 mitochondria, was stable over time. A similar increase in
basal respiration was also observed in isolated Δrcf2 mitochondria. These results
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reveal that deletion of Rcf2, similar to Rcf1, causes sub-threshold OXPHOS
defect, apparently resulting in respiratory uncoupling in vivo.
The Δrcf1;Δrcf2 mutant displays a stronger respiratory growth defect than
either of the single mutants. Our lab was the first to characterize the Δrcf1;Δrcf2
mutant and to demonstrate the adverse effect of deleting both Rcf1 and Rcf2
(Strogolova et al., 2012). The work presented in this dissertation continues the
characterization of this yeast mutant lacking both Rcf1 and Rcf2. Deletion of Rcf2
in Δrcf1 background severely impaired the respiration-based growth. However, it
did not further decrease complex IV levels and the electron transport; they were
found to be decreased to a similar extent in the isolated Δrcf1 and Δrcf1;Δrcf2
mitochondria. As shown here, Δrcf1;Δrcf2 cellular oxygen consumption was
similar to that of the Δrcf1, however, an enhanced instability of state 2 OCR was
observed relative to that described earlier for the Δrcf1 mitochondria. The results
presented in this dissertation indicate that the growth defect of the Δrcf1;Δrcf2
mutant cannot be solely attributed to a decreased content of complex IV or
decreased electron transport activity.

5.1.b. Rcf1 and Rcf2 promote efficient OXPHOS coupling

Mitochondrial ETC and ATP synthesis activities are interdependent and
coupled by the PMF. OXPHOS coupling is defined as optimal stoichiometry of
the oxidation and phosphorylation activities.
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As reported here, Δrcf1 and Δrcf1;Δrcf2 mitochondria were similar in the
levels of ETC enzymes complex III and complex IV. Electron transport activity of
complex III in the Δrcf1;Δrcf2 mitochondria was not adversely affected; complex
III activity was even increased in the absence of Rcf1 and Rcf2 proteins. How is
the observed respiratory growth defect observed in the Δrcf1;Δrcf2 strain, but not
in the Δrcf1 strain explained? Multiple lines of evidence indicate that the
OXPHOS coupling and PMF generation were decreased in Δrcf1, Δrcf2, and
Δrcf1;Δrcf2 mitochondria. First, complex IV activity, which is constrained by the
PMF, appeared less constrained in Δrcf1, Δrcf2, and Δrcf1;Δrcf2 mitochondria.
This was evidenced by decreased stimulation of OCR by the PMF-dissipating
uncoupler, CCCP. Indeed, direct measurements of membrane potential
component of the PMF indicate it was reduced in Δrcf1, Δrcf2, and Δrcf1;Δrcf2
mitochondria compared to wild-type control. Reduced PMF is less able to
constrain complex IV oxygen consumption and explains elevated basal oxygen
consumption in the absence of Rcf1 and Rcf2, relative to their complex IV aa3
content.
Furthermore, uncoupling was progressive as electron transfer was
occurring in Δrcf1;Δrcf2 mitochondria, as demonstrated by the continuous
increase in state 2 OCR over time when NADH was used as a substrate (as
mentioned earlier, a similar but less prominent trend was observed in Δrcf1 state
2 OCR). Increasing state 2 OCR over incubation time indicates either increasing
proton leak and/or an inability of proton pumping to counteract it, indicating that
the absence of Rcf1 may be correlated with a proton leak of the IM. The OCR
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remained elevated and PMF remained low in Δrcf1;Δrcf2 mitochondria for a
significantly extended time after the ADP addition (delayed state 4), relative to
the wild type control. The finding that the instability of state 2 OCR was more
pronounced when Rcf2 deletion was combined with Rcf1 deletion, suggests that
the effect of Rcf1 and Rcf2 deletion is cumulative, consistent with a proton leak
observed in the absence of Rcf1 combined with reduced proton-pumping ability
of complex IV in the absence of Rcf2 is absent.
This study is the first time that a role of Rcf1 and Rcf2 in mitochondrial
PMF homeostasis has been described. Consistent with the decreased PMF, ATP
synthesis was impaired in Δrcf1, Δrcf2 and Δrcf1;Δrcf2 mitochondria. The
addition of increasing concentrations of ADP to the Δrcf1;Δrcf2 mitochondria
minimally stimulated the OCR (ETC) activity. Compared to Δrcf1 or Δrcf2
mitochondria, the Δrcf1;Δrcf2 mitochondria had the largest ATP synthesis defect
(45% of WT). This defect was apparent when 100 µM ADP was added, below
physiological levels of ADP in the mitochondria, estimated to be >200 µM (Gout
et al., 2014). The cumulative effect of Rcf1 and Rcf2 deletion on the PMF and
ATP synthesis may explain why Δrcf1;Δrcf2 strain unlike the Δrcf1 strain, exhibits
a respiration-based growth defect.
The pH component of the PMF is influenced by cytoplasmic pH and ATP.
ATP generated by glycolysis and fermentation can support mitochondrial
membrane potential in OXPHOS deficient cells (reference). The interplay of
cytosolic and mitochondrial pH is important for cellular pH homeostasis; this is
evidenced by the connection between vacuolar pH and mitochondrial function
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(Hughes and Gottschling, 2012). Future work is needed to evaluate the effect of
Rcf1 and Rcf2 deletion on mitochondrial PMF in vivo and address the
consequences of respiration-based deficiency caused by Rcf1 and Rcf2
deficiency on cellular pH homeostasis, for example during growth in basic or
acidic media.

5.1.c. Rcf1 and Rcf2 support CL binding proteins AAC and Atp9

In addition to PMF-dependent phenotypes, some of the differences
observed in Δrcf1;Δrcf2 mitochondria (altered native AAC gel mobility, decreased
F1Fo ATP hydrolysis levels, lower sensitivity of respiratory growth to oligomycin)
do not appear to be directly related to lower PMF. All of OXPHOS enzymes have
lipids as integral components, including F1Fo ATP synthase and AAC, which bind
cardiolipin (CL) and other lipids. These differences may be due to a more general
role of Rcf1 and Rcf2 in the delivery of phospholipids to OXPHOS proteins.
Although total mitochondrial lipid composition is not altered by the absence of
Rcf1 and Rcf2 (Garlich et al., 2017), these proteins may play a role in lipid
association with transmembrane proteins, such as Cox3 or AAC, or lipid
distribution between protein complexes of the IM. The Arg67 and Trp68 residues
within the QRRQ motif resemble the Arg433 and Trp434 residues of the
mitochondrial IM protein Mic60, which have been shown to be critical for Mic60’s
lipid binding properties (Hessenberger et al., 2017). Rcf1 and Rcf2 propensity for
lipid binding has not been examined to date; however, their interactome (Cox3,
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Cytc1, Qcr6, AAC) contains almost exclusively lipid binding (specifically
cardiolipin (CL) binding) proteins (Strogolova et al., 2012, Garlich et al., 2017, J.
Garlich, PhD dissertation). A number of phenotypes have been observed in RCFdeficient yeast mitochondria: lower detection of ATP synthase Atp9 subunit,
decreased rate of F1Fo-ATP hydrolysis, decreased sensitivity of ATP synthase to
oligomycin, altered AAC mobility on BN-PAGE consistent with loss of CL
molecules. These varied phenotypes in absence of RCF proteins could possibly
be related to altered lipid composition of the F1FO ATP synthase and AAC
complexes.
Like Cox3, Atp9 subunit of the Fo sector of the F1Fo-ATP synthase is a
mitochondrially encoded lipid-binding OXPHOS subunit that binds CL. Although
we did not detect Atp9-Rcf1/2 interaction, we report here that Atp9 steady state
levels were decreased in Δrcf1;Δrcf2 mitochondria. However, a corresponding
decrease in the assembled F1Fo-ATP synthase (on a BN-PAGE) was not
detected. This may be due to altered solubilization or oligomerization
stoichiometry of Atp9 preventing its detection by SDS-PAGE (Atp9 forms a
homooligomeric ring of the Fo sector and thus an altered stoichiometry of Atp9
within the Fo sector in principle is possible). Atp9 is the site of F1Fo-ATP synthase
oligomycin binding and inhibition (Symersky et al., 2012). As reported here, Δrcf1
and Δrcf1;Δrcf2 mutants exhibited decreased senstivity to oligomycin, which may
be attributable to altered Atp9 conformation or CL binding, or to an increase in
F1FO ATP synthase independent ATP synthesis. Interestingly, interaction of Atp9
with complex IV assembly intermediates containing also Rcf1 (McStay et al.,
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2012, Su et al., 2014) was reported recently, and proposed to accelerate Atp9
ring formation. These observations raise the possibility that Rcf1 may interact
with Atp9 and possibly influence Atp9 CL binding.
CL molecules are critical to mitochondrial function. Lipid-protein
interactions “seal” the transmembrane OXPHOS enzymes and mediate lateral
proton currents between supercomplex III-IV and ATP synthase (Haines and
Dencher, 2002, Mehdipour and Hummer, 2016, Sjöholm et al., 2017), supporting
ΔpH homeostasis. CL is important for complex IV stability and proton pumping
(discussed in more detail in the section 5.1.e); and association of CL with ATP
synthase is important to support its rotation in the IM and prevent proton leak
(Duncan et al., 2016). Therefore, altering CL distribution and/or tight association
with protein complexes interferes with OXPHOS and with PMF generation.
Notably, screening of yeast deletion library for nigericin hypersensitive mutants
indicated that deletion of CRD1 (CL synthase) confers hypersensitivity to
nigericin (Jakubkova et al., 2016), a phenotype which we also observed in the
Δrcf2 strain. Genetic deletion of CL synthase decreases OXPHOS coupling,
characterized by increased state 2 OCR and lower Δψ (Baile et al., 2013);
removal of cardiolipin (CL) also destabilizes complex IV (Sedlák and Robinson,
2015). OXPHOS de-coupling and specifically sensitivity of Δrcf2 to nigericin
reported in this dissertation study may be related to an altered CL distribution
between OXPHOS complexes.
Interestingly, recent therapeutic use of cell-penetrating aromatic-cationic
peptides containing just a few amino acids, that selectively target cardiolipin and
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increase coupling efficiency, and reportedly promote tissue regeneration (Szeto
and Schiller, 2011, Szeto and Liu, 2018). These short peptides (Szeto-Schiller
peptides) are proposed to bind CL and prevent its peroxidation, which plays a
role in CL loss with age and ensuing mitochondrial dysfunctions. Intriguing
possibility that Rcf1 and Rcf2 may bind CL raise a possibility for a similar role for
Rcf1 and Rcf2 in yeast mitochondria. Future experiments are needed to explore
possible Rcf1 and Rcf2 lipid-binding properties, and may utilize Rcf1 or Rcf2
truncations, including perhaps an extreme truncation, QRRQ motif alone.

5.1.d. Rcf1 and Rcf2 influence PMF dependent protein translocation

In addition to decreased ATP synthesis, PMF is essential for the import of
nuclear-encoded and insertion of mitochondrially-encoded OXPHOS proteins into
the inner membrane (IM). Results presented here indicate that reduced PMF in
the absence of Rcf1 and Rcf2 interferes with these processes.
We looked at the proteolytic processing state of a number of mitochondrial
proteins, because for many proteins, these maturation events are supported
through the mitochondrial PMF. We first detected two forms of Mcr1, which is
sorted into an outer membrane (OM) anchored larger form (Mcr34) or an IMS
localized smaller form (Mcr32) which is proteolytically matured by Imp1 peptidase
at the IM surface (Schneider et al., 1991). Formation of Mcr32 requires import of
the N-terminal region of the protein across the IM in a Δψ dependent manner
(Hahne et al., 1994, Haucke et al., 1997). In the absence of Rcf1 and Rcf2,
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formation of Mcr32 was not impaired, rather, it was even increased in Δrcf1;Δrcf2
mitochondria relative to the wild type control.
Another protein, Ccp1, also displayed altered proteolytic maturation when
Rcf1 was missing. Ccp1 is matured by Pcp1 peptidase in a manner which
involves the activities of the Yta10/12 proteins, which are thought to dislocate
cleavage site of the Ccp1 from the lipid environment of the IM to a soluble
environment of the peptidase (Tatsuta et al., 2007). This process was adversely
affected in the absence of Rcf1.
Finally, the maturation of the mitochondrially encoded Cox2 precursor
(pCox2) was also partially impaired in the absence of Rcf1/Rcf2. Cleavage of the
N-terminal presequence of pCox2 by Imp1 requires export of N-terminus to the
IMS, a process supported by both Δψ and ΔpH (Herrmann et al., 1995).
Collectively, whether these various processing defects are indications of a
lowered PMF or an imbalance of Δψ and ΔpH, is unknown. Yet, these observed
defects serve to further illustrate the pleiotropic nature of the defects caused by
the absence of Rcf1 and Rcf2.

5.1.e. Possible complex IV proton pumping defect.

How could Rcf1 and Rcf2 support PMF maintenance? The results
presented in this dissertation study indicate that, in the absence of Rcf1 and
Rcf2, not only complex IV protein content but also its ability to transfer protons
was impaired. Complex IV is the primary proton pump (there is no complex I in
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yeast mitochondria; complex III is not a proton pump and contributes to PMF
generation via a redox loop mechanism with constant stoichiometry). The data
presented here indicate that Δrcf1 mitochondria had lower PMF; the decrease
could be attributed to the decreased complex IV levels. However, the Δrcf2
mitochondria had complex IV levels similar to wild type mitochondria and
elevated oxygen consumption; yet Δrcf2 mitochondria exhibited lower PMF than
wild type mitochondria. The comparison of Δrcf1 and Δrcf1;Δrcf2 mitochondria
show that the removal of Rcf2 resulted in progressive OXPHOS uncoupling and
inability to repolarize after ADP addition, without noticeable changes in complex
IV levels and electron transport activity. Thus, Rcf2 plays an important role in
PMF maintenance and repolarization, possibly regulating complex IV proton
pumping. This hypothesis is corroborated by the findings of our collaborators
(Ngoc Hoang and Jonathan Hosler at the University of Mississippi Medical
Center). Using TMPD/ascorbate to simultaneously measure OCR and membrane
potential generated by bioenergetically isolated complex IV, they confirmed a
complex IV proton translocation defect in intact Δrcf2 and Δrcf1;Δrcf2
mitochondria, indicating that the proton pumping capacity of complex IV is
impaired when Rcf2 is absent (Strogolova et al., manuscript in preparation).
Complex IV proton pumping can be de-coupled from electron transport
and oxygen consumption. Proton pumping is driven by the redox energy released
during the transport of electrons and is constrained by the PMF (Nicholls and
Ferguson, 2013). However, at least under some conditions, complex IV can
consume oxygen without pumping protons. Such de-coupling was reported in

136

purified bacterial cytochrome c oxidase and in mammalian tissues (Brzezinski
and Johansson, 2010; Kadenbach, 2003). One mechanism for de-coupling could
be a proton back-leak pathway identified in the bovine complex IV enzyme
(Muramoto et al., 2010). This pathway is postulated to be conformationally gated,
and similar slipping of protons was reported in the homologous E.coli enzyme
cytochrome bo3 (Li et al 2015).
Loss of proton pumping in a catalytically active cytochrome c oxidase is a
hallmark of the suicide inactivation phenomenon (Bratton et al., 1999, Gilderson
et al., 2003, Hosler, 2004). This phenomenon was first characterized in the
purified bacterial enzyme and was attributed to a loss of subunit 3 (Cox3)
(Bratton et al., 1999). Suicide inactivation is a sequence of events initiated by
structural changes in the binuclear center (BNC) formed by heme a3 and copper
CuB physically associated with the Cox1 subunit. These changes lower the redox
potential of the BNC, resulting in a loss of proton pumping, followed by the loss of
copper CuB and inactivation of electron transport. Although Cox3 does not
directly participate in electron transport, it is intimately associated with and
influences the activity of Cox1. Cox3 displays sequence conservation as high as
that of the catalytic subunit Cox1, indicating that it is likely to be highly important
for facilitating proton uptake and pumping (Penttilä 1983, Varanasi and Hosler
2012). Cox3’s interaction with Cox1 is supported by phospholipid molecules (CL
and phosphatidylglycerol) (Bratton et al., 1999). These lipids are essential for
complex IV structural stability (Musatov and Robinson, 2012, Musatov and
Robinson, 2014) and are suggested to play a role in channeling oxygen to the
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catalytic center of the enzyme (Penttilä 1983, Mills and Hosler 2005, Varanasi
and Hosler 2012). Suicide inactivation of cytochrome c oxidase may thus involve
changes in Cox3’s position relative to Cox1 and associated lipids.
Rcf1 and Rcf2 associate with a subpopulation of complex IV in the
mitochondria and likely are regulating its conformational dynamics. Evidence for
heterogeneity of complex IV, i.e. that two or more distinct subpopulations of
complex IV exist in mitochondria, has been published (Moody et al., 1991,
Rydström Lundin et al., 2016). These complex IV subpopulations display
differences in EPR spectra, cyanide binding, CO binding, and dithionite reduction
kinetics. In the absence of Rcf1 or Rcf2, the heterogeneity of complex IV is
reported to increase, shifting the balance to a greater proportion of a minor
subpopulation with a lower redox potential of the BNC (Rydström Lundin et al.,
2016, Rydström Lundin and Brzezinski 2017, Schäfer et al., 2018), and redox
potential of the BNC determines proton pumping capacity of the enzyme
(Sharma and Wikström, 2014). Therefore, it is likely that a subpopulation of
complex IV that does not pump protons becomes more abundant in the absence
of Rcf1 or Rcf2. Rcf1 and Rcf2 proteins may serve to influence complex IV
enzyme proton pumping function and/or acting to counteract complex IV
instability, which may lead to the suicide inactivation of the enzyme.

5.2. Model: Rcf1 and Rcf2 repair or remodel complex IV to increase
complex IV proton-pumping efficiency.
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We propose that Rcf1 and Rcf2 regulate complex IV proton pumping
ability by ensuring the correct conformation of Cox3 subunit and/or associated
lipid (CL) molecules and this may play an active role in repairing the complex IV
enzyme to prevent it’s premature and irreversible suicide inactivation. While
many assembly chaperones of Cox1 and Cox2 are known, Rcf1 was the first
protein to act as an assembly partner of Cox3 (Strogolova et al., 2012).
Additionally, we propose that Rcf1 through its Arg65 and Trp66 residues located
within its conserved QRRQ motif at the turn between the two transmembrane
helices may bind lipid head groups near the membrane interface. Rcf1
transmembrane helices flanking the QRRQ motif structurally resemble the lipid
binding cleft of Cox3 (Zhou et al., 2018, J. Hosler, personal communication).
Rcf1 is proposed to mediate Cox3 lipidation and correct assembly into the
complex IV enzyme (Figure 20). Consistent with its participation in the complex
IV assembly and/or restructuring, Rcf1-associated complex IV is missing late
assembling subunits Cox12 and Cox13 (Garlich et al., 2017).
We further propose that Rcf1 and Rcf2 play a role in repair of partially
inactivated complex IV subpopulation (i.e. possibly undergoing suicide
inactivation) as a consequence of normal catalytic activity (Figure 20). As
discussed earlier, data to indicate the existence of a partially inactive complex IV
subpopulation (i.e. that does not pump protons) that is naturally present in
mitochondria and is increased in the absence of Rcf1 or Rcf2, has been
published (Rydström Lundin et al., 2016, Rydström Lundin and Brzezinski 2017,
Schäfer et al., 2018). Partial inactivation of complex IV may result in its
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Figure 20. Proposed function of Rcf1 and Rcf2 in complex IV (cytochrome c oxidase)
repair/remodeling. Assembly of complex III and IV subunits (red) together to form a
supercomplex III2IV1-2 is completed by joining of peripheral subunits (e.g. Cox12). For
simplicity,only complex III and complex IV is depicted. Rcf1 (blue) assists complex IV subunit 3
(Cox3) assembly into the supercomplex. Catalytic activity or oxidative stress changes complex IV
conformation (or result in damage, e.g. lipid peroxidation) which bring about changes in Cox1Cox3 interface (black line) and loss of proton pumping activity. The loss of proton pumping
activity leads to complex IV degradation. Rcf1 recognizes and interacts with the subpopulation of
supercomplex with impaired proton pumping. Association of Rcf1 stabilizes complex IV,
preventing its degradation. Rcf2 initiates repair/remodeling of Rcf1-associated enzymes. Rcf1
and Rcf2 repair the supercomplex, replacing lipids and/or changing conformation of Cox3.
Complete repair restores proton pumping activity to complex IV and supports its steady state
levels.
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proteolytic turnover, unless it is repaired. Suicide inactivation of cytochrome c
oxidase due to changes in Cox3 relationship with Cox1 may involve the
associated lipids. Oxidative stress damage to CL (e.g. peroxidation) inactivates
complex IV (Paradies et al., 1998). It is unknown whether the lipids associated
with Cox3 are displaced or damaged and thus need to be repositioned and/or
exchanged during the natural lifespan of the complex IV enzyme. Overall, little is
known about complex IV repair or remodeling (Sinkler et al., 2017). A previously
hypothesized Rcf1 modification of complex IV lipid composition (Garlich et al.,
2017) is proposed to support complex IV proton pumping and prevent complex IV
degradation considering the aforementioned role of lipids at the Cox1-Cox3
interface, in complex IV proton pumping and stability.
A repair role for Rcf1 and Rcf2 is consistent with the dynamic nature of
their interaction with complex IV and supercomplex III-IV and explains the partial
inactivation of complex IV from Δrcf1 mitochondria previously reported (Rydström
Lundin and Brzezinski, 2017). As reported here, proton-pumping activity of
complex IV but not its stability in Δrcf2 mitochondria appears to be negatively
affected. Rcf2 interaction with complex IV is less well characterized. Our lab
previously reported (i) that Rcf1 and Rcf2 associate with complex IV
independently; (ii) the association of Rcf1 with complex IV is stronger than Rcf2
(as indicated by its retention with complex IV when solubilized with a more
stringent detergent); however, lower level of complex IV are recovered with Rcf1
than with Rcf2, and (iii) Rcf2 successfully competes with Rcf1, as the absence of
Rcf2 promoted more Rcf1-complex IV interaction (Strogolova et al 2012). Based
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on this information, we propose that Rcf2 association may complete the repair
and stimulate the dissociation of Rcf1 from the enzyme (Figure 20).
Consequently, when Rcf2 is absent we propose that complex IV enzyme that has
defective proton pumping capacity accumulates in the mitochondria.
We speculate that both Rcf1 and Rcf2 play a role in repairing complex IV
proton pumping. Rcf1 or Rcf2 alone may complete the repair process but less
effectively. Rcf1 is speculated to play a role in stabilization of partially inactive
complex IV (e.g. containing damaged/oxidized CL molecules). In the absence of
Rcf1, the partially inactive complex IV would be proteolytically degraded,
contributing to the reduced levels of complex IV in the absence of Rcf1. In the
absence of Rcf2, partially inactive complex IV is stabilized and can contribute to
oxygen consumption activity, albeit with reduced proton pumping capacity. The
action of Rcf2 in the repair beyond promoting Rcf1 dissociation, deserves further
future investigation. According to the model shown in Figure 20, when both Rcf1
and Rcf2 are removed, complex IV is not repaired, the result is lower levels of
complex IV combined with a gradual loss of its proton pumping capacity.
The hypothesis that Rcf1 and Rcf2 restore the proton-pumping activity of
complex IV can be tested by stimulating complex IV and CL damage with
conditions known to stimulate oxidative stress or hypoxic conditions, which in
mammalian mitochondria are also linked to reactive oxygen species generation
and elevated oxidative damage.
Future studies by our collaborators will be focused on characterizing
proton pumping of complex IV purified from Δrcf1;Δrcf2 mitochondria. Moreover,
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further studies should be done to characterize its lipid composition. Functional
consequences of Rcf1 and Rcf2 deletion on other OXPHOS and non-OXPHOS
processes should be explored in future experiments. For this purpose, a
Δrcf1;Δrcf2 strain lacking complex IV will be generated by deleting complex IV
assembly factors (Cox10 or Cox11). Similarly, the effects of Rcf1 and Rcf2
deletion on complex IV function in absence of complex III could be studied in a
similarly constructed strain lacking complex III (Δrcf1;Δrcf2;Δcor1).

5.3. The overall importance of HIGD proteins

We propose that yeast HIGD proteins Rcf1 and Rcf2 regulate the coupling
of electron and proton transfer activity of complex IV, possibly by interaction with
negatively charged CL molecules integral to complex IV enzyme. We anticipate
that this function be evolutionarily conserved in homologous HIGD proteins in
mammalian mitochondria and in bacteria.
Cytochrome c oxidase (complex IV) is an A-type enzyme of the bacterial
heme copper oxidase family, postulated to have evolved later than the closely
related B and C type enzymes. The evolution of heme copper oxidases
corresponds to the time when oxygen concentration increased in the
atmosphere, when heme copper oxidase enzyme family evolved from nitric oxide
reductase family, and likely performed an oxygen scavenging function (Sharma
and Wikström, 2014). Proton pumping is not central to cytochrome oxidase
family; enzymes of B and C type are inefficient in proton pumping and are leaky
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to protons even at a low PMF (Rauhamäki and Wikström, 2014). Evolution of
proton pumping D-channel in A-type enzymes supported more efficient proton
pumping and aerobic energy generation. A-type enzymes are widely
phylogenetically distributed and are present in all α-proteobacteria lineages
(Sousa et al., 2012). Proteins with homology to the HIGD are also found in
bacteria and appear to be limited to α-proteobacteria. It is possible that the αproteobacteria HIGD protein homologs function similarly to yeast Rcf1 and Rcf2
and support more efficient proton pumping of A-type cytochrome c oxidases and
aerobic energy generation.
HIGD protein homologs in mammalian mitochondria are subdivided into
constitutively expressed type 2 isoforms and stress-inducible type 1 isoforms,
and classification is largely based on differences in the HIGD QRRQ motif
(Figure 3A). Verification of the importance of conserved cationic amino acids of
the QRRQ motif for PMF generation is beyond the scope of the current study, but
should be addressed in the future, because mutations in HIGD motif sequence
can strengthen or weaken association of Rcf1 with complex IV (Garlich et al.,
2017). Therefore, HIGD QRRQ motif sequence may be a conserved feature
providing the means to influence association of HIGD proteins with complex IV
and thus have an impact on coupling of electron and proton transfer activity of
complex IV.
The type 2 HIGD proteins contain a canonical QRRQ motif sequence,
QX3RXRX3Q, i.e. similar to the QRRQ motif of yeast Rcf1 and Rcf2. Highest
level of expression of these isoforms are in heart, kidney and leukocytes tissues
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(An et al., 2011). The functional relevance of the mammalian mitochondria type 2
HIGD proteins have not yet been studied. The QRRQ motif of the type 1 HIGD
proteins displays sequence variation, this class of HIGD protein isoforms contain
a V/IHLIHMRX3Q sequence. Highest level of expression of these isoforms are in
brain and heart tissues (Wang et al., 2006, An et al., 2011) The mammalian type
1 HIGD proteins have been shown to associate with isolated mammalian
complex IV and can accelerate electron transfer (Hayashi et al., 2015). The effect
of these type 1 proteins on proton pumping capacity of the complex IV is,
however, unknown. Yeast do not have type 1 HIGD proteins and when
expressed in yeast, type 1 proteins did not associate with complex IV or support
respiratory growth of the Δrcf1;Δrcf2 mutant, suggestive of a divergent function of
type 1 and type 2 proteins (Strogolova et al., 2012, Garlich et al., 2017, J. Garlich
PhD dissertation).
We envision that the HIGD proteins in mammalian mitochondria may
associate with complex IV and increase or decrease the of proton-pumping
capacity. Mammalian mitochondria exhibit great physiological plasticity.This
plasticity requires uncoupling, for example when stress or Ca2+ concentration
cause PMF fluctuations, ΔpHm increase, and associated ROS production by
mammalian mitochondrial complex I enzyme (Lambert and Brand, 2004).
Phenotypes observed in mammalian cells in the absence of specific HIGD
isoforms – changes in mitochondrial morphology, increased cell death, sensitivity
to hypoxia and oxidative stress – are all phenotypes adversely affected by
alterations in PMF. Increased complex IV proton pumping counteracts proton
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leak and supports OXPHOS ATP synthesis on which differentiated, respiring
mammalian cells depend for survival, especially under conditions of
hypoxia/ischemia. On the other hand, de-coupling of complex IV electron
transport from proton pumping may also be physiologically relevant under certain
metabolic and/or growth conditions, i.e. in tissues are dependent on glycolytic
rather than OXPHOS metabolism. This includes undifferentiated stem cells,
which depend on uncoupling of OXPHOS to preserve pluripotency (Zhang et al.,
2012). Thus under these conditions it may be advantageous for the cell to have a
mitochondrial complex IV enzyme with a disengaged proton pumping capacity.
The mechanisms of uncoupling of OXPHOS in undifferentiated stem cells are
unexplored and the expression and function of HIGD isoforms in stem cells have
not yet been addressed.
Uncoupling of complex IV may serve to accommodate activity of nonOXPHOS intermembrane space (IMS) cytochrome c reducing enzymes, such as
Erv1/Mia40 protein translocation disulfide relay system, cytochrome c
peroxidase, or cytochrome b2. The activity of these cytochrome c reducing
enzymes is supported by the re-oxidation of their substrate cytochrome c by
complex IV. A high PMF that inhibits complex IV and thus cytochrome c reoxidation would inhibit these enzymes’ activity. Decreasing the stringency of
complex IV proton pumping may allow it to re-oxidize cytochrome c under
conditions of high PMF. The Erv1/Mia40 import pathway is essential for cell
viability and must occur even during OXPHOS suppression.
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The work presented here indicates that the Rcf1 and Rcf2 proteins,
members of the HIGD type 2 protein family, support mitochondrial PMF
generation, possibly through repairing of a partially inactive complex IV.
Additional evidence presented here add support to the suggestion that the
function of Rcf1 and Rcf2 may be related to incorporation and/or restructuring of
lipid molecules which are physically and functionally associated with components
of the mitochondrial OXPHOS system. It is important to continue deciphering the
function of HIGD protein family and the mechanisms underlying the protective
effect of the HIGD type 1 proteins in vulnerable populations such as neurons and
pancreatic cells. Recent successful use of hypoxia as a therapy for mitochondrial
disease raises the possibility that the expression of HIGD proteins may be a
promising therapeutic strategy as well.
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